data_1g9p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1g9p _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.986 0.422 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.92 27.69 49.08 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.85 8.76 33.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.475 -1.015 . . . . 0.0 110.404 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.14 -5.66 70.86 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.109 -0.995 . . . . 0.0 111.068 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -125.2 140.39 52.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.134 -1.215 . . . . 0.0 109.423 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.27 165.18 33.77 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.77 0.795 . . . . 0.0 110.862 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.44 -26.48 11.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 p -147.32 -177.97 5.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.0 -36.51 82.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.441 -0.787 . . . . 0.0 109.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -68.41 -10.22 53.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.429 -0.794 . . . . 0.0 110.913 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -89.05 14.54 10.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -115.68 -170.85 1.86 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 m -115.92 -176.51 2.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -49.19 77.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.532 -0.73 . . . . 0.0 110.133 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tt -55.15 -23.85 23.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.435 -0.791 . . . . 0.0 110.228 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -132.7 86.97 42.68 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.74 6.75 4.67 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.934 2.423 . . . . 0.0 112.068 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.8 p -126.12 147.83 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.057 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.4 t -123.94 97.35 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.39 144.0 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.643 -0.661 . . . . 0.0 110.003 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 59.69 35.85 22.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.652 . . . . 0.0 110.025 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.4 28.21 64.38 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -140.35 166.25 25.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.977 . . . . 0.0 109.27 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.3 m -108.19 138.78 43.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 20.0 m . . . . . 0 N--CA 1.484 1.273 0 O-C-N 121.506 -0.746 . . . . 0.0 109.055 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.4 34.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.44 11.77 20.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.427 -1.043 . . . . 0.0 110.293 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.74 -4.78 72.65 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -125.43 136.87 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.57 1.185 . . . . 0.0 109.213 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.2 p -150.72 170.67 18.66 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.73 0.776 . . . . 0.0 110.84 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -117.09 -6.25 11.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.3 p -166.68 173.08 9.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.89 -37.97 86.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 109.974 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -68.4 -10.67 56.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.424 -0.798 . . . . 0.0 110.975 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.61 15.13 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.276 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.8 m -117.42 -170.9 1.94 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.091 -1.006 . . . . 0.0 109.93 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.3 m -115.74 -177.27 3.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.25 -49.1 78.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 mt -54.85 -25.31 27.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.118 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.5 p -131.74 86.74 47.6 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.46 6.16 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.915 2.41 . . . . 0.0 112.089 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.9 p -125.78 145.98 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.03 -1.044 . . . . 0.0 110.803 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -127.05 148.41 50.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.726 -0.609 . . . . 0.0 109.985 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 59.59 33.02 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.706 -0.621 . . . . 0.0 109.934 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.87 72.37 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -144.59 168.21 20.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.595 -0.944 . . . . 0.0 109.462 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.7 m -108.71 139.3 43.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 110.15 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 20.3 m . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 120.951 0.405 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.93 48.17 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -94.16 8.95 39.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.556 -0.967 . . . . 0.0 110.456 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -5.29 70.37 Favored Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.236 -0.915 . . . . 0.0 111.155 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -124.76 137.64 54.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.093 -1.24 . . . . 0.0 109.339 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 p -150.85 173.83 13.79 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.8 0.809 . . . . 0.0 110.751 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -124.11 4.26 8.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 p -175.44 170.19 3.04 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.04 -38.76 89.92 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.0 109.837 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -68.52 -10.77 57.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.772 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.79 15.38 9.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.131 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -117.58 -171.09 1.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.147 -0.971 . . . . 0.0 109.897 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -115.26 -175.98 2.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.475 -0.765 . . . . 0.0 109.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -46.09 89.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.72 -23.5 42.78 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.447 -0.783 . . . . 0.0 110.153 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.1 p -133.8 87.51 35.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.74 5.04 5.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.4 p -126.13 146.37 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.051 -1.03 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.3 t -124.59 97.34 5.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -126.62 146.67 50.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.621 -0.674 . . . . 0.0 109.855 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 60.17 33.7 21.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.615 -0.678 . . . . 0.0 109.85 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.62 29.09 68.92 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -142.39 166.76 23.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 109.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.81 140.03 42.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.45 -0.781 . . . . 0.0 110.138 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 19.4 m . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.73 30.0 27.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.98 12.4 17.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.566 -0.961 . . . . 0.0 110.283 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.12 -2.43 75.92 Favored Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.159 -0.963 . . . . 0.0 111.025 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -125.95 137.98 53.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.134 -1.215 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -150.44 166.32 30.47 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.725 0.774 . . . . 0.0 110.792 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -26.37 11.27 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -148.24 -179.47 6.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.1 -37.76 88.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 mtt-85 -67.86 -10.16 50.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.513 -0.742 . . . . 0.0 111.16 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.02 14.73 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.429 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -115.35 -172.28 2.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.085 -1.009 . . . . 0.0 109.974 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -113.99 -175.52 2.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -0.773 . . . . 0.0 109.721 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -63.31 -46.1 88.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.941 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.93 -23.32 44.38 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.447 -0.783 . . . . 0.0 110.114 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 45.4 p -132.74 86.87 42.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -77.58 5.15 5.4 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.879 2.386 . . . . 0.0 112.265 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 7.7 p -127.06 146.68 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.97 -1.081 . . . . 0.0 110.941 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.23 96.38 5.02 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -124.83 145.13 49.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.748 -0.595 . . . . 0.0 109.95 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 60.01 34.52 21.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.621 -0.674 . . . . 0.0 109.839 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.03 29.0 67.17 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -141.83 167.27 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.585 -0.95 . . . . 0.0 109.337 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.8 m -108.79 138.06 45.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.373 -0.829 . . . . 0.0 110.265 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.41 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 19.4 m . . . . . 0 N--CA 1.485 1.286 0 O-C-N 121.657 -0.652 . . . . 0.0 109.274 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 120.86 0.362 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.92 28.53 37.54 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -96.91 7.32 46.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -1.016 . . . . 0.0 110.524 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.96 -4.36 70.98 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 121.181 -0.949 . . . . 0.0 111.134 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -125.21 139.13 54.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.091 -1.241 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 p -150.44 166.08 31.22 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.687 0.756 . . . . 0.0 110.954 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.2 m -106.81 -26.44 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.2 p -148.16 -178.57 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.02 -36.69 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.409 -0.807 . . . . 0.0 109.901 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -10.58 54.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.464 -0.772 . . . . 0.0 111.016 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.86 15.55 9.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.8 m -115.5 -170.54 1.79 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.926 . . . . 0.0 109.981 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -116.38 -177.18 3.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.974 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.5 -49.61 76.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.58 -0.7 . . . . 0.0 110.241 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 tp -55.21 -23.56 22.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.7 p -132.82 88.27 38.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.0 108.955 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -80.12 7.62 4.57 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.82 2.347 . . . . 0.0 111.921 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.51 146.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.048 -1.032 . . . . 0.0 110.695 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.99 97.61 5.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -125.71 144.25 50.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.695 -0.628 . . . . 0.0 110.02 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 59.89 36.06 21.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.649 -0.657 . . . . 0.0 109.939 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.42 64.13 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -140.33 165.9 26.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.565 -0.962 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -109.04 139.1 44.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.424 -0.798 . . . . 0.0 110.24 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.39 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.16 10.59 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.85 16.08 13.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.532 -0.981 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.95 8.43 61.16 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.012 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -129.55 134.77 47.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.173 -1.192 . . . . 0.0 109.058 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.67 166.92 28.9 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.902 0.858 . . . . 0.0 111.18 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 m -106.78 -28.71 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -145.42 -177.37 5.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.25 -37.55 83.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.311 -0.868 . . . . 0.0 110.011 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.46 -10.37 50.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.39 -0.819 . . . . 0.0 111.052 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.74 15.1 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 0.0 110.321 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.6 m -114.74 -171.31 1.91 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.088 -1.008 . . . . 0.0 110.163 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.01 -179.26 3.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 110.046 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.28 -50.53 72.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.176 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -54.56 -23.99 19.07 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.353 -0.842 . . . . 0.0 110.219 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.2 p -132.42 89.08 37.51 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.92 10.33 3.69 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.875 2.383 . . . . 0.0 111.648 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.4 p -126.18 145.29 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.742 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.8 t -122.89 96.94 5.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -125.81 145.98 49.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.736 -0.602 . . . . 0.0 110.001 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 59.33 34.94 23.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.75 -0.594 . . . . 0.0 109.872 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.33 27.67 65.87 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 m -140.84 168.78 18.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.477 -1.014 . . . . 0.0 109.425 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.55 140.18 43.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 30.6 m . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.53 31.69 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -90.4 12.58 18.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.974 . . . . 0.0 110.214 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 -3.87 76.29 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.15 -0.969 . . . . 0.0 110.988 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.258 . . . . 0.0 109.405 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.43 166.26 30.65 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.813 0.816 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -106.63 -28.21 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -145.75 -177.4 5.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.79 -36.52 80.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.394 -0.816 . . . . 0.0 109.848 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -67.85 -10.47 53.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.17 14.51 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.452 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.1 m -116.49 -169.77 1.69 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -117.52 -177.57 3.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.458 -0.776 . . . . 0.0 110.352 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.17 -52.3 65.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.631 . . . . 0.0 110.227 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -52.9 -25.52 12.0 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.35 -0.844 . . . . 0.0 110.14 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.2 p -132.77 87.74 40.01 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.93 8.91 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.793 2.329 . . . . 0.0 111.675 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 12.5 p -125.66 145.0 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.2 t -122.99 96.52 5.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -125.29 146.51 49.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.609 -0.682 . . . . 0.0 109.919 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 59.9 33.64 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.601 -0.687 . . . . 0.0 109.878 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.28 29.31 71.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -143.16 168.03 20.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 0.0 109.352 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.1 m -109.61 141.45 42.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.41 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 26.3 m . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 120.967 0.413 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.68 29.01 49.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.02 9.86 35.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.522 -0.987 . . . . 0.0 110.409 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.56 72.6 Favored Glycine 0 N--CA 1.49 2.271 0 O-C-N 121.121 -0.987 . . . . 0.0 111.084 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -125.1 137.04 54.19 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.648 1.224 . . . . 0.0 109.276 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.52 165.9 31.84 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.814 0.816 . . . . 0.0 110.987 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 p -106.13 -26.95 11.38 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.56 -177.7 5.92 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.75 -35.76 80.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.431 -0.793 . . . . 0.0 109.874 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -67.95 -10.83 56.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.496 -0.753 . . . . 0.0 110.939 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.41 16.44 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 0.0 110.096 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.5 m -116.92 -170.98 1.94 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.1 m -116.89 -178.79 3.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.333 -0.854 . . . . 0.0 110.058 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -61.13 -50.74 71.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.579 -0.7 . . . . 0.0 110.143 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 tp -53.45 -24.94 14.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.33 -0.856 . . . . 0.0 110.128 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.9 p -132.67 88.88 37.08 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.66 8.77 4.37 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.803 2.336 . . . . 0.0 111.533 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 12.3 p -125.64 144.14 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.109 -0.995 . . . . 0.0 110.448 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.01 96.64 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -129.06 150.93 50.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.739 -0.601 . . . . 0.0 109.63 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 60.56 30.91 20.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.737 -0.602 . . . . 0.0 109.647 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.03 28.27 70.19 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -144.7 170.49 16.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.972 . . . . 0.0 109.484 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.6 m -109.62 141.88 41.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 110.239 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 28.2 m . . . . . 0 C--N 1.308 -1.216 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.53 28.31 33.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.8 14.05 24.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.982 . . . . 0.0 110.18 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.89 9.54 59.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -129.28 133.01 47.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.233 -1.157 . . . . 0.0 108.898 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.9 p -150.91 166.88 29.25 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -106.53 -28.23 10.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -146.53 -177.79 5.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.45 -35.55 79.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -67.97 -10.83 56.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.19 16.66 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.206 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.0 m -115.62 -171.45 1.97 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 110.304 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.8 m -113.12 177.82 4.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 109.956 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.12 -47.71 83.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.67 . . . . 0.0 109.811 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.41 -25.8 38.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 p -131.26 88.91 43.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.44 9.93 3.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.881 2.387 . . . . 0.0 111.946 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.1 p -125.6 144.41 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.067 -1.021 . . . . 0.0 110.735 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -122.76 95.81 4.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -127.34 149.98 49.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 0.0 109.759 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 59.87 32.21 21.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.721 -0.612 . . . . 0.0 109.626 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.27 28.11 68.7 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m -143.53 170.45 15.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -1.001 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.9 m -109.57 140.61 43.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.417 -0.802 . . . . 0.0 110.268 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 24.6 m . . . . . 0 C--N 1.308 -1.2 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.92 0.391 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.71 27.6 50.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.14 8.26 42.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -1.03 . . . . 0.0 110.443 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.46 -8.87 66.45 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.187 -0.946 . . . . 0.0 111.084 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -123.48 138.96 54.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -1.179 . . . . 0.0 109.37 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 p -150.07 166.66 29.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.678 0.751 . . . . 0.0 110.768 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 p -107.72 -24.87 11.54 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 p -149.96 -179.75 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.38 -35.65 81.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -68.37 -10.85 57.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.413 -0.804 . . . . 0.0 110.883 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.37 15.9 9.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.152 -0.967 . . . . 0.0 110.137 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.8 m -116.26 -170.86 1.89 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -118.21 -176.72 3.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 109.829 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.38 -48.03 81.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.608 -0.683 . . . . 0.0 109.991 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.19 -23.9 24.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.468 -0.77 . . . . 0.0 110.104 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 p -133.56 87.93 35.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.13 5.98 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.912 2.408 . . . . 0.0 112.093 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.91 146.13 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.011 -1.056 . . . . 0.0 110.831 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.6 t -124.13 96.14 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 150.26 50.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.678 -0.639 . . . . 0.0 109.802 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.29 31.62 20.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.556 -0.715 . . . . 0.0 109.72 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.33 71.51 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -144.71 169.28 18.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.975 . . . . 0.0 109.509 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.4 m -108.82 139.12 44.08 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.483 1.206 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 178.603 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 34.75 20.84 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -95.23 21.89 7.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.492 -1.005 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.59 7.13 64.1 Favored Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.382 -0.824 . . . . 0.0 111.305 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -129.8 133.67 47.11 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 118.734 1.267 . . . . 0.0 109.339 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.28 167.73 26.94 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.728 0.775 . . . . 0.0 110.987 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.1 p -106.27 -29.55 9.73 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 p -145.6 -177.4 5.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.91 -37.66 84.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 109.983 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -68.02 -9.68 47.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.415 -0.803 . . . . 0.0 111.133 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 13.91 10.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.118 -0.989 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.4 m -114.6 -171.16 1.88 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 110.065 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.1 m -112.82 179.93 3.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.745 . . . . 0.0 109.932 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.04 -47.0 88.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.627 -0.671 . . . . 0.0 109.921 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.93 -27.96 54.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.1 p -128.99 87.17 55.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -80.91 7.8 4.69 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.92 2.413 . . . . 0.0 111.909 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 13.0 p -125.3 143.41 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.061 -1.025 . . . . 0.0 110.684 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -121.97 95.77 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -121.3 143.47 49.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 110.111 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 59.16 35.35 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.802 -0.561 . . . . 0.0 109.992 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.85 29.89 71.56 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -141.64 166.4 24.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.605 -0.938 . . . . 0.0 109.295 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.54 140.23 43.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.405 -0.81 . . . . 0.0 110.446 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 22.4 m . . . . . 0 C--N 1.309 -1.155 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.88 28.88 24.88 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -91.23 11.66 22.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.607 -0.937 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.58 1.35 70.9 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.092 -1.005 . . . . 0.0 111.027 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -126.29 136.71 53.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.17 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.2 p -150.57 166.28 30.74 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.607 0.717 . . . . 0.0 110.797 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -107.25 -24.7 11.8 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p -150.04 178.79 8.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -63.36 -37.52 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -67.97 -10.47 53.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.477 -0.764 . . . . 0.0 111.099 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.35 15.8 9.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.5 m -114.28 -172.98 2.2 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 109.956 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.4 m -114.02 -175.81 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.46 -45.32 87.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.801 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.01 -20.84 41.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.254 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.7 p -133.74 88.28 33.67 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.77 4.93 5.23 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.95 2.433 . . . . 0.0 112.397 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.416 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 7.5 p -128.21 147.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.975 -1.078 . . . . 0.0 110.961 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -123.6 97.42 5.38 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -127.74 147.11 50.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.708 -0.62 . . . . 0.0 109.997 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 59.99 33.97 21.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.64 -0.662 . . . . 0.0 109.901 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.29 29.34 68.62 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -143.45 167.96 20.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.595 -0.944 . . . . 0.0 109.343 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.7 m -108.9 138.13 45.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.8 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.416 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 18.3 m . . . . . 0 N--CA 1.486 1.363 0 O-C-N 121.594 -0.691 . . . . 0.0 109.262 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.74 28.94 33.59 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -90.26 11.81 20.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.53 -0.983 . . . . 0.0 110.274 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.88 73.52 Favored Glycine 0 N--CA 1.49 2.293 0 O-C-N 121.217 -0.927 . . . . 0.0 111.162 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -126.26 136.84 53.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.059 -1.26 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -150.54 166.06 31.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.726 0.774 . . . . 0.0 110.9 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.1 m -106.19 -26.93 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -148.11 -178.94 6.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.7 -36.52 83.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 109.893 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -67.95 -10.56 54.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.983 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.79 15.69 9.32 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 110.282 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.0 m -115.46 -171.34 1.94 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.089 -1.007 . . . . 0.0 110.015 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.8 m -115.57 -178.62 3.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.54 -0.725 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.41 -49.58 76.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.665 -0.647 . . . . 0.0 110.168 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.72 -24.31 21.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.351 -0.843 . . . . 0.0 110.09 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -132.06 87.29 44.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.2 7.51 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.864 2.376 . . . . 0.0 112.123 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.9 p -126.02 145.17 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.046 . . . . 0.0 110.892 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.95 95.63 4.69 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 148.78 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.756 -0.59 . . . . 0.0 109.793 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 59.45 33.04 22.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.816 -0.552 . . . . 0.0 109.808 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.92 28.9 69.35 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -143.49 169.29 17.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.507 -0.996 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.1 m -109.13 139.05 44.54 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 20.3 m . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.002 0.429 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.1 27.78 55.26 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.4 7.65 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.431 -1.041 . . . . 0.0 110.392 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.52 -2.7 71.26 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.177 -0.952 . . . . 0.0 111.207 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.969 -1.312 . . . . 0.0 109.474 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.17 166.5 29.64 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.74 0.781 . . . . 0.0 111.092 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.99 -28.11 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -145.66 -177.96 5.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.25 -36.71 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -67.86 -10.47 53.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.98 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -88.4 14.78 8.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.362 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.6 m -115.62 -169.91 1.68 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 110.207 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 m -114.24 179.48 3.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -51.69 68.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.655 -0.653 . . . . 0.0 109.952 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.09 -25.59 13.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.392 -0.817 . . . . 0.0 109.997 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.9 p -132.24 87.9 41.86 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.12 11.22 3.34 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.819 2.346 . . . . 0.0 111.702 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -125.74 145.47 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.618 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -123.22 97.57 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.24 145.41 50.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.67 . . . . 0.0 109.944 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.12 34.9 21.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.647 -0.658 . . . . 0.0 109.827 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.79 27.94 64.97 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -140.68 167.7 21.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -1.02 . . . . 0.0 109.374 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.28 140.38 43.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.029 0.442 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.86 28.03 67.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.92 7.3 38.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.478 -1.013 . . . . 0.0 110.383 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.27 -17.22 54.96 Favored Glycine 0 N--CA 1.488 2.127 0 O-C-N 121.217 -0.927 . . . . 0.0 111.105 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 147.17 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.92 173.24 14.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 0.0 110.596 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -123.83 6.16 8.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.2 p -177.63 169.73 2.08 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.28 -39.12 91.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.367 -0.833 . . . . 0.0 109.809 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -68.88 -10.5 57.38 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.76 15.13 10.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.4 m -116.01 -171.06 1.91 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.088 -1.008 . . . . 0.0 109.874 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.6 m -114.03 -177.87 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.446 -0.784 . . . . 0.0 109.749 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.29 -48.05 81.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.64 -0.663 . . . . 0.0 110.018 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -23.6 27.28 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.387 -0.821 . . . . 0.0 110.065 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.4 p -132.93 87.7 39.43 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.15 6.15 4.89 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.772 2.314 . . . . 0.0 112.198 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.9 p -126.11 146.86 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.997 -1.064 . . . . 0.0 110.852 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -124.94 98.04 5.52 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -130.76 148.07 52.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.672 -0.643 . . . . 0.0 109.796 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 59.86 33.97 21.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.71 -0.619 . . . . 0.0 109.791 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.68 25.88 61.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 m -142.06 156.79 45.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.463 -1.022 . . . . 0.0 109.385 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -98.47 140.51 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.526 -0.733 . . . . 0.0 110.052 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 21.3 m . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.039 0.447 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.6 29.96 54.16 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' CB ' ' NH1' ' A' ' 10' ' ' ARG . 7.7 m120 -89.88 11.38 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.992 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -7.79 72.39 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.187 -0.946 . . . . 0.0 111.07 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -125.59 140.8 52.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.061 -1.258 . . . . 0.0 109.689 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -150.35 167.9 25.67 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.625 0.726 . . . . 0.0 110.81 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 t -107.45 -28.04 10.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.9 p -146.52 179.11 7.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -64.04 -38.48 91.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 109.938 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -67.81 -9.78 47.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.159 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.75 13.75 9.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.084 -1.01 . . . . 0.0 110.455 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.2 m -114.42 -168.92 1.44 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.043 -1.036 . . . . 0.0 109.928 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 m -116.67 -176.55 2.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.373 -0.829 . . . . 0.0 110.195 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.41 -51.75 68.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.656 -0.653 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.93 -24.51 16.59 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.292 -0.88 . . . . 0.0 110.11 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.1 p -133.91 88.9 31.04 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.31 9.76 3.96 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.77 2.313 . . . . 0.0 111.531 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 13.7 p -126.34 146.08 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.98 96.97 5.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 142.22 50.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.676 -0.64 . . . . 0.0 110.091 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 59.55 36.8 22.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.696 -0.627 . . . . 0.0 110.003 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.52 28.93 65.73 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -140.12 165.58 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.634 -0.921 . . . . 0.0 109.265 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -108.6 139.91 42.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.467 -0.77 . . . . 0.0 110.216 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 27.5 m . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.92 0.391 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.2 28.81 55.31 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -89.79 9.44 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.491 -1.005 . . . . 0.0 110.37 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.99 -6.6 70.17 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 121.213 -0.93 . . . . 0.0 111.276 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -124.62 139.6 53.71 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 118.694 1.247 . . . . 0.0 109.784 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 p -150.51 166.24 30.81 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.722 0.773 . . . . 0.0 110.604 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.1 m -106.3 -26.47 11.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.9 -178.65 6.48 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.88 -36.43 83.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.473 -0.767 . . . . 0.0 109.937 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.99 -10.6 54.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.497 -0.752 . . . . 0.0 111.025 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.12 15.97 9.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 110.168 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.9 m -115.38 -171.39 1.95 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.145 -0.972 . . . . 0.0 110.079 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.3 m -114.9 -178.59 3.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.055 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.31 -50.21 73.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.615 -0.678 . . . . 0.0 110.056 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mp -54.62 -24.27 20.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.354 -0.841 . . . . 0.0 110.209 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 78.4 p -131.92 88.02 42.9 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.89 8.2 4.18 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -125.86 145.41 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.02 -1.05 . . . . 0.0 110.767 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -123.96 96.38 4.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -126.0 147.18 49.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.685 -0.635 . . . . 0.0 109.946 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mtm-85 60.16 33.26 21.12 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.654 -0.654 . . . . 0.0 109.757 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.8 29.53 70.52 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -142.92 167.56 21.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.589 -0.948 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -108.68 138.68 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.494 -0.754 . . . . 0.0 110.24 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.353 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.56 27.74 46.17 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -90.28 10.98 22.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -1.047 . . . . 0.0 110.287 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.4 -3.38 73.26 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 121.187 -0.946 . . . . 0.0 111.093 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -124.53 136.34 53.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.268 . . . . 0.0 109.472 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.3 p -150.76 168.14 25.31 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.657 0.742 . . . . 0.0 110.783 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.3 m -112.5 -10.95 13.68 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -163.63 175.15 10.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.41 -37.06 84.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 109.82 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -68.31 -11.06 58.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.444 -0.785 . . . . 0.0 110.981 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 16.76 8.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.7 m -116.27 -172.19 2.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.025 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.9 m -114.75 -178.08 3.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.52 -0.738 . . . . 0.0 109.746 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.47 -47.67 82.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.06 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -23.32 35.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.326 -0.859 . . . . 0.0 110.151 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.5 p -132.13 87.33 44.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.45 5.86 4.84 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.854 2.369 . . . . 0.0 112.279 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.8 p -125.9 146.61 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.036 -1.04 . . . . 0.0 110.857 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.6 t -124.61 94.78 4.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -127.12 150.8 49.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.718 -0.614 . . . . 0.0 109.823 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.99 31.1 20.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.71 -0.619 . . . . 0.0 109.679 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 30.1 74.39 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -146.06 169.98 17.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.949 . . . . 0.0 109.558 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.96 139.34 43.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.462 -0.774 . . . . 0.0 110.396 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 19.7 m . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.913 0.387 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.06 28.74 44.17 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -110.85 10.97 22.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -1.026 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.94 8.28 60.84 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.19 -0.944 . . . . 0.0 110.931 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -129.31 135.2 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.129 -1.218 . . . . 0.0 108.941 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.72 165.41 33.55 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.821 0.82 . . . . 0.0 111.138 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -105.59 -28.62 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -145.04 -176.7 5.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -68.27 -36.29 79.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.385 -0.822 . . . . 0.0 109.868 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -68.1 -10.31 52.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.351 -0.843 . . . . 0.0 110.956 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.55 15.69 8.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.272 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.5 m -114.25 -171.21 1.87 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.27 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.8 m -114.38 -179.23 3.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.494 -0.754 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.7 -49.94 74.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.618 -0.676 . . . . 0.0 110.121 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -23.89 19.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.33 -0.856 . . . . 0.0 110.129 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.0 p -132.88 89.43 34.62 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.56 9.69 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.818 2.345 . . . . 0.0 111.609 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 13.4 p -126.16 145.12 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.7 t -122.68 98.16 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -126.51 145.81 50.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.708 -0.62 . . . . 0.0 109.931 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.72 35.14 22.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.634 -0.666 . . . . 0.0 109.931 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.42 65.95 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 m -141.68 167.88 21.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.456 -1.026 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.6 m -109.57 141.11 42.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.805 . . . . 0.0 110.18 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 25.8 m . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 30.47 30.63 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.2 13.14 15.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.967 . . . . 0.0 110.302 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.44 -2.47 77.56 Favored Glycine 0 N--CA 1.489 2.175 0 O-C-N 121.234 -0.916 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -126.28 138.08 53.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.993 -1.298 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.85 168.11 25.45 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.73 0.776 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -107.35 -28.24 9.99 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.3 p -146.89 -179.37 6.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.26 -37.25 86.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.0 109.996 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -68.09 -9.9 49.8 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.494 -0.754 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.17 14.86 9.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.3 m -114.73 -170.41 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.053 -1.029 . . . . 0.0 110.093 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -115.94 -176.71 3.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.504 -0.748 . . . . 0.0 110.077 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.75 -49.81 74.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.1 -23.59 21.51 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.357 -0.839 . . . . 0.0 110.153 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.6 p -134.31 89.48 27.56 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.21 8.7 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.758 2.305 . . . . 0.0 111.456 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 11.9 p -125.02 145.17 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.0 110.466 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -125.83 98.9 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -126.91 145.83 50.53 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.897 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 60.09 33.88 21.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.678 . . . . 0.0 109.808 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.98 28.98 69.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -140.51 165.61 26.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -1.016 . . . . 0.0 109.5 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.77 142.45 42.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.421 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 23.5 m . . . . . 0 C--N 1.308 -1.219 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 tt -157.91 87.7 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.642 . . . . 0.0 109.527 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.95 56.99 1.02 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.635 -0.666 . . . . 0.0 109.288 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.9 t -177.32 96.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.87 -29.9 62.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.741 -0.6 . . . . 0.0 109.661 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -137.98 -78.91 0.37 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.58 -0.7 . . . . 0.0 110.04 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.92 27.69 49.08 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.85 8.76 33.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.475 -1.015 . . . . 0.0 110.404 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.14 -5.66 70.86 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.109 -0.995 . . . . 0.0 111.068 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -125.2 140.39 52.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.134 -1.215 . . . . 0.0 109.423 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.27 165.18 33.77 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.77 0.795 . . . . 0.0 110.862 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.44 -26.48 11.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 p -147.32 -177.97 5.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.0 -36.51 82.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.441 -0.787 . . . . 0.0 109.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -68.41 -10.22 53.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.429 -0.794 . . . . 0.0 110.913 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -89.05 14.54 10.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -115.68 -170.85 1.86 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 m -115.92 -176.51 2.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -49.19 77.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.532 -0.73 . . . . 0.0 110.133 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tt -55.15 -23.85 23.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.435 -0.791 . . . . 0.0 110.228 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -132.7 86.97 42.68 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.74 6.75 4.67 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.934 2.423 . . . . 0.0 112.068 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.8 p -126.12 147.83 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.057 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.4 t -123.94 97.35 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.39 144.0 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.643 -0.661 . . . . 0.0 110.003 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 59.69 35.85 22.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.652 . . . . 0.0 110.025 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.4 28.21 64.38 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -140.35 166.25 25.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.977 . . . . 0.0 109.27 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.3 m -108.19 138.78 43.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 20.0 m -150.7 -172.61 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 O-C-N 121.506 -0.746 . . . . 0.0 109.055 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.3 p -83.77 120.4 25.98 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.286 0.565 . . . . 0.0 109.769 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.9 p -60.6 -57.6 12.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.716 -0.615 . . . . 0.0 109.75 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.62 -150.25 39.59 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.0 179.91 3.52 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.416 2.744 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.27 -94.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.1 tp -139.3 158.89 43.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.548 -0.972 . . . . 0.0 109.447 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -63.0 173.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.514 -0.741 . . . . 0.0 109.499 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.6 -77.17 0.64 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.78 133.47 6.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.2 mt -74.71 -24.87 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.513 -0.993 . . . . 0.0 109.964 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.19 97.09 5.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.565 -0.71 . . . . 0.0 109.456 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.06 105.82 0.18 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.64 29.96 10.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mt -130.98 144.07 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.6 -0.941 . . . . 0.0 109.503 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.71 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mt -131.37 -170.72 2.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.31 83.48 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.612 -0.68 . . . . 0.0 109.518 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.2 t -177.17 96.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.7 mt -73.45 -30.86 63.46 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -145.65 -78.6 0.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.709 -0.619 . . . . 0.0 109.756 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.4 34.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.44 11.77 20.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.427 -1.043 . . . . 0.0 110.293 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.74 -4.78 72.65 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -125.43 136.87 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.57 1.185 . . . . 0.0 109.213 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.2 p -150.72 170.67 18.66 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.73 0.776 . . . . 0.0 110.84 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -117.09 -6.25 11.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.3 p -166.68 173.08 9.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.89 -37.97 86.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 109.974 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -68.4 -10.67 56.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.424 -0.798 . . . . 0.0 110.975 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.61 15.13 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.276 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.8 m -117.42 -170.9 1.94 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.091 -1.006 . . . . 0.0 109.93 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.3 m -115.74 -177.27 3.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.25 -49.1 78.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 mt -54.85 -25.31 27.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.118 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.5 p -131.74 86.74 47.6 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.46 6.16 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.915 2.41 . . . . 0.0 112.089 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.9 p -125.78 145.98 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.03 -1.044 . . . . 0.0 110.803 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -127.05 148.41 50.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.726 -0.609 . . . . 0.0 109.985 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 59.59 33.02 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.706 -0.621 . . . . 0.0 109.934 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.87 72.37 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -144.59 168.21 20.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.595 -0.944 . . . . 0.0 109.462 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.7 m -108.71 139.3 43.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 110.15 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 20.3 m -150.63 -173.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -83.62 121.61 27.48 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.294 0.569 . . . . 0.0 109.829 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.6 p -59.64 -29.21 67.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.719 -0.613 . . . . 0.0 109.722 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.5 80.16 0.74 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.76 50.54 2.28 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.412 2.742 . . . . 0.0 110.425 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.74 -32.45 2.53 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.0 137.11 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.585 -0.95 . . . . 0.0 109.26 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -103.07 -174.01 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.611 -0.681 . . . . 0.0 109.552 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.04 -71.54 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.82 -106.85 1.0 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.59 53.51 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.65 -0.912 . . . . 0.0 109.4 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.9 mt -63.1 159.3 17.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.42 -0.8 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.21 59.18 0.28 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.34 -119.58 0.9 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.76 160.49 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.925 . . . . 0.0 109.309 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.695 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 tp -153.71 108.68 3.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.518 -0.739 . . . . 0.0 109.456 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.38 44.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.675 -0.64 . . . . 0.0 109.286 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.1 t -177.44 96.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.53 -33.96 76.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.805 -0.559 . . . . 0.0 109.593 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -136.75 -79.86 0.39 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.63 -0.669 . . . . 0.0 110.01 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.93 48.17 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -94.16 8.95 39.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.556 -0.967 . . . . 0.0 110.456 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -5.29 70.37 Favored Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.236 -0.915 . . . . 0.0 111.155 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -124.76 137.64 54.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.093 -1.24 . . . . 0.0 109.339 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 p -150.85 173.83 13.79 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.8 0.809 . . . . 0.0 110.751 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -124.11 4.26 8.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 p -175.44 170.19 3.04 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.04 -38.76 89.92 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.0 109.837 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -68.52 -10.77 57.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.772 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.79 15.38 9.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.131 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -117.58 -171.09 1.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.147 -0.971 . . . . 0.0 109.897 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -115.26 -175.98 2.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.475 -0.765 . . . . 0.0 109.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -46.09 89.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.72 -23.5 42.78 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.447 -0.783 . . . . 0.0 110.153 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.1 p -133.8 87.51 35.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.74 5.04 5.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.4 p -126.13 146.37 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.051 -1.03 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.3 t -124.59 97.34 5.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -126.62 146.67 50.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.621 -0.674 . . . . 0.0 109.855 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 60.17 33.7 21.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.615 -0.678 . . . . 0.0 109.85 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.62 29.09 68.92 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -142.39 166.76 23.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 109.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.81 140.03 42.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.45 -0.781 . . . . 0.0 110.138 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 19.4 m -150.59 -174.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 m -83.25 118.49 23.67 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.276 0.56 . . . . 0.0 110.007 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.8 p -63.16 -49.66 73.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.724 -0.61 . . . . 0.0 109.384 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.16 151.18 5.93 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.87 78.3 2.72 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 123.251 2.634 . . . . 0.0 110.44 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.29 106.9 3.0 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mt -84.96 107.6 17.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.913 . . . . 0.0 109.557 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.8 t -97.98 -38.83 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.588 -0.695 . . . . 0.0 109.459 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.49 -85.68 1.53 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.46 -172.18 39.11 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.3 mm -100.46 34.81 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.564 -0.962 . . . . 0.0 109.328 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.4 mt -113.02 85.09 2.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.13 -102.02 0.21 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.37 29.62 44.13 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mt 60.61 162.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.582 -0.951 . . . . 0.0 109.529 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.508 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.82 37.92 2.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.686 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.93 40.27 1.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.564 -0.71 . . . . 0.0 109.42 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.7 t -177.61 97.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.7 mt -73.87 -30.96 62.92 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -145.45 -77.72 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.666 -0.646 . . . . 0.0 109.744 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.73 30.0 27.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.98 12.4 17.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.566 -0.961 . . . . 0.0 110.283 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.12 -2.43 75.92 Favored Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.159 -0.963 . . . . 0.0 111.025 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -125.95 137.98 53.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.134 -1.215 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -150.44 166.32 30.47 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.725 0.774 . . . . 0.0 110.792 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -26.37 11.27 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -148.24 -179.47 6.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.1 -37.76 88.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 mtt-85 -67.86 -10.16 50.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.513 -0.742 . . . . 0.0 111.16 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.02 14.73 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.429 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -115.35 -172.28 2.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.085 -1.009 . . . . 0.0 109.974 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -113.99 -175.52 2.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -0.773 . . . . 0.0 109.721 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -63.31 -46.1 88.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.941 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.93 -23.32 44.38 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.447 -0.783 . . . . 0.0 110.114 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 45.4 p -132.74 86.87 42.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -77.58 5.15 5.4 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.879 2.386 . . . . 0.0 112.265 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 7.7 p -127.06 146.68 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.97 -1.081 . . . . 0.0 110.941 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.23 96.38 5.02 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -124.83 145.13 49.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.748 -0.595 . . . . 0.0 109.95 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 60.01 34.52 21.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.621 -0.674 . . . . 0.0 109.839 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.03 29.0 67.17 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -141.83 167.27 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.585 -0.95 . . . . 0.0 109.337 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.8 m -108.79 138.06 45.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.373 -0.829 . . . . 0.0 110.265 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.41 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 19.4 m -150.82 -173.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.657 -0.652 . . . . 0.0 109.274 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -80.67 116.11 20.51 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.324 0.583 . . . . 0.0 109.88 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 p -57.1 -30.31 64.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.671 -0.643 . . . . 0.0 110.101 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.95 -68.08 0.02 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -86.09 101.95 0.65 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.42 2.747 . . . . 0.0 110.486 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -129.24 -47.3 0.16 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tp 58.37 61.01 2.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.487 -1.008 . . . . 0.0 109.763 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 m -110.76 -173.68 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.503 -0.748 . . . . 0.0 109.507 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.88 133.7 23.0 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -108.77 -134.55 7.18 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.78 33.05 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.997 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.9 mt -111.12 131.38 55.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.58 -0.7 . . . . 0.0 109.461 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.83 -108.07 0.01 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.3 106.19 0.23 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.434 HD12 HG21 ' A' ' 44' ' ' ILE . 41.7 mm -108.89 -30.71 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.613 -0.933 . . . . 0.0 109.41 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.453 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.07 88.94 2.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.27 47.81 2.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.619 -0.675 . . . . 0.0 109.337 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -177.12 96.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.6 mt -71.31 -31.11 67.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.686 -0.634 . . . . 0.0 109.741 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -133.74 -80.68 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.594 -0.691 . . . . 0.0 110.088 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.92 28.53 37.54 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -96.91 7.32 46.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -1.016 . . . . 0.0 110.524 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.96 -4.36 70.98 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 121.181 -0.949 . . . . 0.0 111.134 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -125.21 139.13 54.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.091 -1.241 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 p -150.44 166.08 31.22 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.687 0.756 . . . . 0.0 110.954 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.2 m -106.81 -26.44 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.2 p -148.16 -178.57 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.02 -36.69 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.409 -0.807 . . . . 0.0 109.901 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -10.58 54.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.464 -0.772 . . . . 0.0 111.016 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.86 15.55 9.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.8 m -115.5 -170.54 1.79 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.926 . . . . 0.0 109.981 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -116.38 -177.18 3.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.974 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.5 -49.61 76.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.58 -0.7 . . . . 0.0 110.241 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 tp -55.21 -23.56 22.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.7 p -132.82 88.27 38.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.0 108.955 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -80.12 7.62 4.57 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.82 2.347 . . . . 0.0 111.921 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.51 146.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.048 -1.032 . . . . 0.0 110.695 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.99 97.61 5.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -125.71 144.25 50.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.695 -0.628 . . . . 0.0 110.02 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 59.89 36.06 21.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.649 -0.657 . . . . 0.0 109.939 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.42 64.13 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -140.33 165.9 26.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.565 -0.962 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -109.04 139.1 44.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.424 -0.798 . . . . 0.0 110.24 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.6 m -150.72 -174.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -86.32 120.26 27.47 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.338 0.59 . . . . 0.0 109.738 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.2 p -60.47 -44.73 95.59 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.633 -0.667 . . . . 0.0 109.632 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.29 173.45 1.76 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.6 -166.2 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.473 2.782 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -108.11 58.87 0.39 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tt -120.11 84.73 2.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.553 -0.969 . . . . 0.0 109.443 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.29 -65.93 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.35 85.46 0.78 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.73 -29.43 6.95 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 40' ' ' ILE . 45.8 mt -126.03 81.33 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.572 -0.958 . . . . 0.0 109.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.89 143.49 26.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.712 -0.618 . . . . 0.0 109.528 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.85 -80.09 0.33 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.11 97.62 0.19 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt 59.53 76.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.564 -0.962 . . . . 0.0 109.696 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.716 -179.897 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 tp -102.17 97.29 7.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.595 -0.691 . . . . 0.0 109.497 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.18 44.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.624 -0.672 . . . . 0.0 109.385 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.8 t -177.56 96.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.0 mt -64.59 -36.69 85.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.719 -0.613 . . . . 0.0 109.368 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -141.92 -76.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.16 10.59 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.85 16.08 13.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.532 -0.981 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.95 8.43 61.16 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.012 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -129.55 134.77 47.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.173 -1.192 . . . . 0.0 109.058 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.67 166.92 28.9 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.902 0.858 . . . . 0.0 111.18 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 m -106.78 -28.71 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -145.42 -177.37 5.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.25 -37.55 83.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.311 -0.868 . . . . 0.0 110.011 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.46 -10.37 50.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.39 -0.819 . . . . 0.0 111.052 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.74 15.1 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 0.0 110.321 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.6 m -114.74 -171.31 1.91 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.088 -1.008 . . . . 0.0 110.163 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.01 -179.26 3.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 110.046 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.28 -50.53 72.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.176 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -54.56 -23.99 19.07 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.353 -0.842 . . . . 0.0 110.219 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.2 p -132.42 89.08 37.51 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.92 10.33 3.69 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.875 2.383 . . . . 0.0 111.648 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.4 p -126.18 145.29 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.742 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.8 t -122.89 96.94 5.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -125.81 145.98 49.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.736 -0.602 . . . . 0.0 110.001 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 59.33 34.94 23.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.75 -0.594 . . . . 0.0 109.872 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.33 27.67 65.87 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 m -140.84 168.78 18.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.477 -1.014 . . . . 0.0 109.425 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.55 140.18 43.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 30.6 m -150.32 178.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -93.96 109.73 21.44 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.169 0.509 . . . . 0.0 109.829 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -59.38 3.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.703 -0.623 . . . . 0.0 109.487 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.35 70.4 1.14 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.05 79.49 1.98 Allowed 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 123.457 2.771 . . . . 0.0 110.364 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.61 84.34 1.53 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.57 29.04 7.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.56 -0.965 . . . . 0.0 109.635 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.95 178.64 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.626 -0.671 . . . . 0.0 109.5 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.75 126.94 2.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 172.33 -155.94 24.38 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.9 mt -113.12 40.57 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.57 -0.959 . . . . 0.0 109.361 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.0 mt -95.61 167.98 10.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.525 -0.734 . . . . 0.0 109.49 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.51 -34.33 2.29 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.03 121.3 0.74 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -101.62 93.38 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.648 -0.913 . . . . 0.0 109.467 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 26.7 tp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.17 76.22 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.532 -0.73 . . . . 0.0 109.295 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.01 34.38 0.25 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.463 -0.773 . . . . 0.0 109.626 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.1 t -177.5 97.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.01 -30.28 58.44 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -147.93 -76.85 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.65 -0.656 . . . . 0.0 109.679 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.53 31.69 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -90.4 12.58 18.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.974 . . . . 0.0 110.214 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 -3.87 76.29 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.15 -0.969 . . . . 0.0 110.988 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.258 . . . . 0.0 109.405 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.43 166.26 30.65 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.813 0.816 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -106.63 -28.21 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -145.75 -177.4 5.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.79 -36.52 80.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.394 -0.816 . . . . 0.0 109.848 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -67.85 -10.47 53.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.17 14.51 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.452 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.1 m -116.49 -169.77 1.69 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -117.52 -177.57 3.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.458 -0.776 . . . . 0.0 110.352 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.17 -52.3 65.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.631 . . . . 0.0 110.227 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -52.9 -25.52 12.0 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.35 -0.844 . . . . 0.0 110.14 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.2 p -132.77 87.74 40.01 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.93 8.91 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.793 2.329 . . . . 0.0 111.675 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 12.5 p -125.66 145.0 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.2 t -122.99 96.52 5.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -125.29 146.51 49.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.609 -0.682 . . . . 0.0 109.919 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 59.9 33.64 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.601 -0.687 . . . . 0.0 109.878 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.28 29.31 71.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -143.16 168.03 20.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 0.0 109.352 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.1 m -109.61 141.45 42.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.41 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 26.3 m -150.3 176.24 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -92.8 108.95 20.38 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.244 0.545 . . . . 0.0 109.815 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -75.21 -50.18 17.02 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.502 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.91 -68.57 0.25 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.86 -165.02 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.465 2.776 . . . . 0.0 110.33 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.75 -44.63 0.1 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.53 71.27 3.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.53 -0.982 . . . . 0.0 109.702 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 m -128.45 160.29 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.534 -0.728 . . . . 0.0 109.416 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.23 87.82 0.04 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.8 173.64 37.33 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.6 mt -99.0 51.22 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.586 -0.949 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.22 178.26 4.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.492 -0.755 . . . . 0.0 109.494 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.69 59.5 4.57 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -157.14 108.57 0.37 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.5 mt -120.57 -41.53 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.472 -1.016 . . . . 0.0 109.439 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.482 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.15 114.48 21.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.632 -0.667 . . . . 0.0 109.64 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.93 60.7 1.7 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.602 -0.686 . . . . 0.0 109.339 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.4 t -177.47 97.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.3 mt -73.86 -30.34 62.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.717 -0.615 . . . . 0.0 109.662 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -135.52 -79.71 0.43 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.612 -0.68 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.68 29.01 49.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.02 9.86 35.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.522 -0.987 . . . . 0.0 110.409 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.56 72.6 Favored Glycine 0 N--CA 1.49 2.271 0 O-C-N 121.121 -0.987 . . . . 0.0 111.084 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -125.1 137.04 54.19 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.648 1.224 . . . . 0.0 109.276 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.52 165.9 31.84 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.814 0.816 . . . . 0.0 110.987 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 p -106.13 -26.95 11.38 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.56 -177.7 5.92 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.75 -35.76 80.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.431 -0.793 . . . . 0.0 109.874 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -67.95 -10.83 56.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.496 -0.753 . . . . 0.0 110.939 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.41 16.44 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 0.0 110.096 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.5 m -116.92 -170.98 1.94 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.1 m -116.89 -178.79 3.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.333 -0.854 . . . . 0.0 110.058 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -61.13 -50.74 71.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.579 -0.7 . . . . 0.0 110.143 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 tp -53.45 -24.94 14.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.33 -0.856 . . . . 0.0 110.128 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.9 p -132.67 88.88 37.08 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.66 8.77 4.37 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.803 2.336 . . . . 0.0 111.533 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 12.3 p -125.64 144.14 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.109 -0.995 . . . . 0.0 110.448 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.01 96.64 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -129.06 150.93 50.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.739 -0.601 . . . . 0.0 109.63 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 60.56 30.91 20.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.737 -0.602 . . . . 0.0 109.647 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.03 28.27 70.19 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -144.7 170.49 16.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.972 . . . . 0.0 109.484 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.6 m -109.62 141.88 41.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 110.239 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 28.2 m -150.31 176.66 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 m -92.52 105.74 17.85 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.105 0.478 . . . . 0.0 109.859 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.24 157.75 0.14 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.01 49.12 1.91 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 123.497 2.798 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.25 51.78 6.57 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.25 158.33 20.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.578 -0.954 . . . . 0.0 109.557 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.35 166.78 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.46 -38.07 1.25 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.99 130.83 10.37 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 40' ' ' ILE . 62.4 mt -90.27 52.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.616 -0.932 . . . . 0.0 109.474 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.0 mt -85.25 110.11 18.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.508 -0.745 . . . . 0.0 109.464 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.2 118.66 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.45 -127.81 1.31 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -111.28 137.7 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.549 -0.971 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.436 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.2 mt -124.9 107.22 10.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.621 -0.675 . . . . 0.0 109.458 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.97 40.27 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.672 -0.643 . . . . 0.0 109.312 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.5 t -177.47 97.24 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 mt -69.44 -33.27 72.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.692 -0.63 . . . . 0.0 109.544 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -133.24 -79.09 0.48 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.651 -0.656 . . . . 0.0 109.741 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.53 28.31 33.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.8 14.05 24.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.982 . . . . 0.0 110.18 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.89 9.54 59.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -129.28 133.01 47.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.233 -1.157 . . . . 0.0 108.898 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.9 p -150.91 166.88 29.25 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -106.53 -28.23 10.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -146.53 -177.79 5.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.45 -35.55 79.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -67.97 -10.83 56.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.19 16.66 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.206 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.0 m -115.62 -171.45 1.97 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 110.304 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.8 m -113.12 177.82 4.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 109.956 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.12 -47.71 83.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.67 . . . . 0.0 109.811 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.41 -25.8 38.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 p -131.26 88.91 43.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.44 9.93 3.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.881 2.387 . . . . 0.0 111.946 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.1 p -125.6 144.41 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.067 -1.021 . . . . 0.0 110.735 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -122.76 95.81 4.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -127.34 149.98 49.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 0.0 109.759 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 59.87 32.21 21.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.721 -0.612 . . . . 0.0 109.626 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.27 28.11 68.7 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m -143.53 170.45 15.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -1.001 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.9 m -109.57 140.61 43.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.417 -0.802 . . . . 0.0 110.268 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 24.6 m -150.44 178.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -91.13 126.57 36.25 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.317 0.58 . . . . 0.0 109.606 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 p -61.02 -52.77 63.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.699 -0.626 . . . . 0.0 109.579 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.1 -76.59 0.22 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.65 66.04 5.65 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.43 2.754 . . . . 0.0 110.614 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -107.51 -33.68 3.06 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.94 140.88 49.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.922 . . . . 0.0 109.169 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.2 m -63.66 -174.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.56 -0.712 . . . . 0.0 109.419 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.35 134.6 1.76 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.79 -126.14 4.94 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.7 mt -94.0 45.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.557 -0.967 . . . . 0.0 109.471 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.9 mt -105.46 36.02 2.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 109.53 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.12 -76.37 0.67 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.65 116.52 3.7 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 tt -88.55 56.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.52 -0.988 . . . . 0.0 109.177 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.52 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mt -145.11 132.86 21.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.18 46.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.648 -0.658 . . . . 0.0 109.227 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -176.84 96.23 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.4 mt -75.94 -28.49 57.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.745 -0.597 . . . . 0.0 109.728 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -138.81 -79.54 0.33 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.542 -0.724 . . . . 0.0 109.969 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.71 27.6 50.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.14 8.26 42.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -1.03 . . . . 0.0 110.443 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.46 -8.87 66.45 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.187 -0.946 . . . . 0.0 111.084 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -123.48 138.96 54.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -1.179 . . . . 0.0 109.37 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 p -150.07 166.66 29.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.678 0.751 . . . . 0.0 110.768 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 p -107.72 -24.87 11.54 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 p -149.96 -179.75 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.38 -35.65 81.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -68.37 -10.85 57.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.413 -0.804 . . . . 0.0 110.883 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.37 15.9 9.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.152 -0.967 . . . . 0.0 110.137 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.8 m -116.26 -170.86 1.89 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -118.21 -176.72 3.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 109.829 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.38 -48.03 81.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.608 -0.683 . . . . 0.0 109.991 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.19 -23.9 24.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.468 -0.77 . . . . 0.0 110.104 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 p -133.56 87.93 35.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.13 5.98 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.912 2.408 . . . . 0.0 112.093 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.91 146.13 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.011 -1.056 . . . . 0.0 110.831 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.6 t -124.13 96.14 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 150.26 50.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.678 -0.639 . . . . 0.0 109.802 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.29 31.62 20.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.556 -0.715 . . . . 0.0 109.72 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.33 71.51 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -144.71 169.28 18.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.975 . . . . 0.0 109.509 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.4 m -108.82 139.12 44.08 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.8 m -150.57 -172.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.5 m -83.09 124.63 30.64 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.0 p -52.87 -49.76 65.18 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.753 -0.592 . . . . 0.0 110.331 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.54 -145.78 49.73 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -83.58 -165.29 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 123.205 2.603 . . . . 0.0 110.487 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.96 -110.13 2.7 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -85.27 157.31 20.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.615 -0.933 . . . . 0.0 109.559 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 t 67.67 -70.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.698 -0.626 . . . . 0.0 109.857 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.64 -147.73 47.27 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.49 154.06 6.62 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 40' ' ' ILE . 57.6 mt -105.84 -23.69 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.541 -0.976 . . . . 0.0 109.981 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.5 mt -140.24 164.49 29.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 109.49 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.25 -83.92 1.1 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.48 -125.84 0.84 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -130.44 108.8 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.643 -0.916 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.511 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.0 99.59 10.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.489 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.96 37.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.666 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.8 t -177.82 97.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -66.85 -35.52 80.22 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -149.04 -75.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.807 -0.558 . . . . 0.0 109.573 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 34.75 20.84 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -95.23 21.89 7.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.492 -1.005 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.59 7.13 64.1 Favored Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.382 -0.824 . . . . 0.0 111.305 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -129.8 133.67 47.11 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 118.734 1.267 . . . . 0.0 109.339 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.28 167.73 26.94 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.728 0.775 . . . . 0.0 110.987 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.1 p -106.27 -29.55 9.73 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 p -145.6 -177.4 5.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.91 -37.66 84.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 109.983 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -68.02 -9.68 47.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.415 -0.803 . . . . 0.0 111.133 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 13.91 10.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.118 -0.989 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.4 m -114.6 -171.16 1.88 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 110.065 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.1 m -112.82 179.93 3.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.745 . . . . 0.0 109.932 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.04 -47.0 88.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.627 -0.671 . . . . 0.0 109.921 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.93 -27.96 54.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.1 p -128.99 87.17 55.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -80.91 7.8 4.69 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.92 2.413 . . . . 0.0 111.909 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 13.0 p -125.3 143.41 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.061 -1.025 . . . . 0.0 110.684 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -121.97 95.77 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -121.3 143.47 49.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 110.111 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 59.16 35.35 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.802 -0.561 . . . . 0.0 109.992 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.85 29.89 71.56 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -141.64 166.4 24.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.605 -0.938 . . . . 0.0 109.295 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.54 140.23 43.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.405 -0.81 . . . . 0.0 110.446 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 22.4 m -150.37 179.55 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.0 t -90.16 116.53 28.23 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.273 0.558 . . . . 0.0 109.79 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 p -61.08 -31.86 71.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.76 -0.588 . . . . 0.0 109.524 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.17 164.78 16.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.24 166.64 9.42 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.439 2.759 . . . . 0.0 110.55 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.46 -68.76 0.03 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.17 82.1 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.54 -0.977 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.62 -174.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.599 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.94 66.31 3.74 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.63 117.94 4.52 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.85 -24.16 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.577 -0.955 . . . . 0.0 109.954 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.88 147.03 36.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.522 -0.736 . . . . 0.0 109.529 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.08 83.48 0.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.26 -131.35 6.47 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mt -88.08 154.24 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.641 -0.917 . . . . 0.0 109.259 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.436 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 tp -164.99 86.26 0.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.671 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.84 39.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.536 -0.727 . . . . 0.0 109.523 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.0 t -177.67 97.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.92 -33.73 74.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.49 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -138.63 -79.3 0.34 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.68 -0.638 . . . . 0.0 109.755 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.88 28.88 24.88 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -91.23 11.66 22.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.607 -0.937 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.58 1.35 70.9 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.092 -1.005 . . . . 0.0 111.027 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -126.29 136.71 53.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.17 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.2 p -150.57 166.28 30.74 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.607 0.717 . . . . 0.0 110.797 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -107.25 -24.7 11.8 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p -150.04 178.79 8.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -63.36 -37.52 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -67.97 -10.47 53.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.477 -0.764 . . . . 0.0 111.099 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.35 15.8 9.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.5 m -114.28 -172.98 2.2 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 109.956 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.4 m -114.02 -175.81 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.46 -45.32 87.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.801 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.01 -20.84 41.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.254 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.7 p -133.74 88.28 33.67 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.77 4.93 5.23 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.95 2.433 . . . . 0.0 112.397 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.416 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 7.5 p -128.21 147.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.975 -1.078 . . . . 0.0 110.961 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -123.6 97.42 5.38 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -127.74 147.11 50.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.708 -0.62 . . . . 0.0 109.997 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 59.99 33.97 21.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.64 -0.662 . . . . 0.0 109.901 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.29 29.34 68.62 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -143.45 167.96 20.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.595 -0.944 . . . . 0.0 109.343 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.7 m -108.9 138.13 45.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.8 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.416 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 18.3 m -150.48 -173.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.594 -0.691 . . . . 0.0 109.262 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -79.72 115.53 19.38 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.378 0.609 . . . . 0.0 109.752 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.4 p -55.12 -28.05 49.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.633 -0.667 . . . . 0.0 110.159 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.1 145.03 17.16 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.2 172.66 8.32 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 123.22 2.613 . . . . 0.0 110.457 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -104.95 31.53 8.48 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.0 tp -141.6 157.52 44.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.613 -0.933 . . . . 0.0 109.411 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 t -84.61 -64.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.491 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.15 -145.5 5.79 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.16 -57.47 0.07 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.8 mp -129.1 46.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.571 -0.958 . . . . 0.0 109.479 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.63 128.01 33.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.463 -0.773 . . . . 0.0 109.51 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.31 55.74 0.03 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.06 -119.85 0.56 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 44' ' ' ILE . 46.1 mm -67.1 -52.65 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.564 -0.962 . . . . 0.0 109.475 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.468 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 pp -155.87 119.72 4.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.597 -0.689 . . . . 0.0 109.386 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.13 41.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.445 -0.785 . . . . 0.0 109.427 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.0 t -177.7 97.02 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.1 mt -62.89 -37.63 87.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.752 -0.592 . . . . 0.0 109.504 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -140.33 -77.91 0.31 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.727 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.74 28.94 33.59 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -90.26 11.81 20.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.53 -0.983 . . . . 0.0 110.274 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.88 73.52 Favored Glycine 0 N--CA 1.49 2.293 0 O-C-N 121.217 -0.927 . . . . 0.0 111.162 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -126.26 136.84 53.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.059 -1.26 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -150.54 166.06 31.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.726 0.774 . . . . 0.0 110.9 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.1 m -106.19 -26.93 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -148.11 -178.94 6.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.7 -36.52 83.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 109.893 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -67.95 -10.56 54.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.983 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.79 15.69 9.32 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 110.282 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.0 m -115.46 -171.34 1.94 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.089 -1.007 . . . . 0.0 110.015 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.8 m -115.57 -178.62 3.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.54 -0.725 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.41 -49.58 76.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.665 -0.647 . . . . 0.0 110.168 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.72 -24.31 21.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.351 -0.843 . . . . 0.0 110.09 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -132.06 87.29 44.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.2 7.51 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.864 2.376 . . . . 0.0 112.123 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.9 p -126.02 145.17 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.046 . . . . 0.0 110.892 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.95 95.63 4.69 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 148.78 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.756 -0.59 . . . . 0.0 109.793 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 59.45 33.04 22.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.816 -0.552 . . . . 0.0 109.808 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.92 28.9 69.35 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -143.49 169.29 17.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.507 -0.996 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.1 m -109.13 139.05 44.54 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 20.3 m -150.59 -174.11 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -85.3 120.24 26.57 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.294 0.569 . . . . 0.0 109.787 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -62.28 -32.46 73.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.0 109.598 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.26 171.24 16.66 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.06 165.7 9.87 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 123.448 2.766 . . . . 0.0 110.51 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.4 -68.71 0.04 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tp -141.46 114.68 8.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.657 -0.908 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.04 175.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.716 . . . . 0.0 109.618 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.9 -100.52 0.94 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.83 147.64 13.31 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 tt -99.81 -21.87 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.655 -0.909 . . . . 0.0 109.989 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.55 154.38 22.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 109.654 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.73 -106.71 2.56 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -155.54 27.21 0.6 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.61 137.69 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.425 -1.044 . . . . 0.0 109.405 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.426 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.56 99.92 12.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.658 -0.651 . . . . 0.0 109.446 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.13 46.42 0.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.596 -0.69 . . . . 0.0 109.348 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.7 t -177.71 97.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.3 mt -71.56 -31.67 67.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.797 -0.564 . . . . 0.0 109.635 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -132.53 -79.68 0.5 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.015 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.1 27.78 55.26 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.4 7.65 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.431 -1.041 . . . . 0.0 110.392 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.52 -2.7 71.26 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.177 -0.952 . . . . 0.0 111.207 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.969 -1.312 . . . . 0.0 109.474 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.17 166.5 29.64 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.74 0.781 . . . . 0.0 111.092 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.99 -28.11 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -145.66 -177.96 5.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.25 -36.71 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -67.86 -10.47 53.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.98 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -88.4 14.78 8.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.362 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.6 m -115.62 -169.91 1.68 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 110.207 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 m -114.24 179.48 3.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -51.69 68.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.655 -0.653 . . . . 0.0 109.952 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.09 -25.59 13.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.392 -0.817 . . . . 0.0 109.997 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.9 p -132.24 87.9 41.86 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.12 11.22 3.34 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.819 2.346 . . . . 0.0 111.702 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -125.74 145.47 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.618 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -123.22 97.57 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.24 145.41 50.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.67 . . . . 0.0 109.944 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.12 34.9 21.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.647 -0.658 . . . . 0.0 109.827 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.79 27.94 64.97 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -140.68 167.7 21.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -1.02 . . . . 0.0 109.374 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.28 140.38 43.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.41 178.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.82 120.55 35.23 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.232 0.539 . . . . 0.0 109.945 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.6 p -72.75 -46.43 53.49 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.63 -162.4 11.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.39 156.67 9.42 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.425 2.75 . . . . 0.0 110.51 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.11 -54.8 0.06 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.26 154.47 40.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.558 -0.966 . . . . 0.0 109.491 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.84 -173.39 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.685 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.52 49.26 2.39 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.62 -179.58 21.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 40' ' ' ILE . 63.0 mt -132.97 42.45 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.591 -0.947 . . . . 0.0 109.454 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.16 39.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.531 -0.731 . . . . 0.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.06 -61.88 4.62 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.1 109.37 0.23 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.55 157.92 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.613 -0.934 . . . . 0.0 109.345 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.68 -179.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.52 -161.0 0.76 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.28 32.36 4.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.505 -0.747 . . . . 0.0 109.513 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -177.93 97.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.7 mt -76.64 -28.77 56.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.725 -0.61 . . . . 0.0 109.906 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.56 -73.99 0.39 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.526 -0.734 . . . . 0.0 110.252 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.86 28.03 67.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.92 7.3 38.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.478 -1.013 . . . . 0.0 110.383 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.27 -17.22 54.96 Favored Glycine 0 N--CA 1.488 2.127 0 O-C-N 121.217 -0.927 . . . . 0.0 111.105 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 147.17 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.92 173.24 14.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 0.0 110.596 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -123.83 6.16 8.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.2 p -177.63 169.73 2.08 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.28 -39.12 91.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.367 -0.833 . . . . 0.0 109.809 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -68.88 -10.5 57.38 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.76 15.13 10.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.4 m -116.01 -171.06 1.91 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.088 -1.008 . . . . 0.0 109.874 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.6 m -114.03 -177.87 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.446 -0.784 . . . . 0.0 109.749 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.29 -48.05 81.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.64 -0.663 . . . . 0.0 110.018 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -23.6 27.28 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.387 -0.821 . . . . 0.0 110.065 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.4 p -132.93 87.7 39.43 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.15 6.15 4.89 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.772 2.314 . . . . 0.0 112.198 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.9 p -126.11 146.86 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.997 -1.064 . . . . 0.0 110.852 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -124.94 98.04 5.52 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -130.76 148.07 52.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.672 -0.643 . . . . 0.0 109.796 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 59.86 33.97 21.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.71 -0.619 . . . . 0.0 109.791 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.68 25.88 61.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 m -142.06 156.79 45.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.463 -1.022 . . . . 0.0 109.385 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -98.47 140.51 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.526 -0.733 . . . . 0.0 110.052 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 21.3 m -150.57 -172.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 p -83.71 119.77 25.19 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.247 0.546 . . . . 0.0 109.993 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 p -63.27 -39.73 95.41 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.22 67.55 1.88 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.97 100.09 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.51 2.807 . . . . 0.0 110.45 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.36 86.13 0.08 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tp -65.5 94.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.617 -0.931 . . . . 0.0 109.583 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 m -110.53 -174.04 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.532 -0.73 . . . . 0.0 109.465 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.04 179.92 6.57 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.04 -137.4 2.25 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.8 mt -87.21 -23.87 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.972 . . . . 0.0 109.962 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.52 83.84 2.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.471 -0.768 . . . . 0.0 109.555 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.05 -45.81 7.39 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.82 103.43 1.37 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 44' ' ' ILE . 57.6 mt -135.11 102.58 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.922 . . . . 0.0 109.467 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.523 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.4 tp -84.8 88.52 7.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.622 -0.674 . . . . 0.0 109.515 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.31 42.72 1.08 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 109.359 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.7 t -177.53 96.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.6 mt -72.11 -31.31 65.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.68 -0.637 . . . . 0.0 109.645 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -144.89 -76.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.581 -0.699 . . . . 0.0 110.032 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.6 29.96 54.16 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' CB ' ' NH1' ' A' ' 10' ' ' ARG . 7.7 m120 -89.88 11.38 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.992 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -7.79 72.39 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.187 -0.946 . . . . 0.0 111.07 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -125.59 140.8 52.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.061 -1.258 . . . . 0.0 109.689 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -150.35 167.9 25.67 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.625 0.726 . . . . 0.0 110.81 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 t -107.45 -28.04 10.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.9 p -146.52 179.11 7.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -64.04 -38.48 91.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 109.938 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -67.81 -9.78 47.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.159 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.75 13.75 9.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.084 -1.01 . . . . 0.0 110.455 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.2 m -114.42 -168.92 1.44 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.043 -1.036 . . . . 0.0 109.928 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 m -116.67 -176.55 2.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.373 -0.829 . . . . 0.0 110.195 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.41 -51.75 68.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.656 -0.653 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.93 -24.51 16.59 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.292 -0.88 . . . . 0.0 110.11 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.1 p -133.91 88.9 31.04 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.31 9.76 3.96 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.77 2.313 . . . . 0.0 111.531 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 13.7 p -126.34 146.08 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.98 96.97 5.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 142.22 50.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.676 -0.64 . . . . 0.0 110.091 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 59.55 36.8 22.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.696 -0.627 . . . . 0.0 110.003 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.52 28.93 65.73 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -140.12 165.58 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.634 -0.921 . . . . 0.0 109.265 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -108.6 139.91 42.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.467 -0.77 . . . . 0.0 110.216 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 27.5 m -150.44 177.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -93.41 108.59 20.24 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.194 0.521 . . . . 0.0 109.759 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.97 -43.6 74.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.744 -0.598 . . . . 0.0 109.627 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.75 91.6 0.08 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.14 85.16 1.27 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.379 2.719 . . . . 0.0 110.465 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.64 -33.78 0.22 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.36 76.44 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.594 -0.945 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 m -114.8 175.99 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.547 -0.72 . . . . 0.0 109.451 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.61 -100.51 2.16 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.62 -173.75 3.6 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.8 tt -93.97 -18.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.616 -0.932 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.79 118.3 6.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.422 -0.799 . . . . 0.0 109.627 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.48 46.79 0.26 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.1 122.5 1.03 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mp 59.47 98.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.963 . . . . 0.0 109.646 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.462 -179.972 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 19.7 tp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.51 98.34 8.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.731 . . . . 0.0 109.488 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.64 50.73 1.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.667 -0.645 . . . . 0.0 109.307 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.9 t -177.91 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.2 mt -65.56 -36.13 82.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.743 -0.598 . . . . 0.0 109.625 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -138.63 -76.24 0.37 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.701 -0.624 . . . . 0.0 110.05 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.2 28.81 55.31 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -89.79 9.44 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.491 -1.005 . . . . 0.0 110.37 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.99 -6.6 70.17 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 121.213 -0.93 . . . . 0.0 111.276 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -124.62 139.6 53.71 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 118.694 1.247 . . . . 0.0 109.784 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 p -150.51 166.24 30.81 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.722 0.773 . . . . 0.0 110.604 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.1 m -106.3 -26.47 11.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.9 -178.65 6.48 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.88 -36.43 83.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.473 -0.767 . . . . 0.0 109.937 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.99 -10.6 54.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.497 -0.752 . . . . 0.0 111.025 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.12 15.97 9.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 110.168 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 83.9 m -115.38 -171.39 1.95 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.145 -0.972 . . . . 0.0 110.079 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.3 m -114.9 -178.59 3.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.055 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.31 -50.21 73.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.615 -0.678 . . . . 0.0 110.056 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mp -54.62 -24.27 20.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.354 -0.841 . . . . 0.0 110.209 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 78.4 p -131.92 88.02 42.9 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.89 8.2 4.18 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -125.86 145.41 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.02 -1.05 . . . . 0.0 110.767 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -123.96 96.38 4.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -126.0 147.18 49.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.685 -0.635 . . . . 0.0 109.946 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mtm-85 60.16 33.26 21.12 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.654 -0.654 . . . . 0.0 109.757 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.8 29.53 70.52 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -142.92 167.56 21.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.589 -0.948 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -108.68 138.68 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.494 -0.754 . . . . 0.0 110.24 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.1 m -150.75 -173.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -86.16 122.63 30.43 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.222 0.534 . . . . 0.0 109.67 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -61.9 -30.63 71.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.707 -0.621 . . . . 0.0 109.631 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.88 74.42 0.44 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.96 54.25 2.41 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.579 2.853 . . . . 0.0 110.549 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.37 50.57 0.11 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.1 tp -163.44 81.84 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.499 -1.001 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 t -133.01 -64.92 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.62 -0.675 . . . . 0.0 109.463 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.98 143.79 8.43 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.78 54.41 0.13 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tp -82.15 -26.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.556 -0.967 . . . . 0.0 109.7 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.28 -179.46 4.37 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.65 -0.656 . . . . 0.0 109.561 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.95 -60.25 2.08 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.58 94.2 2.35 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -129.13 -56.14 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.652 -0.911 . . . . 0.0 109.518 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.47 -179.914 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.94 76.61 8.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.566 -0.708 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.84 55.06 1.28 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.153 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -177.41 96.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.28 -36.18 83.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.693 -0.629 . . . . 0.0 109.496 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -139.12 -78.17 0.34 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.708 -0.62 . . . . 0.0 109.725 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.56 27.74 46.17 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -90.28 10.98 22.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -1.047 . . . . 0.0 110.287 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.4 -3.38 73.26 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 121.187 -0.946 . . . . 0.0 111.093 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -124.53 136.34 53.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.268 . . . . 0.0 109.472 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.3 p -150.76 168.14 25.31 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.657 0.742 . . . . 0.0 110.783 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.3 m -112.5 -10.95 13.68 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -163.63 175.15 10.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.41 -37.06 84.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 109.82 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -68.31 -11.06 58.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.444 -0.785 . . . . 0.0 110.981 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 16.76 8.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.7 m -116.27 -172.19 2.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.025 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.9 m -114.75 -178.08 3.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.52 -0.738 . . . . 0.0 109.746 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.47 -47.67 82.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.06 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -23.32 35.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.326 -0.859 . . . . 0.0 110.151 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.5 p -132.13 87.33 44.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.45 5.86 4.84 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.854 2.369 . . . . 0.0 112.279 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 14.8 p -125.9 146.61 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.036 -1.04 . . . . 0.0 110.857 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.6 t -124.61 94.78 4.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -127.12 150.8 49.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.718 -0.614 . . . . 0.0 109.823 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.99 31.1 20.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.71 -0.619 . . . . 0.0 109.679 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 30.1 74.39 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -146.06 169.98 17.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.949 . . . . 0.0 109.558 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.96 139.34 43.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.462 -0.774 . . . . 0.0 110.396 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 19.7 m -150.75 -171.95 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.19 120.36 25.71 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.329 0.585 . . . . 0.0 109.738 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.9 p -59.69 -28.16 67.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.642 -0.661 . . . . 0.0 109.84 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.97 -177.69 19.33 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -86.43 141.14 6.63 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 123.452 2.768 . . . . 0.0 110.565 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.92 -61.28 0.04 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.1 mp -75.92 172.49 12.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.628 -0.925 . . . . 0.0 109.317 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.0 t 66.88 -71.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.673 -0.642 . . . . 0.0 109.983 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.12 179.81 16.12 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.24 147.16 17.26 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.9 tp -66.82 -24.99 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.964 . . . . 0.0 109.85 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.7 mt -104.46 163.03 12.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.515 -0.741 . . . . 0.0 109.524 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.54 75.24 0.16 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.13 112.79 0.27 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.4 mt -99.07 82.25 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.95 . . . . 0.0 109.359 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.466 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.52 98.55 2.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.518 -0.739 . . . . 0.0 109.35 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.14 36.4 2.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.489 -0.757 . . . . 0.0 109.543 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.9 t -177.42 95.5 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 mt -77.57 -26.92 51.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.699 -0.626 . . . . 0.0 109.793 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -122.43 -81.29 0.64 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.466 -0.771 . . . . 0.0 110.031 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.06 28.74 44.17 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -110.85 10.97 22.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -1.026 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.94 8.28 60.84 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.19 -0.944 . . . . 0.0 110.931 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -129.31 135.2 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.129 -1.218 . . . . 0.0 108.941 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.72 165.41 33.55 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.821 0.82 . . . . 0.0 111.138 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -105.59 -28.62 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -145.04 -176.7 5.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -68.27 -36.29 79.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.385 -0.822 . . . . 0.0 109.868 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -68.1 -10.31 52.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.351 -0.843 . . . . 0.0 110.956 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.55 15.69 8.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.272 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.5 m -114.25 -171.21 1.87 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.27 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.8 m -114.38 -179.23 3.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.494 -0.754 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.7 -49.94 74.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.618 -0.676 . . . . 0.0 110.121 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -23.89 19.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.33 -0.856 . . . . 0.0 110.129 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.0 p -132.88 89.43 34.62 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.56 9.69 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.818 2.345 . . . . 0.0 111.609 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 13.4 p -126.16 145.12 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.7 t -122.68 98.16 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -126.51 145.81 50.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.708 -0.62 . . . . 0.0 109.931 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.72 35.14 22.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.634 -0.666 . . . . 0.0 109.931 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.42 65.95 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 m -141.68 167.88 21.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.456 -1.026 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.6 m -109.57 141.11 42.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.805 . . . . 0.0 110.18 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 25.8 m -150.23 177.25 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.7 t -93.36 108.02 19.75 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.234 0.54 . . . . 0.0 109.91 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.9 -72.42 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.677 -0.64 . . . . 0.0 109.314 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.4 86.72 0.04 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.86 38.52 0.38 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.672 2.914 . . . . 0.0 110.904 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.33 94.66 0.01 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tt -173.39 127.97 0.43 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.545 -0.974 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.46 -173.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.618 -0.677 . . . . 0.0 109.476 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.06 171.52 52.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.08 167.07 25.28 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 tt -106.58 -21.7 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.502 -0.999 . . . . 0.0 109.959 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.75 120.64 18.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.62 87.45 0.79 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.06 -134.99 1.76 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 pt -74.33 169.24 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.49 -1.006 . . . . 0.0 109.511 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt -88.69 96.83 10.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.547 -0.721 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.43 55.54 1.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.356 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.5 t -177.75 97.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.9 mt -70.04 -33.23 71.7 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -146.24 -76.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.664 -0.648 . . . . 0.0 109.75 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 30.47 30.63 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.2 13.14 15.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.967 . . . . 0.0 110.302 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.44 -2.47 77.56 Favored Glycine 0 N--CA 1.489 2.175 0 O-C-N 121.234 -0.916 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -126.28 138.08 53.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.993 -1.298 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.85 168.11 25.45 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.73 0.776 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -107.35 -28.24 9.99 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.3 p -146.89 -179.37 6.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.26 -37.25 86.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.0 109.996 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -68.09 -9.9 49.8 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.494 -0.754 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.17 14.86 9.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.3 m -114.73 -170.41 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.053 -1.029 . . . . 0.0 110.093 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -115.94 -176.71 3.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.504 -0.748 . . . . 0.0 110.077 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.75 -49.81 74.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.1 -23.59 21.51 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.357 -0.839 . . . . 0.0 110.153 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.6 p -134.31 89.48 27.56 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.21 8.7 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.758 2.305 . . . . 0.0 111.456 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 11.9 p -125.02 145.17 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.0 110.466 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -125.83 98.9 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -126.91 145.83 50.53 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.897 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 60.09 33.88 21.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.678 . . . . 0.0 109.808 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.98 28.98 69.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -140.51 165.61 26.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -1.016 . . . . 0.0 109.5 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.77 142.45 42.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.421 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 23.5 m -150.39 172.44 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.4 t -95.2 110.34 22.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.173 0.511 . . . . 0.0 109.723 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.3 p -118.8 -54.31 2.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.694 -0.629 . . . . 0.0 109.555 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.96 -80.74 0.28 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.74 -165.32 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.444 2.763 . . . . 0.0 110.372 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.62 79.85 0.32 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.7 tt -148.76 86.99 1.53 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.568 -0.96 . . . . 0.0 109.551 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.78 166.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.571 -0.705 . . . . 0.0 109.154 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.76 85.14 1.03 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.87 163.65 13.8 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.9 mt -109.33 49.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.548 -0.972 . . . . 0.0 109.353 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.6 mt -95.39 165.73 12.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.474 -0.766 . . . . 0.0 109.441 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.7 45.6 0.02 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 175.58 -117.86 0.63 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.9 pt -62.7 148.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.579 -0.954 . . . . 0.0 109.527 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.468 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.986 0.422 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.92 27.69 49.08 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.85 8.76 33.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.475 -1.015 . . . . 0.0 110.404 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.14 -5.66 70.86 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.109 -0.995 . . . . 0.0 111.068 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -125.2 140.39 52.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.134 -1.215 . . . . 0.0 109.423 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.27 165.18 33.77 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.77 0.795 . . . . 0.0 110.862 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.44 -26.48 11.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 p -147.32 -177.97 5.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.0 -36.51 82.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.441 -0.787 . . . . 0.0 109.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -68.41 -10.22 53.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.429 -0.794 . . . . 0.0 110.913 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -89.05 14.54 10.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 21' ' ' THR . 99.2 m -115.68 -170.85 1.86 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 m -115.92 -176.51 2.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -49.19 77.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.532 -0.73 . . . . 0.0 110.133 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 20' ' ' LEU . 2.6 tt -55.15 -23.85 23.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.435 -0.791 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 75.9 p -132.7 86.97 42.68 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.74 6.75 4.67 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.934 2.423 . . . . 0.0 112.068 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -126.12 147.83 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.057 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.4 t -123.94 97.35 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' HG11 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.39 144.0 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.643 -0.661 . . . . 0.0 110.003 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 59.69 35.85 22.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.652 . . . . 0.0 110.025 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.4 28.21 64.38 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -140.35 166.25 25.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.977 . . . . 0.0 109.27 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.3 m -108.19 138.78 43.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.0 m . . . . . 0 N--CA 1.484 1.273 0 O-C-N 121.506 -0.746 . . . . 0.0 109.055 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.4 34.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.44 11.77 20.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.427 -1.043 . . . . 0.0 110.293 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.74 -4.78 72.65 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -125.43 136.87 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.57 1.185 . . . . 0.0 109.213 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.2 p -150.72 170.67 18.66 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.73 0.776 . . . . 0.0 110.84 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -117.09 -6.25 11.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.3 p -166.68 173.08 9.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.89 -37.97 86.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 109.974 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -68.4 -10.67 56.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.424 -0.798 . . . . 0.0 110.975 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.61 15.13 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.276 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 21' ' ' THR . 96.8 m -117.42 -170.9 1.94 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.091 -1.006 . . . . 0.0 109.93 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.3 m -115.74 -177.27 3.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.25 -49.1 78.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 mt -54.85 -25.31 27.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.118 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 65.5 p -131.74 86.74 47.6 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.46 6.16 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.915 2.41 . . . . 0.0 112.089 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -125.78 145.98 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.03 -1.044 . . . . 0.0 110.803 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -127.05 148.41 50.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.726 -0.609 . . . . 0.0 109.985 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 59.59 33.02 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.706 -0.621 . . . . 0.0 109.934 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.87 72.37 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -144.59 168.21 20.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.595 -0.944 . . . . 0.0 109.462 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.7 m -108.71 139.3 43.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 110.15 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.3 m . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 120.951 0.405 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.93 48.17 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -94.16 8.95 39.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.556 -0.967 . . . . 0.0 110.456 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -5.29 70.37 Favored Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.236 -0.915 . . . . 0.0 111.155 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -124.76 137.64 54.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.093 -1.24 . . . . 0.0 109.339 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 p -150.85 173.83 13.79 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.8 0.809 . . . . 0.0 110.751 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -124.11 4.26 8.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 p -175.44 170.19 3.04 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.04 -38.76 89.92 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.0 109.837 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -68.52 -10.77 57.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.772 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.79 15.38 9.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.131 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 21' ' ' THR . 93.8 m -117.58 -171.09 1.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.147 -0.971 . . . . 0.0 109.897 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -115.26 -175.98 2.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.475 -0.765 . . . . 0.0 109.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -46.09 89.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 20' ' ' LEU . 3.4 tt -56.72 -23.5 42.78 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.447 -0.783 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 57.1 p -133.8 87.51 35.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.74 5.04 5.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.4 p -126.13 146.37 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.051 -1.03 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.3 t -124.59 97.34 5.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -126.62 146.67 50.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.621 -0.674 . . . . 0.0 109.855 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 60.17 33.7 21.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.615 -0.678 . . . . 0.0 109.85 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.62 29.09 68.92 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -142.39 166.76 23.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 109.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.81 140.03 42.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.45 -0.781 . . . . 0.0 110.138 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.4 m . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.73 30.0 27.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.98 12.4 17.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.566 -0.961 . . . . 0.0 110.283 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.12 -2.43 75.92 Favored Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.159 -0.963 . . . . 0.0 111.025 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -125.95 137.98 53.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.134 -1.215 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -150.44 166.32 30.47 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.725 0.774 . . . . 0.0 110.792 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -26.37 11.27 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -148.24 -179.47 6.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.1 -37.76 88.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 mtt-85 -67.86 -10.16 50.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.513 -0.742 . . . . 0.0 111.16 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.02 14.73 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.429 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -115.35 -172.28 2.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.085 -1.009 . . . . 0.0 109.974 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -113.99 -175.52 2.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -0.773 . . . . 0.0 109.721 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -63.31 -46.1 88.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.941 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.1 mp -56.93 -23.32 44.38 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.447 -0.783 . . . . 0.0 110.114 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 45.4 p -132.74 86.87 42.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -77.58 5.15 5.4 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.879 2.386 . . . . 0.0 112.265 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.7 p -127.06 146.68 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.97 -1.081 . . . . 0.0 110.941 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.23 96.38 5.02 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -124.83 145.13 49.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.748 -0.595 . . . . 0.0 109.95 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 60.01 34.52 21.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.621 -0.674 . . . . 0.0 109.839 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.03 29.0 67.17 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -141.83 167.27 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.585 -0.95 . . . . 0.0 109.337 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.8 m -108.79 138.06 45.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.373 -0.829 . . . . 0.0 110.265 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.712 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.4 m . . . . . 0 N--CA 1.485 1.286 0 O-C-N 121.657 -0.652 . . . . 0.0 109.274 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 120.86 0.362 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.92 28.53 37.54 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -96.91 7.32 46.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -1.016 . . . . 0.0 110.524 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.96 -4.36 70.98 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 121.181 -0.949 . . . . 0.0 111.134 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -125.21 139.13 54.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.091 -1.241 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 p -150.44 166.08 31.22 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.687 0.756 . . . . 0.0 110.954 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.2 m -106.81 -26.44 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.2 p -148.16 -178.57 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.02 -36.69 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.409 -0.807 . . . . 0.0 109.901 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -10.58 54.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.464 -0.772 . . . . 0.0 111.016 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.86 15.55 9.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 21' ' ' THR . 88.8 m -115.5 -170.54 1.79 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.926 . . . . 0.0 109.981 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -116.38 -177.18 3.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.974 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.5 -49.61 76.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.58 -0.7 . . . . 0.0 110.241 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 tp -55.21 -23.56 22.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 81.7 p -132.82 88.27 38.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.0 108.955 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -80.12 7.62 4.57 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.82 2.347 . . . . 0.0 111.921 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -125.51 146.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.048 -1.032 . . . . 0.0 110.695 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.99 97.61 5.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -125.71 144.25 50.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.695 -0.628 . . . . 0.0 110.02 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 59.89 36.06 21.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.649 -0.657 . . . . 0.0 109.939 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.42 64.13 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -140.33 165.9 26.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.565 -0.962 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -109.04 139.1 44.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.424 -0.798 . . . . 0.0 110.24 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 23' ' ' VAL . 24.6 m . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.16 10.59 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.85 16.08 13.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.532 -0.981 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.95 8.43 61.16 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.012 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -129.55 134.77 47.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.173 -1.192 . . . . 0.0 109.058 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.67 166.92 28.9 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.902 0.858 . . . . 0.0 111.18 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 m -106.78 -28.71 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -145.42 -177.37 5.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.25 -37.55 83.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.311 -0.868 . . . . 0.0 110.011 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.46 -10.37 50.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.39 -0.819 . . . . 0.0 111.052 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.74 15.1 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 0.0 110.321 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' THR . 90.6 m -114.74 -171.31 1.91 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.088 -1.008 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.01 -179.26 3.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 110.046 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.28 -50.53 72.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.176 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -54.56 -23.99 19.07 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.353 -0.842 . . . . 0.0 110.219 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 70.2 p -132.42 89.08 37.51 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.92 10.33 3.69 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.875 2.383 . . . . 0.0 111.648 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.4 p -126.18 145.29 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.742 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.8 t -122.89 96.94 5.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -125.81 145.98 49.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.736 -0.602 . . . . 0.0 110.001 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 59.33 34.94 23.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.75 -0.594 . . . . 0.0 109.872 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.33 27.67 65.87 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 m -140.84 168.78 18.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.477 -1.014 . . . . 0.0 109.425 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.55 140.18 43.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 23' ' ' VAL . 30.6 m . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.53 31.69 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -90.4 12.58 18.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.974 . . . . 0.0 110.214 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 -3.87 76.29 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.15 -0.969 . . . . 0.0 110.988 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.258 . . . . 0.0 109.405 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.43 166.26 30.65 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.813 0.816 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -106.63 -28.21 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -145.75 -177.4 5.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.79 -36.52 80.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.394 -0.816 . . . . 0.0 109.848 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -67.85 -10.47 53.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.17 14.51 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.452 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 21' ' ' THR . 75.1 m -116.49 -169.77 1.69 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -117.52 -177.57 3.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.458 -0.776 . . . . 0.0 110.352 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.17 -52.3 65.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.631 . . . . 0.0 110.227 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -52.9 -25.52 12.0 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.35 -0.844 . . . . 0.0 110.14 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 62.2 p -132.77 87.74 40.01 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.93 8.91 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.793 2.329 . . . . 0.0 111.675 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.5 p -125.66 145.0 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.2 t -122.99 96.52 5.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -125.29 146.51 49.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.609 -0.682 . . . . 0.0 109.919 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 59.9 33.64 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.601 -0.687 . . . . 0.0 109.878 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.28 29.31 71.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -143.16 168.03 20.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 0.0 109.352 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.1 m -109.61 141.45 42.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.74 ' O ' HG12 ' A' ' 23' ' ' VAL . 26.3 m . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 120.967 0.413 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.68 29.01 49.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.02 9.86 35.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.522 -0.987 . . . . 0.0 110.409 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.56 72.6 Favored Glycine 0 N--CA 1.49 2.271 0 O-C-N 121.121 -0.987 . . . . 0.0 111.084 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -125.1 137.04 54.19 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.648 1.224 . . . . 0.0 109.276 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.52 165.9 31.84 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.814 0.816 . . . . 0.0 110.987 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 p -106.13 -26.95 11.38 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.56 -177.7 5.92 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.75 -35.76 80.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.431 -0.793 . . . . 0.0 109.874 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -67.95 -10.83 56.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.496 -0.753 . . . . 0.0 110.939 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.41 16.44 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 0.0 110.096 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' THR . 94.5 m -116.92 -170.98 1.94 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.1 m -116.89 -178.79 3.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.333 -0.854 . . . . 0.0 110.058 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -61.13 -50.74 71.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.579 -0.7 . . . . 0.0 110.143 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 tp -53.45 -24.94 14.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.33 -0.856 . . . . 0.0 110.128 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 60.9 p -132.67 88.88 37.08 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.66 8.77 4.37 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.803 2.336 . . . . 0.0 111.533 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.3 p -125.64 144.14 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.109 -0.995 . . . . 0.0 110.448 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.01 96.64 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -129.06 150.93 50.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.739 -0.601 . . . . 0.0 109.63 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 60.56 30.91 20.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.737 -0.602 . . . . 0.0 109.647 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.03 28.27 70.19 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -144.7 170.49 16.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.972 . . . . 0.0 109.484 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.6 m -109.62 141.88 41.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 110.239 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 23' ' ' VAL . 28.2 m . . . . . 0 C--N 1.308 -1.216 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.53 28.31 33.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.8 14.05 24.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.982 . . . . 0.0 110.18 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.89 9.54 59.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -129.28 133.01 47.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.233 -1.157 . . . . 0.0 108.898 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.9 p -150.91 166.88 29.25 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -106.53 -28.23 10.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -146.53 -177.79 5.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.45 -35.55 79.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -67.97 -10.83 56.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.19 16.66 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.206 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' THR . 91.0 m -115.62 -171.45 1.97 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 110.304 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.8 m -113.12 177.82 4.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 109.956 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.12 -47.71 83.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.67 . . . . 0.0 109.811 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.41 -25.8 38.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 64.8 p -131.26 88.91 43.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.44 9.93 3.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.881 2.387 . . . . 0.0 111.946 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.1 p -125.6 144.41 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.067 -1.021 . . . . 0.0 110.735 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -122.76 95.81 4.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -127.34 149.98 49.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 0.0 109.759 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 59.87 32.21 21.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.721 -0.612 . . . . 0.0 109.626 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.27 28.11 68.7 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m -143.53 170.45 15.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -1.001 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.9 m -109.57 140.61 43.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.417 -0.802 . . . . 0.0 110.268 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.751 ' O ' HG12 ' A' ' 23' ' ' VAL . 24.6 m . . . . . 0 C--N 1.308 -1.2 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.92 0.391 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.71 27.6 50.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.14 8.26 42.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -1.03 . . . . 0.0 110.443 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.46 -8.87 66.45 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.187 -0.946 . . . . 0.0 111.084 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 33.5 ptt180 -123.48 138.96 54.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -1.179 . . . . 0.0 109.37 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 12.1 p -150.07 166.66 29.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.678 0.751 . . . . 0.0 110.768 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 p -107.72 -24.87 11.54 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 p -149.96 -179.75 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.38 -35.65 81.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -68.37 -10.85 57.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.413 -0.804 . . . . 0.0 110.883 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.7 OUTLIER -90.37 15.9 9.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.152 -0.967 . . . . 0.0 110.137 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' THR . 87.8 m -116.26 -170.86 1.89 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -118.21 -176.72 3.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 109.829 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.38 -48.03 81.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.608 -0.683 . . . . 0.0 109.991 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.19 -23.9 24.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.468 -0.77 . . . . 0.0 110.104 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 77.7 p -133.56 87.93 35.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.13 5.98 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.912 2.408 . . . . 0.0 112.093 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 30' ' ' VAL . 11.2 p -125.91 146.13 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.011 -1.056 . . . . 0.0 110.831 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.6 t -124.13 96.14 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 150.26 50.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.678 -0.639 . . . . 0.0 109.802 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.29 31.62 20.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.556 -0.715 . . . . 0.0 109.72 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.33 71.51 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 3.1 m -144.71 169.28 18.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.975 . . . . 0.0 109.509 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.4 m -108.82 139.12 44.08 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.8 m . . . . . 0 N--CA 1.483 1.206 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 34.75 20.84 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -95.23 21.89 7.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.492 -1.005 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.59 7.13 64.1 Favored Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.382 -0.824 . . . . 0.0 111.305 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -129.8 133.67 47.11 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 118.734 1.267 . . . . 0.0 109.339 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.28 167.73 26.94 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.728 0.775 . . . . 0.0 110.987 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.1 p -106.27 -29.55 9.73 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 p -145.6 -177.4 5.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.91 -37.66 84.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 109.983 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -68.02 -9.68 47.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.415 -0.803 . . . . 0.0 111.133 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 13.91 10.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.118 -0.989 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' THR . 80.4 m -114.6 -171.16 1.88 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 110.065 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.1 m -112.82 179.93 3.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.745 . . . . 0.0 109.932 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.04 -47.0 88.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.627 -0.671 . . . . 0.0 109.921 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.93 -27.96 54.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 67.1 p -128.99 87.17 55.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -80.91 7.8 4.69 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.92 2.413 . . . . 0.0 111.909 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.0 p -125.3 143.41 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.061 -1.025 . . . . 0.0 110.684 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -121.97 95.77 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -121.3 143.47 49.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 110.111 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 59.16 35.35 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.802 -0.561 . . . . 0.0 109.992 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.85 29.89 71.56 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -141.64 166.4 24.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.605 -0.938 . . . . 0.0 109.295 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.54 140.23 43.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.405 -0.81 . . . . 0.0 110.446 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 23' ' ' VAL . 22.4 m . . . . . 0 C--N 1.309 -1.155 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.88 28.88 24.88 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -91.23 11.66 22.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.607 -0.937 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.58 1.35 70.9 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.092 -1.005 . . . . 0.0 111.027 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -126.29 136.71 53.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.17 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 13.2 p -150.57 166.28 30.74 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.607 0.717 . . . . 0.0 110.797 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -107.25 -24.7 11.8 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p -150.04 178.79 8.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -63.36 -37.52 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -67.97 -10.47 53.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.477 -0.764 . . . . 0.0 111.099 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 4.7 m-20 -90.35 15.8 9.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 21' ' ' THR . 94.5 m -114.28 -172.98 2.2 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.4 m -114.02 -175.81 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.46 -45.32 87.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.801 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.063 HD12 HG23 ' A' ' 21' ' ' THR . 1.3 pp -58.01 -20.84 41.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.254 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 1.063 HG23 HD12 ' A' ' 20' ' ' LEU . 22.7 p -133.74 88.28 33.67 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.77 4.93 5.23 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.95 2.433 . . . . 0.0 112.397 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.5 p -128.21 147.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.975 -1.078 . . . . 0.0 110.961 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -123.6 97.42 5.38 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -127.74 147.11 50.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.708 -0.62 . . . . 0.0 109.997 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 59.99 33.97 21.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.64 -0.662 . . . . 0.0 109.901 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.29 29.34 68.62 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -143.45 167.96 20.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.595 -0.944 . . . . 0.0 109.343 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.7 m -108.9 138.13 45.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.8 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 23' ' ' VAL . 18.3 m . . . . . 0 N--CA 1.486 1.363 0 O-C-N 121.594 -0.691 . . . . 0.0 109.262 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.74 28.94 33.59 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -90.26 11.81 20.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.53 -0.983 . . . . 0.0 110.274 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.88 73.52 Favored Glycine 0 N--CA 1.49 2.293 0 O-C-N 121.217 -0.927 . . . . 0.0 111.162 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -126.26 136.84 53.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.059 -1.26 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 9.3 p -150.54 166.06 31.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.726 0.774 . . . . 0.0 110.9 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.1 m -106.19 -26.93 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -148.11 -178.94 6.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.7 -36.52 83.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 109.893 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -67.95 -10.56 54.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.983 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.3 m-20 -89.79 15.69 9.32 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 110.282 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' THR . 90.0 m -115.46 -171.34 1.94 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.089 -1.007 . . . . 0.0 110.015 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.8 m -115.57 -178.62 3.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.54 -0.725 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.41 -49.58 76.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.665 -0.647 . . . . 0.0 110.168 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.72 -24.31 21.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.351 -0.843 . . . . 0.0 110.09 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 75.9 p -132.06 87.29 44.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.2 7.51 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.864 2.376 . . . . 0.0 112.123 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -126.02 145.17 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.046 . . . . 0.0 110.892 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.95 95.63 4.69 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 148.78 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.756 -0.59 . . . . 0.0 109.793 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 59.45 33.04 22.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.816 -0.552 . . . . 0.0 109.808 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.92 28.9 69.35 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -143.49 169.29 17.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.507 -0.996 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.1 m -109.13 139.05 44.54 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.3 m . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.002 0.429 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.1 27.78 55.26 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.4 7.65 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.431 -1.041 . . . . 0.0 110.392 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.52 -2.7 71.26 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.177 -0.952 . . . . 0.0 111.207 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.969 -1.312 . . . . 0.0 109.474 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 7.6 p -150.17 166.5 29.64 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.74 0.781 . . . . 0.0 111.092 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.99 -28.11 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -145.66 -177.96 5.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.25 -36.71 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -67.86 -10.47 53.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.98 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 3.8 m-20 -88.4 14.78 8.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.362 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' THR . 96.6 m -115.62 -169.91 1.68 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 110.207 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 m -114.24 179.48 3.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -51.69 68.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.655 -0.653 . . . . 0.0 109.952 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.09 -25.59 13.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.392 -0.817 . . . . 0.0 109.997 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 65.9 p -132.24 87.9 41.86 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.12 11.22 3.34 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.819 2.346 . . . . 0.0 111.702 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.3 p -125.74 145.47 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.618 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -123.22 97.57 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.24 145.41 50.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.67 . . . . 0.0 109.944 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.12 34.9 21.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.647 -0.658 . . . . 0.0 109.827 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.79 27.94 64.97 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -140.68 167.7 21.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -1.02 . . . . 0.0 109.374 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.28 140.38 43.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.754 ' O ' HG12 ' A' ' 23' ' ' VAL . 29.4 m . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.029 0.442 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.86 28.03 67.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.92 7.3 38.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.478 -1.013 . . . . 0.0 110.383 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.27 -17.22 54.96 Favored Glycine 0 N--CA 1.488 2.127 0 O-C-N 121.217 -0.927 . . . . 0.0 111.105 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 147.17 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.92 173.24 14.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 0.0 110.596 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -123.83 6.16 8.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.2 p -177.63 169.73 2.08 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.28 -39.12 91.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.367 -0.833 . . . . 0.0 109.809 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -68.88 -10.5 57.38 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.76 15.13 10.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' THR . 89.4 m -116.01 -171.06 1.91 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.088 -1.008 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.6 m -114.03 -177.87 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.446 -0.784 . . . . 0.0 109.749 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.29 -48.05 81.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.64 -0.663 . . . . 0.0 110.018 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -23.6 27.28 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.387 -0.821 . . . . 0.0 110.065 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 74.4 p -132.93 87.7 39.43 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.15 6.15 4.89 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.772 2.314 . . . . 0.0 112.198 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -126.11 146.86 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.997 -1.064 . . . . 0.0 110.852 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -124.94 98.04 5.52 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -130.76 148.07 52.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.672 -0.643 . . . . 0.0 109.796 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 59.86 33.97 21.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.71 -0.619 . . . . 0.0 109.791 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.68 25.88 61.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 m -142.06 156.79 45.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.463 -1.022 . . . . 0.0 109.385 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -98.47 140.51 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.526 -0.733 . . . . 0.0 110.052 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 23' ' ' VAL . 21.3 m . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.039 0.447 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.6 29.96 54.16 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' CB ' ' NH1' ' A' ' 10' ' ' ARG . 7.7 m120 -89.88 11.38 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.992 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -7.79 72.39 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.187 -0.946 . . . . 0.0 111.07 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -125.59 140.8 52.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.061 -1.258 . . . . 0.0 109.689 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -150.35 167.9 25.67 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.625 0.726 . . . . 0.0 110.81 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 t -107.45 -28.04 10.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.9 p -146.52 179.11 7.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -64.04 -38.48 91.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 109.938 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -67.81 -9.78 47.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.159 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.75 13.75 9.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.084 -1.01 . . . . 0.0 110.455 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 21' ' ' THR . 78.2 m -114.42 -168.92 1.44 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.043 -1.036 . . . . 0.0 109.928 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 m -116.67 -176.55 2.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.373 -0.829 . . . . 0.0 110.195 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.41 -51.75 68.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.656 -0.653 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.93 -24.51 16.59 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.292 -0.88 . . . . 0.0 110.11 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 72.1 p -133.91 88.9 31.04 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.31 9.76 3.96 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.77 2.313 . . . . 0.0 111.531 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.7 p -126.34 146.08 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.98 96.97 5.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 142.22 50.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.676 -0.64 . . . . 0.0 110.091 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 59.55 36.8 22.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.696 -0.627 . . . . 0.0 110.003 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.52 28.93 65.73 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -140.12 165.58 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.634 -0.921 . . . . 0.0 109.265 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -108.6 139.91 42.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.467 -0.77 . . . . 0.0 110.216 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 23' ' ' VAL . 27.5 m . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.92 0.391 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.2 28.81 55.31 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -89.79 9.44 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.491 -1.005 . . . . 0.0 110.37 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.99 -6.6 70.17 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 121.213 -0.93 . . . . 0.0 111.276 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -124.62 139.6 53.71 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 118.694 1.247 . . . . 0.0 109.784 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 p -150.51 166.24 30.81 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.722 0.773 . . . . 0.0 110.604 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.1 m -106.3 -26.47 11.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.9 -178.65 6.48 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.88 -36.43 83.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.473 -0.767 . . . . 0.0 109.937 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.99 -10.6 54.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.497 -0.752 . . . . 0.0 111.025 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.12 15.97 9.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 110.168 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' THR . 83.9 m -115.38 -171.39 1.95 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.145 -0.972 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.3 m -114.9 -178.59 3.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.055 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.31 -50.21 73.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.615 -0.678 . . . . 0.0 110.056 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mp -54.62 -24.27 20.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.354 -0.841 . . . . 0.0 110.209 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 78.4 p -131.92 88.02 42.9 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.89 8.2 4.18 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -125.86 145.41 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.02 -1.05 . . . . 0.0 110.767 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -123.96 96.38 4.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -126.0 147.18 49.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.685 -0.635 . . . . 0.0 109.946 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mtm-85 60.16 33.26 21.12 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.654 -0.654 . . . . 0.0 109.757 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.8 29.53 70.52 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -142.92 167.56 21.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.589 -0.948 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -108.68 138.68 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.494 -0.754 . . . . 0.0 110.24 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.752 ' O ' HG12 ' A' ' 23' ' ' VAL . 26.1 m . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.56 27.74 46.17 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.28 10.98 22.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -1.047 . . . . 0.0 110.287 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.4 -3.38 73.26 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 121.187 -0.946 . . . . 0.0 111.093 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -124.53 136.34 53.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.268 . . . . 0.0 109.472 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.3 p -150.76 168.14 25.31 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.657 0.742 . . . . 0.0 110.783 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.3 m -112.5 -10.95 13.68 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -163.63 175.15 10.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.41 -37.06 84.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 109.82 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -68.31 -11.06 58.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.444 -0.785 . . . . 0.0 110.981 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 16.76 8.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 21' ' ' THR . 88.7 m -116.27 -172.19 2.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.025 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.9 m -114.75 -178.08 3.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.52 -0.738 . . . . 0.0 109.746 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.47 -47.67 82.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.06 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.24 -23.32 35.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.326 -0.859 . . . . 0.0 110.151 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 77.5 p -132.13 87.33 44.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.45 5.86 4.84 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.854 2.369 . . . . 0.0 112.279 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -125.9 146.61 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.036 -1.04 . . . . 0.0 110.857 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.6 t -124.61 94.78 4.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -127.12 150.8 49.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.718 -0.614 . . . . 0.0 109.823 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.99 31.1 20.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.71 -0.619 . . . . 0.0 109.679 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 30.1 74.39 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -146.06 169.98 17.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.949 . . . . 0.0 109.558 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.96 139.34 43.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.462 -0.774 . . . . 0.0 110.396 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.714 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.7 m . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.913 0.387 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.06 28.74 44.17 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -110.85 10.97 22.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -1.026 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.94 8.28 60.84 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.19 -0.944 . . . . 0.0 110.931 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -129.31 135.2 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.129 -1.218 . . . . 0.0 108.941 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.72 165.41 33.55 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.821 0.82 . . . . 0.0 111.138 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -105.59 -28.62 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -145.04 -176.7 5.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -68.27 -36.29 79.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.385 -0.822 . . . . 0.0 109.868 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -68.1 -10.31 52.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.351 -0.843 . . . . 0.0 110.956 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.55 15.69 8.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.272 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 21' ' ' THR . 87.5 m -114.25 -171.21 1.87 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.27 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.8 m -114.38 -179.23 3.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.494 -0.754 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.7 -49.94 74.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.618 -0.676 . . . . 0.0 110.121 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -54.64 -23.89 19.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.33 -0.856 . . . . 0.0 110.129 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 71.0 p -132.88 89.43 34.62 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.56 9.69 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.818 2.345 . . . . 0.0 111.609 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.4 p -126.16 145.12 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.7 t -122.68 98.16 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' A' ' 23' ' ' VAL . 18.4 mtmt -126.51 145.81 50.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.708 -0.62 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.72 35.14 22.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.634 -0.666 . . . . 0.0 109.931 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.42 65.95 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 m -141.68 167.88 21.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.456 -1.026 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.6 m -109.57 141.11 42.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.805 . . . . 0.0 110.18 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 23' ' ' VAL . 25.8 m . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 30.47 30.63 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.2 13.14 15.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.967 . . . . 0.0 110.302 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.44 -2.47 77.56 Favored Glycine 0 N--CA 1.489 2.175 0 O-C-N 121.234 -0.916 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 4.3 ptp180 -126.28 138.08 53.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.993 -1.298 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.85 168.11 25.45 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.73 0.776 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -107.35 -28.24 9.99 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.3 p -146.89 -179.37 6.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.26 -37.25 86.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.0 109.996 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -68.09 -9.9 49.8 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.494 -0.754 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.17 14.86 9.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' THR . 84.3 m -114.73 -170.41 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.053 -1.029 . . . . 0.0 110.093 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -115.94 -176.71 3.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.504 -0.748 . . . . 0.0 110.077 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.75 -49.81 74.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.1 -23.59 21.51 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.357 -0.839 . . . . 0.0 110.153 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 63.6 p -134.31 89.48 27.56 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.21 8.7 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.758 2.305 . . . . 0.0 111.456 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 30' ' ' VAL . 11.9 p -125.02 145.17 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.0 110.466 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -125.83 98.9 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -126.91 145.83 50.53 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.897 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 60.09 33.88 21.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.678 . . . . 0.0 109.808 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.98 28.98 69.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -140.51 165.61 26.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -1.016 . . . . 0.0 109.5 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.77 142.45 42.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 23' ' ' VAL . 23.5 m . . . . . 0 C--N 1.308 -1.219 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 2' ' ' LEU . 5.2 tt -157.91 87.7 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.642 . . . . 0.0 109.527 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -148.95 56.99 1.02 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.635 -0.666 . . . . 0.0 109.288 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.9 t -177.32 96.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.87 -29.9 62.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.741 -0.6 . . . . 0.0 109.661 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -137.98 -78.91 0.37 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.58 -0.7 . . . . 0.0 110.04 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.92 27.69 49.08 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.85 8.76 33.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.475 -1.015 . . . . 0.0 110.404 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.14 -5.66 70.86 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.109 -0.995 . . . . 0.0 111.068 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -125.2 140.39 52.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.134 -1.215 . . . . 0.0 109.423 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.27 165.18 33.77 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.77 0.795 . . . . 0.0 110.862 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.44 -26.48 11.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 p -147.32 -177.97 5.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.0 -36.51 82.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.441 -0.787 . . . . 0.0 109.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -68.41 -10.22 53.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.429 -0.794 . . . . 0.0 110.913 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -89.05 14.54 10.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 21' ' ' THR . 99.2 m -115.68 -170.85 1.86 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 m -115.92 -176.51 2.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.565 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 2.8 tt0 -61.49 -49.19 77.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.532 -0.73 . . . . 0.0 110.133 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 20' ' ' LEU . 2.6 tt -55.15 -23.85 23.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.435 -0.791 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 75.9 p -132.7 86.97 42.68 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.74 6.75 4.67 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.934 2.423 . . . . 0.0 112.068 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -126.12 147.83 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.057 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.4 t -123.94 97.35 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' HG11 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.39 144.0 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.643 -0.661 . . . . 0.0 110.003 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 59.69 35.85 22.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.652 . . . . 0.0 110.025 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.4 28.21 64.38 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -140.35 166.25 25.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.977 . . . . 0.0 109.27 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.3 m -108.19 138.78 43.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.0 m -150.7 -172.61 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 O-C-N 121.506 -0.746 . . . . 0.0 109.055 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.3 p -83.77 120.4 25.98 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.286 0.565 . . . . 0.0 109.769 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.9 p -60.6 -57.6 12.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.716 -0.615 . . . . 0.0 109.75 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.62 -150.25 39.59 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.0 179.91 3.52 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.416 2.744 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.27 -94.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 36' ' ' LEU . 9.1 tp -139.3 158.89 43.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.548 -0.972 . . . . 0.0 109.447 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -63.0 173.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.514 -0.741 . . . . 0.0 109.499 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.6 -77.17 0.64 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.78 133.47 6.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.408 ' HB ' HD12 ' A' ' 41' ' ' LEU . 47.2 mt -74.71 -24.87 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.513 -0.993 . . . . 0.0 109.964 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 40' ' ' ILE . 5.1 mp -119.19 97.09 5.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.565 -0.71 . . . . 0.0 109.456 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.06 105.82 0.18 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.64 29.96 10.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mt -130.98 144.07 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.6 -0.941 . . . . 0.0 109.503 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.721 ' O ' HD23 ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.71 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mt -131.37 -170.72 2.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . . . -170.31 83.48 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.612 -0.68 . . . . 0.0 109.518 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.2 t -177.17 96.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 15' ' ' ARG . 45.7 mt -73.45 -30.86 63.46 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -145.65 -78.6 0.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.709 -0.619 . . . . 0.0 109.756 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.4 34.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.44 11.77 20.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.427 -1.043 . . . . 0.0 110.293 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.74 -4.78 72.65 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -125.43 136.87 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.57 1.185 . . . . 0.0 109.213 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.2 p -150.72 170.67 18.66 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.73 0.776 . . . . 0.0 110.84 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -117.09 -6.25 11.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.3 p -166.68 173.08 9.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.89 -37.97 86.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 109.974 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.562 ' O ' HD12 ' A' ' 5' ' ' LEU . 12.3 ttt180 -68.4 -10.67 56.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.424 -0.798 . . . . 0.0 110.975 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.61 15.13 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.276 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 21' ' ' THR . 96.8 m -117.42 -170.9 1.94 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.091 -1.006 . . . . 0.0 109.93 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.3 m -115.74 -177.27 3.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 3' ' ' ALA . 1.3 tt0 -61.25 -49.1 78.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 109.976 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 mt -54.85 -25.31 27.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.118 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 65.5 p -131.74 86.74 47.6 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.46 6.16 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.915 2.41 . . . . 0.0 112.089 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -125.78 145.98 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.03 -1.044 . . . . 0.0 110.803 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -127.05 148.41 50.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.726 -0.609 . . . . 0.0 109.985 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 59.59 33.02 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.706 -0.621 . . . . 0.0 109.934 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.87 72.37 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -144.59 168.21 20.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.595 -0.944 . . . . 0.0 109.462 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.7 m -108.71 139.3 43.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 110.15 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.3 m -150.63 -173.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -83.62 121.61 27.48 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.294 0.569 . . . . 0.0 109.829 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.6 p -59.64 -29.21 67.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.719 -0.613 . . . . 0.0 109.722 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.5 80.16 0.74 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.76 50.54 2.28 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.412 2.742 . . . . 0.0 110.425 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.74 -32.45 2.53 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.0 137.11 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.585 -0.95 . . . . 0.0 109.26 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -103.07 -174.01 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.611 -0.681 . . . . 0.0 109.552 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.04 -71.54 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.82 -106.85 1.0 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 40' ' ' ILE . 4.6 mp -116.59 53.51 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.65 -0.912 . . . . 0.0 109.4 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.9 mt -63.1 159.3 17.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.42 -0.8 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.21 59.18 0.28 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.34 -119.58 0.9 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.76 160.49 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.925 . . . . 0.0 109.309 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.695 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 tp -153.71 108.68 3.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.518 -0.739 . . . . 0.0 109.456 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.38 44.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.675 -0.64 . . . . 0.0 109.286 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.1 t -177.44 96.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.53 -33.96 76.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.805 -0.559 . . . . 0.0 109.593 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -136.75 -79.86 0.39 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.63 -0.669 . . . . 0.0 110.01 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.93 48.17 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -94.16 8.95 39.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.556 -0.967 . . . . 0.0 110.456 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -5.29 70.37 Favored Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.236 -0.915 . . . . 0.0 111.155 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -124.76 137.64 54.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.093 -1.24 . . . . 0.0 109.339 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 p -150.85 173.83 13.79 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.8 0.809 . . . . 0.0 110.751 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -124.11 4.26 8.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 p -175.44 170.19 3.04 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.04 -38.76 89.92 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.0 109.837 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -68.52 -10.77 57.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.772 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.79 15.38 9.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.131 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 21' ' ' THR . 93.8 m -117.58 -171.09 1.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.147 -0.971 . . . . 0.0 109.897 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -115.26 -175.98 2.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.475 -0.765 . . . . 0.0 109.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -46.09 89.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 20' ' ' LEU . 3.4 tt -56.72 -23.5 42.78 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.447 -0.783 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 57.1 p -133.8 87.51 35.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.74 5.04 5.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.4 p -126.13 146.37 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.051 -1.03 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.3 t -124.59 97.34 5.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -126.62 146.67 50.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.621 -0.674 . . . . 0.0 109.855 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 60.17 33.7 21.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.615 -0.678 . . . . 0.0 109.85 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.62 29.09 68.92 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -142.39 166.76 23.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 109.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.81 140.03 42.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.45 -0.781 . . . . 0.0 110.138 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.4 m -150.59 -174.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 m -83.25 118.49 23.67 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.276 0.56 . . . . 0.0 110.007 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.8 p -63.16 -49.66 73.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.724 -0.61 . . . . 0.0 109.384 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.16 151.18 5.93 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.87 78.3 2.72 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 123.251 2.634 . . . . 0.0 110.44 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.29 106.9 3.0 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mt -84.96 107.6 17.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.913 . . . . 0.0 109.557 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.8 t -97.98 -38.83 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.588 -0.695 . . . . 0.0 109.459 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.49 -85.68 1.53 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.46 -172.18 39.11 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 40' ' ' ILE . 40.3 mm -100.46 34.81 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.564 -0.962 . . . . 0.0 109.328 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.4 mt -113.02 85.09 2.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.13 -102.02 0.21 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.37 29.62 44.13 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 45' ' ' LEU . 11.4 mt 60.61 162.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.582 -0.951 . . . . 0.0 109.529 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' N ' HG22 ' A' ' 44' ' ' ILE . 6.1 mp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.508 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.428 ' N ' HD23 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -137.82 37.92 2.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.686 . . . . 0.0 109.432 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -100.93 40.27 1.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.564 -0.71 . . . . 0.0 109.42 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.7 t -177.61 97.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.7 mt -73.87 -30.96 62.92 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -145.45 -77.72 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.666 -0.646 . . . . 0.0 109.744 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.73 30.0 27.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.98 12.4 17.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.566 -0.961 . . . . 0.0 110.283 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.12 -2.43 75.92 Favored Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.159 -0.963 . . . . 0.0 111.025 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -125.95 137.98 53.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.134 -1.215 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -150.44 166.32 30.47 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.725 0.774 . . . . 0.0 110.792 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -26.37 11.27 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -148.24 -179.47 6.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.1 -37.76 88.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 mtt-85 -67.86 -10.16 50.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.513 -0.742 . . . . 0.0 111.16 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.02 14.73 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.429 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -115.35 -172.28 2.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.085 -1.009 . . . . 0.0 109.974 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -113.99 -175.52 2.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -0.773 . . . . 0.0 109.721 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 15.8 tt0 -63.31 -46.1 88.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.941 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.1 mp -56.93 -23.32 44.38 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.447 -0.783 . . . . 0.0 110.114 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 45.4 p -132.74 86.87 42.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -77.58 5.15 5.4 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.879 2.386 . . . . 0.0 112.265 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.7 p -127.06 146.68 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.97 -1.081 . . . . 0.0 110.941 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.23 96.38 5.02 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -124.83 145.13 49.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.748 -0.595 . . . . 0.0 109.95 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 60.01 34.52 21.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.621 -0.674 . . . . 0.0 109.839 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.03 29.0 67.17 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -141.83 167.27 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.585 -0.95 . . . . 0.0 109.337 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.8 m -108.79 138.06 45.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.373 -0.829 . . . . 0.0 110.265 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.712 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.4 m -150.82 -173.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.657 -0.652 . . . . 0.0 109.274 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -80.67 116.11 20.51 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.324 0.583 . . . . 0.0 109.88 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 p -57.1 -30.31 64.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.671 -0.643 . . . . 0.0 110.101 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.95 -68.08 0.02 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -86.09 101.95 0.65 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.42 2.747 . . . . 0.0 110.486 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -129.24 -47.3 0.16 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tp 58.37 61.01 2.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.487 -1.008 . . . . 0.0 109.763 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 m -110.76 -173.68 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.503 -0.748 . . . . 0.0 109.507 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.88 133.7 23.0 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -108.77 -134.55 7.18 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 40' ' ' ILE . 39.8 mm -119.78 33.05 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.997 . . . . 0.0 109.521 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.9 mt -111.12 131.38 55.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.58 -0.7 . . . . 0.0 109.461 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.83 -108.07 0.01 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.3 106.19 0.23 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.7 mm -108.89 -30.71 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.613 -0.933 . . . . 0.0 109.41 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.453 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -132.07 88.94 2.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.775 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -127.27 47.81 2.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.619 -0.675 . . . . 0.0 109.337 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -177.12 96.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.6 mt -71.31 -31.11 67.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.686 -0.634 . . . . 0.0 109.741 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -133.74 -80.68 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.594 -0.691 . . . . 0.0 110.088 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.92 28.53 37.54 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -96.91 7.32 46.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -1.016 . . . . 0.0 110.524 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.96 -4.36 70.98 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 121.181 -0.949 . . . . 0.0 111.134 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -125.21 139.13 54.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.091 -1.241 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 p -150.44 166.08 31.22 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.687 0.756 . . . . 0.0 110.954 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.2 m -106.81 -26.44 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.2 p -148.16 -178.57 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.02 -36.69 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.409 -0.807 . . . . 0.0 109.901 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -10.58 54.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.464 -0.772 . . . . 0.0 111.016 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.86 15.55 9.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 21' ' ' THR . 88.8 m -115.5 -170.54 1.79 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.926 . . . . 0.0 109.981 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -116.38 -177.18 3.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.974 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.775 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 4.2 tt0 -61.5 -49.61 76.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.58 -0.7 . . . . 0.0 110.241 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 tp -55.21 -23.56 22.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 81.7 p -132.82 88.27 38.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.0 108.955 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -80.12 7.62 4.57 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.82 2.347 . . . . 0.0 111.921 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -125.51 146.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.048 -1.032 . . . . 0.0 110.695 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.99 97.61 5.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -125.71 144.25 50.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.695 -0.628 . . . . 0.0 110.02 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 59.89 36.06 21.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.649 -0.657 . . . . 0.0 109.939 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.42 64.13 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -140.33 165.9 26.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.565 -0.962 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -109.04 139.1 44.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.424 -0.798 . . . . 0.0 110.24 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 23' ' ' VAL . 24.6 m -150.72 -174.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -86.32 120.26 27.47 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.338 0.59 . . . . 0.0 109.738 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.2 p -60.47 -44.73 95.59 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.633 -0.667 . . . . 0.0 109.632 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.29 173.45 1.76 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.6 -166.2 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.473 2.782 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -108.11 58.87 0.39 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tt -120.11 84.73 2.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.553 -0.969 . . . . 0.0 109.443 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.29 -65.93 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.35 85.46 0.78 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.73 -29.43 6.95 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.8 mt -126.03 81.33 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.572 -0.958 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -92.89 143.49 26.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.712 -0.618 . . . . 0.0 109.528 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.85 -80.09 0.33 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.11 97.62 0.19 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt 59.53 76.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.564 -0.962 . . . . 0.0 109.696 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.716 -179.897 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 tp -102.17 97.29 7.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.595 -0.691 . . . . 0.0 109.497 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.818 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -162.18 44.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.624 -0.672 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.8 t -177.56 96.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.0 mt -64.59 -36.69 85.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.719 -0.613 . . . . 0.0 109.368 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -141.92 -76.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.16 10.59 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.85 16.08 13.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.532 -0.981 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.95 8.43 61.16 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.012 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -129.55 134.77 47.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.173 -1.192 . . . . 0.0 109.058 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.67 166.92 28.9 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.902 0.858 . . . . 0.0 111.18 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 m -106.78 -28.71 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -145.42 -177.37 5.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.25 -37.55 83.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.311 -0.868 . . . . 0.0 110.011 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.46 -10.37 50.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.39 -0.819 . . . . 0.0 111.052 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.74 15.1 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 0.0 110.321 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' THR . 90.6 m -114.74 -171.31 1.91 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.088 -1.008 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.01 -179.26 3.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 110.046 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.818 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -61.28 -50.53 72.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.176 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -54.56 -23.99 19.07 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.353 -0.842 . . . . 0.0 110.219 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 70.2 p -132.42 89.08 37.51 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.2 Cg_endo -82.92 10.33 3.69 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.875 2.383 . . . . 0.0 111.648 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.4 p -126.18 145.29 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.742 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.8 t -122.89 96.94 5.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -125.81 145.98 49.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.736 -0.602 . . . . 0.0 110.001 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 59.33 34.94 23.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.75 -0.594 . . . . 0.0 109.872 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.33 27.67 65.87 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 m -140.84 168.78 18.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.477 -1.014 . . . . 0.0 109.425 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.55 140.18 43.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 23' ' ' VAL . 30.6 m -150.32 178.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 33.5 t -93.96 109.73 21.44 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.169 0.509 . . . . 0.0 109.829 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -59.38 3.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.703 -0.623 . . . . 0.0 109.487 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.35 70.4 1.14 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.05 79.49 1.98 Allowed 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 123.457 2.771 . . . . 0.0 110.364 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.61 84.34 1.53 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.57 29.04 7.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.56 -0.965 . . . . 0.0 109.635 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.95 178.64 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.626 -0.671 . . . . 0.0 109.5 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.75 126.94 2.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 172.33 -155.94 24.38 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 40' ' ' ILE . 56.9 mt -113.12 40.57 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.57 -0.959 . . . . 0.0 109.361 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.663 HD13 HD11 ' A' ' 44' ' ' ILE . 42.0 mt -95.61 167.98 10.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.525 -0.734 . . . . 0.0 109.49 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.51 -34.33 2.29 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.03 121.3 0.74 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.663 HD11 HD13 ' A' ' 41' ' ' LEU . 41.0 mm -101.62 93.38 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.648 -0.913 . . . . 0.0 109.467 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 26.7 tp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 2' ' ' LEU . 0.3 OUTLIER -107.17 76.22 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.532 -0.73 . . . . 0.0 109.295 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -158.01 34.38 0.25 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.463 -0.773 . . . . 0.0 109.626 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.1 t -177.5 97.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 15' ' ' ARG . 26.6 mt -76.01 -30.28 58.44 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -147.93 -76.85 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.65 -0.656 . . . . 0.0 109.679 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.53 31.69 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -90.4 12.58 18.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.974 . . . . 0.0 110.214 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 -3.87 76.29 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.15 -0.969 . . . . 0.0 110.988 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.258 . . . . 0.0 109.405 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.43 166.26 30.65 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.813 0.816 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -106.63 -28.21 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -145.75 -177.4 5.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.79 -36.52 80.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.394 -0.816 . . . . 0.0 109.848 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.643 ' O ' HD12 ' A' ' 5' ' ' LEU . 32.8 ttt85 -67.85 -10.47 53.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.975 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.17 14.51 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.452 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 21' ' ' THR . 75.1 m -116.49 -169.77 1.69 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -117.52 -177.57 3.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.458 -0.776 . . . . 0.0 110.352 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.623 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 5.8 tt0 -60.17 -52.3 65.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.631 . . . . 0.0 110.227 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -52.9 -25.52 12.0 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.35 -0.844 . . . . 0.0 110.14 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 62.2 p -132.77 87.74 40.01 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.0 Cg_endo -82.93 8.91 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.793 2.329 . . . . 0.0 111.675 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.5 p -125.66 145.0 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.2 t -122.99 96.52 5.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -125.29 146.51 49.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.609 -0.682 . . . . 0.0 109.919 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 59.9 33.64 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.601 -0.687 . . . . 0.0 109.878 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.28 29.31 71.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -143.16 168.03 20.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 0.0 109.352 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.1 m -109.61 141.45 42.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.74 ' O ' HG12 ' A' ' 23' ' ' VAL . 26.3 m -150.3 176.24 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 12.2 p -92.8 108.95 20.38 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.244 0.545 . . . . 0.0 109.815 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -75.21 -50.18 17.02 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.502 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.91 -68.57 0.25 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HG2' HG11 ' A' ' 37' ' ' VAL . 43.3 Cg_endo -86.86 -165.02 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.465 2.776 . . . . 0.0 110.33 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.75 -44.63 0.1 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.53 71.27 3.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.53 -0.982 . . . . 0.0 109.702 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.655 HG11 ' HG2' ' A' ' 34' ' ' PRO . 15.8 m -128.45 160.29 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.534 -0.728 . . . . 0.0 109.416 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.23 87.82 0.04 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.8 173.64 37.33 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 40' ' ' ILE . 57.6 mt -99.0 51.22 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.586 -0.949 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -101.22 178.26 4.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.492 -0.755 . . . . 0.0 109.494 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.69 59.5 4.57 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -157.14 108.57 0.37 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.5 mt -120.57 -41.53 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.472 -1.016 . . . . 0.0 109.439 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.482 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 1' ' ' LEU . 4.2 mp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.15 114.48 21.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.632 -0.667 . . . . 0.0 109.64 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -132.93 60.7 1.7 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.602 -0.686 . . . . 0.0 109.339 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.4 t -177.47 97.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.3 mt -73.86 -30.34 62.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.717 -0.615 . . . . 0.0 109.662 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -135.52 -79.71 0.43 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.612 -0.68 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.68 29.01 49.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.02 9.86 35.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.522 -0.987 . . . . 0.0 110.409 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.56 72.6 Favored Glycine 0 N--CA 1.49 2.271 0 O-C-N 121.121 -0.987 . . . . 0.0 111.084 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -125.1 137.04 54.19 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.648 1.224 . . . . 0.0 109.276 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.52 165.9 31.84 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.814 0.816 . . . . 0.0 110.987 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 p -106.13 -26.95 11.38 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.56 -177.7 5.92 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.75 -35.76 80.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.431 -0.793 . . . . 0.0 109.874 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -67.95 -10.83 56.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.496 -0.753 . . . . 0.0 110.939 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.41 16.44 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 0.0 110.096 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' THR . 94.5 m -116.92 -170.98 1.94 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.1 m -116.89 -178.79 3.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.333 -0.854 . . . . 0.0 110.058 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 20.9 tp10 -61.13 -50.74 71.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.579 -0.7 . . . . 0.0 110.143 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 tp -53.45 -24.94 14.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.33 -0.856 . . . . 0.0 110.128 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 60.9 p -132.67 88.88 37.08 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 40.8 Cg_endo -82.66 8.77 4.37 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.803 2.336 . . . . 0.0 111.533 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.3 p -125.64 144.14 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.109 -0.995 . . . . 0.0 110.448 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.01 96.64 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -129.06 150.93 50.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.739 -0.601 . . . . 0.0 109.63 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 60.56 30.91 20.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.737 -0.602 . . . . 0.0 109.647 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.03 28.27 70.19 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -144.7 170.49 16.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.972 . . . . 0.0 109.484 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.6 m -109.62 141.88 41.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 110.239 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 23' ' ' VAL . 28.2 m -150.31 176.66 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 11.1 m -92.52 105.74 17.85 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.105 0.478 . . . . 0.0 109.859 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.24 157.75 0.14 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.01 49.12 1.91 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 123.497 2.798 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.25 51.78 6.57 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.25 158.33 20.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.578 -0.954 . . . . 0.0 109.557 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 38' ' ' GLY . 3.6 t -123.35 166.78 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 37' ' ' VAL . . . 145.46 -38.07 1.25 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.99 130.83 10.37 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 40' ' ' ILE . 62.4 mt -90.27 52.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.616 -0.932 . . . . 0.0 109.474 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.0 mt -85.25 110.11 18.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.508 -0.745 . . . . 0.0 109.464 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.2 118.66 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.45 -127.81 1.31 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -111.28 137.7 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.549 -0.971 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.436 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 2' ' ' LEU . 10.2 mt -124.9 107.22 10.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.621 -0.675 . . . . 0.0 109.458 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -168.97 40.27 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.672 -0.643 . . . . 0.0 109.312 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.5 t -177.47 97.24 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 mt -69.44 -33.27 72.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.692 -0.63 . . . . 0.0 109.544 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -133.24 -79.09 0.48 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.651 -0.656 . . . . 0.0 109.741 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.53 28.31 33.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.8 14.05 24.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.982 . . . . 0.0 110.18 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.89 9.54 59.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -129.28 133.01 47.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.233 -1.157 . . . . 0.0 108.898 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.9 p -150.91 166.88 29.25 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -106.53 -28.23 10.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -146.53 -177.79 5.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.45 -35.55 79.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -67.97 -10.83 56.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.19 16.66 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.206 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' THR . 91.0 m -115.62 -171.45 1.97 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 110.304 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.8 m -113.12 177.82 4.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 109.956 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.598 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 5.6 tt0 -62.12 -47.71 83.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.67 . . . . 0.0 109.811 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.41 -25.8 38.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 64.8 p -131.26 88.91 43.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.3 Cg_endo -81.44 9.93 3.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.881 2.387 . . . . 0.0 111.946 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.1 p -125.6 144.41 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.067 -1.021 . . . . 0.0 110.735 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -122.76 95.81 4.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -127.34 149.98 49.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 0.0 109.759 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 59.87 32.21 21.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.721 -0.612 . . . . 0.0 109.626 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.27 28.11 68.7 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m -143.53 170.45 15.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -1.001 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.9 m -109.57 140.61 43.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.417 -0.802 . . . . 0.0 110.268 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.751 ' O ' HG12 ' A' ' 23' ' ' VAL . 24.6 m -150.44 178.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 1.5 m -91.13 126.57 36.25 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.317 0.58 . . . . 0.0 109.606 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 p -61.02 -52.77 63.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.699 -0.626 . . . . 0.0 109.579 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.1 -76.59 0.22 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.65 66.04 5.65 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.43 2.754 . . . . 0.0 110.614 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -107.51 -33.68 3.06 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.94 140.88 49.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.922 . . . . 0.0 109.169 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.2 m -63.66 -174.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.56 -0.712 . . . . 0.0 109.419 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.35 134.6 1.76 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.79 -126.14 4.94 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 40' ' ' ILE . 55.7 mt -94.0 45.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.557 -0.967 . . . . 0.0 109.471 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.9 mt -105.46 36.02 2.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 109.53 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.12 -76.37 0.67 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.65 116.52 3.7 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 44' ' ' ILE . 6.7 tt -88.55 56.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.52 -0.988 . . . . 0.0 109.177 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.52 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mt -145.11 132.86 21.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.622 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -104.18 46.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.648 -0.658 . . . . 0.0 109.227 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -176.84 96.23 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 15' ' ' ARG . 40.4 mt -75.94 -28.49 57.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.745 -0.597 . . . . 0.0 109.728 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -138.81 -79.54 0.33 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.542 -0.724 . . . . 0.0 109.969 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.71 27.6 50.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.14 8.26 42.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -1.03 . . . . 0.0 110.443 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.46 -8.87 66.45 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.187 -0.946 . . . . 0.0 111.084 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 33.5 ptt180 -123.48 138.96 54.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -1.179 . . . . 0.0 109.37 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 12.1 p -150.07 166.66 29.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.678 0.751 . . . . 0.0 110.768 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 p -107.72 -24.87 11.54 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 p -149.96 -179.75 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.38 -35.65 81.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.542 ' O ' HD12 ' A' ' 5' ' ' LEU . 41.1 mtt180 -68.37 -10.85 57.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.413 -0.804 . . . . 0.0 110.883 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.7 OUTLIER -90.37 15.9 9.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.152 -0.967 . . . . 0.0 110.137 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' THR . 87.8 m -116.26 -170.86 1.89 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -118.21 -176.72 3.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 109.829 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 4.4 tm-20 -62.38 -48.03 81.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.608 -0.683 . . . . 0.0 109.991 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.19 -23.9 24.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.468 -0.77 . . . . 0.0 110.104 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 77.7 p -133.56 87.93 35.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.13 5.98 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.912 2.408 . . . . 0.0 112.093 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 30' ' ' VAL . 11.2 p -125.91 146.13 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.011 -1.056 . . . . 0.0 110.831 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.6 t -124.13 96.14 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 150.26 50.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.678 -0.639 . . . . 0.0 109.802 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.29 31.62 20.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.556 -0.715 . . . . 0.0 109.72 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.33 71.51 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 3.1 m -144.71 169.28 18.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.975 . . . . 0.0 109.509 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.4 m -108.82 139.12 44.08 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.8 m -150.57 -172.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.5 m -83.09 124.63 30.64 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.0 p -52.87 -49.76 65.18 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.753 -0.592 . . . . 0.0 110.331 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.54 -145.78 49.73 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -83.58 -165.29 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 123.205 2.603 . . . . 0.0 110.487 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.96 -110.13 2.7 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -85.27 157.31 20.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.615 -0.933 . . . . 0.0 109.559 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 t 67.67 -70.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.698 -0.626 . . . . 0.0 109.857 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.64 -147.73 47.27 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.49 154.06 6.62 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.84 -23.69 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.541 -0.976 . . . . 0.0 109.981 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 41' ' ' LEU . 15.5 mt -140.24 164.49 29.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 109.49 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.25 -83.92 1.1 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.48 -125.84 0.84 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -130.44 108.8 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.643 -0.916 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.511 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -84.0 99.59 10.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.489 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.96 37.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.666 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.8 t -177.82 97.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -66.85 -35.52 80.22 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -149.04 -75.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.807 -0.558 . . . . 0.0 109.573 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 34.75 20.84 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -95.23 21.89 7.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.492 -1.005 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.59 7.13 64.1 Favored Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.382 -0.824 . . . . 0.0 111.305 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -129.8 133.67 47.11 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 118.734 1.267 . . . . 0.0 109.339 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.28 167.73 26.94 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.728 0.775 . . . . 0.0 110.987 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.1 p -106.27 -29.55 9.73 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 p -145.6 -177.4 5.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.91 -37.66 84.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 109.983 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -68.02 -9.68 47.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.415 -0.803 . . . . 0.0 111.133 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 13.91 10.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.118 -0.989 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' THR . 80.4 m -114.6 -171.16 1.88 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 110.065 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.1 m -112.82 179.93 3.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.745 . . . . 0.0 109.932 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.04 -47.0 88.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.627 -0.671 . . . . 0.0 109.921 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.93 -27.96 54.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 67.1 p -128.99 87.17 55.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.3 Cg_endo -80.91 7.8 4.69 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.92 2.413 . . . . 0.0 111.909 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.0 p -125.3 143.41 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.061 -1.025 . . . . 0.0 110.684 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -121.97 95.77 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -121.3 143.47 49.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 110.111 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 59.16 35.35 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.802 -0.561 . . . . 0.0 109.992 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.85 29.89 71.56 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -141.64 166.4 24.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.605 -0.938 . . . . 0.0 109.295 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.54 140.23 43.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.405 -0.81 . . . . 0.0 110.446 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 23' ' ' VAL . 22.4 m -150.37 179.55 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.413 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.0 t -90.16 116.53 28.23 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.273 0.558 . . . . 0.0 109.79 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 p -61.08 -31.86 71.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.76 -0.588 . . . . 0.0 109.524 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.17 164.78 16.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.24 166.64 9.42 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.439 2.759 . . . . 0.0 110.55 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.46 -68.76 0.03 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.17 82.1 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.54 -0.977 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.62 -174.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.599 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.94 66.31 3.74 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.63 117.94 4.52 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.606 ' H ' HD12 ' A' ' 40' ' ' ILE . 4.5 mp -86.85 -24.16 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.577 -0.955 . . . . 0.0 109.954 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -141.88 147.03 36.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.522 -0.736 . . . . 0.0 109.529 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.08 83.48 0.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.26 -131.35 6.47 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mt -88.08 154.24 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.641 -0.917 . . . . 0.0 109.259 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.436 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 1' ' ' LEU . 2.9 mm? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 tp -164.99 86.26 0.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.671 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -171.84 39.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.536 -0.727 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.0 t -177.67 97.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.92 -33.73 74.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.49 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -138.63 -79.3 0.34 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.68 -0.638 . . . . 0.0 109.755 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.88 28.88 24.88 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -91.23 11.66 22.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.607 -0.937 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.58 1.35 70.9 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.092 -1.005 . . . . 0.0 111.027 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -126.29 136.71 53.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.17 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 13.2 p -150.57 166.28 30.74 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.607 0.717 . . . . 0.0 110.797 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -107.25 -24.7 11.8 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p -150.04 178.79 8.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -63.36 -37.52 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -67.97 -10.47 53.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.477 -0.764 . . . . 0.0 111.099 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 4.7 m-20 -90.35 15.8 9.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 21' ' ' THR . 94.5 m -114.28 -172.98 2.2 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.4 m -114.02 -175.81 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.693 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 1.8 tt0 -64.46 -45.32 87.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.801 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.063 HD12 HG23 ' A' ' 21' ' ' THR . 1.3 pp -58.01 -20.84 41.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.254 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 1.063 HG23 HD12 ' A' ' 20' ' ' LEU . 22.7 p -133.74 88.28 33.67 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.77 4.93 5.23 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.95 2.433 . . . . 0.0 112.397 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.5 p -128.21 147.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.975 -1.078 . . . . 0.0 110.961 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -123.6 97.42 5.38 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -127.74 147.11 50.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.708 -0.62 . . . . 0.0 109.997 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 59.99 33.97 21.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.64 -0.662 . . . . 0.0 109.901 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.29 29.34 68.62 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -143.45 167.96 20.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.595 -0.944 . . . . 0.0 109.343 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.7 m -108.9 138.13 45.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.8 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 23' ' ' VAL . 18.3 m -150.48 -173.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.594 -0.691 . . . . 0.0 109.262 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -79.72 115.53 19.38 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.378 0.609 . . . . 0.0 109.752 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.4 p -55.12 -28.05 49.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.633 -0.667 . . . . 0.0 110.159 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.1 145.03 17.16 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.2 172.66 8.32 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 123.22 2.613 . . . . 0.0 110.457 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -104.95 31.53 8.48 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 36' ' ' LEU . 8.0 tp -141.6 157.52 44.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.613 -0.933 . . . . 0.0 109.411 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 t -84.61 -64.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.491 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.15 -145.5 5.79 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.16 -57.47 0.07 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 40' ' ' ILE . 4.8 mp -129.1 46.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.571 -0.958 . . . . 0.0 109.479 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.63 128.01 33.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.463 -0.773 . . . . 0.0 109.51 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.31 55.74 0.03 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.06 -119.85 0.56 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.1 mm -67.1 -52.65 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.564 -0.962 . . . . 0.0 109.475 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' O ' HD23 ' A' ' 45' ' ' LEU . 1.4 tt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 1' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 2' ' ' LEU . 1.1 pp -155.87 119.72 4.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.597 -0.689 . . . . 0.0 109.386 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.13 41.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.445 -0.785 . . . . 0.0 109.427 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.0 t -177.7 97.02 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.1 mt -62.89 -37.63 87.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.752 -0.592 . . . . 0.0 109.504 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -140.33 -77.91 0.31 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.727 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.74 28.94 33.59 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -90.26 11.81 20.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.53 -0.983 . . . . 0.0 110.274 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.88 73.52 Favored Glycine 0 N--CA 1.49 2.293 0 O-C-N 121.217 -0.927 . . . . 0.0 111.162 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -126.26 136.84 53.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.059 -1.26 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 9.3 p -150.54 166.06 31.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.726 0.774 . . . . 0.0 110.9 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.1 m -106.19 -26.93 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -148.11 -178.94 6.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.7 -36.52 83.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 109.893 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -67.95 -10.56 54.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.983 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.3 m-20 -89.79 15.69 9.32 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 110.282 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' THR . 90.0 m -115.46 -171.34 1.94 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.089 -1.007 . . . . 0.0 110.015 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.8 m -115.57 -178.62 3.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.54 -0.725 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.41 -49.58 76.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.665 -0.647 . . . . 0.0 110.168 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.72 -24.31 21.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.351 -0.843 . . . . 0.0 110.09 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 75.9 p -132.06 87.29 44.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.2 7.51 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.864 2.376 . . . . 0.0 112.123 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -126.02 145.17 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.046 . . . . 0.0 110.892 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.95 95.63 4.69 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 148.78 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.756 -0.59 . . . . 0.0 109.793 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 59.45 33.04 22.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.816 -0.552 . . . . 0.0 109.808 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.92 28.9 69.35 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -143.49 169.29 17.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.507 -0.996 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.1 m -109.13 139.05 44.54 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.3 m -150.59 -174.11 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -85.3 120.24 26.57 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.294 0.569 . . . . 0.0 109.787 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -62.28 -32.46 73.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.0 109.598 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.26 171.24 16.66 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.06 165.7 9.87 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 123.448 2.766 . . . . 0.0 110.51 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.4 -68.71 0.04 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tp -141.46 114.68 8.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.657 -0.908 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.04 175.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.716 . . . . 0.0 109.618 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.9 -100.52 0.94 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.83 147.64 13.31 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 tt -99.81 -21.87 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.655 -0.909 . . . . 0.0 109.989 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.55 154.38 22.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 109.654 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.73 -106.71 2.56 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.435 ' H ' HD12 ' A' ' 44' ' ' ILE . . . -155.54 27.21 0.6 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.435 HD12 ' H ' ' A' ' 43' ' ' GLY . 4.6 mp -140.61 137.69 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.425 -1.044 . . . . 0.0 109.405 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.426 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -88.56 99.92 12.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.658 -0.651 . . . . 0.0 109.446 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -101.13 46.42 0.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.596 -0.69 . . . . 0.0 109.348 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.407 ' H ' HD23 ' A' ' 2' ' ' LEU . 52.7 t -177.71 97.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.3 mt -71.56 -31.67 67.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.797 -0.564 . . . . 0.0 109.635 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -132.53 -79.68 0.5 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.015 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.1 27.78 55.26 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.4 7.65 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.431 -1.041 . . . . 0.0 110.392 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.52 -2.7 71.26 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.177 -0.952 . . . . 0.0 111.207 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.969 -1.312 . . . . 0.0 109.474 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 7.6 p -150.17 166.5 29.64 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.74 0.781 . . . . 0.0 111.092 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.99 -28.11 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -145.66 -177.96 5.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.25 -36.71 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -67.86 -10.47 53.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.98 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 3.8 m-20 -88.4 14.78 8.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.362 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' THR . 96.6 m -115.62 -169.91 1.68 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 110.207 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 m -114.24 179.48 3.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.586 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 0.9 OUTLIER -60.68 -51.69 68.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.655 -0.653 . . . . 0.0 109.952 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.09 -25.59 13.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.392 -0.817 . . . . 0.0 109.997 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 65.9 p -132.24 87.9 41.86 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 41.8 Cg_endo -83.12 11.22 3.34 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.819 2.346 . . . . 0.0 111.702 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.3 p -125.74 145.47 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.618 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -123.22 97.57 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.24 145.41 50.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.67 . . . . 0.0 109.944 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.12 34.9 21.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.647 -0.658 . . . . 0.0 109.827 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.79 27.94 64.97 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -140.68 167.7 21.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -1.02 . . . . 0.0 109.374 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.28 140.38 43.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.754 ' O ' HG12 ' A' ' 23' ' ' VAL . 29.4 m -150.41 178.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -94.82 120.55 35.23 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.232 0.539 . . . . 0.0 109.945 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.6 p -72.75 -46.43 53.49 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.63 -162.4 11.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.39 156.67 9.42 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.425 2.75 . . . . 0.0 110.51 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.11 -54.8 0.06 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.26 154.47 40.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.558 -0.966 . . . . 0.0 109.491 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.84 -173.39 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.685 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.52 49.26 2.39 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.62 -179.58 21.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 40' ' ' ILE . 63.0 mt -132.97 42.45 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.591 -0.947 . . . . 0.0 109.454 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.16 39.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.531 -0.731 . . . . 0.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.06 -61.88 4.62 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.1 109.37 0.23 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.55 157.92 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.613 -0.934 . . . . 0.0 109.345 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.68 -179.982 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.52 -161.0 0.76 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -131.28 32.36 4.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.505 -0.747 . . . . 0.0 109.513 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -177.93 97.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.7 mt -76.64 -28.77 56.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.725 -0.61 . . . . 0.0 109.906 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.56 -73.99 0.39 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.526 -0.734 . . . . 0.0 110.252 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.86 28.03 67.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.92 7.3 38.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.478 -1.013 . . . . 0.0 110.383 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.27 -17.22 54.96 Favored Glycine 0 N--CA 1.488 2.127 0 O-C-N 121.217 -0.927 . . . . 0.0 111.105 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 147.17 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.92 173.24 14.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 0.0 110.596 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -123.83 6.16 8.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.2 p -177.63 169.73 2.08 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.28 -39.12 91.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.367 -0.833 . . . . 0.0 109.809 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -68.88 -10.5 57.38 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.76 15.13 10.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' THR . 89.4 m -116.01 -171.06 1.91 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.088 -1.008 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.6 m -114.03 -177.87 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.446 -0.784 . . . . 0.0 109.749 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 4.5 tt0 -62.29 -48.05 81.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.64 -0.663 . . . . 0.0 110.018 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -23.6 27.28 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.387 -0.821 . . . . 0.0 110.065 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 74.4 p -132.93 87.7 39.43 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.15 6.15 4.89 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.772 2.314 . . . . 0.0 112.198 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -126.11 146.86 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.997 -1.064 . . . . 0.0 110.852 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -124.94 98.04 5.52 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -130.76 148.07 52.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.672 -0.643 . . . . 0.0 109.796 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 59.86 33.97 21.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.71 -0.619 . . . . 0.0 109.791 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.68 25.88 61.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 m -142.06 156.79 45.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.463 -1.022 . . . . 0.0 109.385 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -98.47 140.51 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.526 -0.733 . . . . 0.0 110.052 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 23' ' ' VAL . 21.3 m -150.57 -172.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 p -83.71 119.77 25.19 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.247 0.546 . . . . 0.0 109.993 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 p -63.27 -39.73 95.41 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.22 67.55 1.88 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.97 100.09 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.51 2.807 . . . . 0.0 110.45 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.36 86.13 0.08 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tp -65.5 94.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.617 -0.931 . . . . 0.0 109.583 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 m -110.53 -174.04 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.532 -0.73 . . . . 0.0 109.465 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.04 179.92 6.57 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.04 -137.4 2.25 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.8 mt -87.21 -23.87 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.972 . . . . 0.0 109.962 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.52 83.84 2.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.471 -0.768 . . . . 0.0 109.555 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.05 -45.81 7.39 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.82 103.43 1.37 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.6 mt -135.11 102.58 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.922 . . . . 0.0 109.467 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.5 mp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.523 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 1' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.4 tp -84.8 88.52 7.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.622 -0.674 . . . . 0.0 109.515 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.31 42.72 1.08 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 109.359 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.7 t -177.53 96.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.6 mt -72.11 -31.31 65.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.68 -0.637 . . . . 0.0 109.645 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -144.89 -76.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.581 -0.699 . . . . 0.0 110.032 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.6 29.96 54.16 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' CB ' ' NH1' ' A' ' 10' ' ' ARG . 7.7 m120 -89.88 11.38 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.992 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -7.79 72.39 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.187 -0.946 . . . . 0.0 111.07 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -125.59 140.8 52.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.061 -1.258 . . . . 0.0 109.689 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -150.35 167.9 25.67 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.625 0.726 . . . . 0.0 110.81 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 t -107.45 -28.04 10.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.9 p -146.52 179.11 7.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -64.04 -38.48 91.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 109.938 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -67.81 -9.78 47.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.159 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.75 13.75 9.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.084 -1.01 . . . . 0.0 110.455 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 21' ' ' THR . 78.2 m -114.42 -168.92 1.44 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.043 -1.036 . . . . 0.0 109.928 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 m -116.67 -176.55 2.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.373 -0.829 . . . . 0.0 110.195 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.41 -51.75 68.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.656 -0.653 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.93 -24.51 16.59 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.292 -0.88 . . . . 0.0 110.11 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 72.1 p -133.91 88.9 31.04 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 41.6 Cg_endo -83.31 9.76 3.96 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.77 2.313 . . . . 0.0 111.531 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.7 p -126.34 146.08 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.98 96.97 5.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 142.22 50.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.676 -0.64 . . . . 0.0 110.091 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 59.55 36.8 22.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.696 -0.627 . . . . 0.0 110.003 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.52 28.93 65.73 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -140.12 165.58 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.634 -0.921 . . . . 0.0 109.265 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -108.6 139.91 42.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.467 -0.77 . . . . 0.0 110.216 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 23' ' ' VAL . 27.5 m -150.44 177.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 15.7 t -93.41 108.59 20.24 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.194 0.521 . . . . 0.0 109.759 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.97 -43.6 74.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.744 -0.598 . . . . 0.0 109.627 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.75 91.6 0.08 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.14 85.16 1.27 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.379 2.719 . . . . 0.0 110.465 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.64 -33.78 0.22 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.36 76.44 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.594 -0.945 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 m -114.8 175.99 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.547 -0.72 . . . . 0.0 109.451 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.61 -100.51 2.16 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.62 -173.75 3.6 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.8 tt -93.97 -18.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.616 -0.932 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.79 118.3 6.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.422 -0.799 . . . . 0.0 109.627 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.48 46.79 0.26 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.684 ' C ' HD12 ' A' ' 44' ' ' ILE . . . -168.1 122.5 1.03 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.684 HD12 ' C ' ' A' ' 43' ' ' GLY . 4.6 mp 59.47 98.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.963 . . . . 0.0 109.646 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.462 -179.972 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 19.7 tp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.51 98.34 8.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.731 . . . . 0.0 109.488 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.583 ' HB1' ' HG3' ' A' ' 19' ' ' GLU . . . -96.64 50.73 1.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.667 -0.645 . . . . 0.0 109.307 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.9 t -177.91 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.2 mt -65.56 -36.13 82.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.743 -0.598 . . . . 0.0 109.625 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -138.63 -76.24 0.37 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.701 -0.624 . . . . 0.0 110.05 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.2 28.81 55.31 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -89.79 9.44 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.491 -1.005 . . . . 0.0 110.37 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.99 -6.6 70.17 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 121.213 -0.93 . . . . 0.0 111.276 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -124.62 139.6 53.71 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 118.694 1.247 . . . . 0.0 109.784 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 p -150.51 166.24 30.81 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.722 0.773 . . . . 0.0 110.604 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.1 m -106.3 -26.47 11.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.9 -178.65 6.48 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.88 -36.43 83.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.473 -0.767 . . . . 0.0 109.937 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.99 -10.6 54.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.497 -0.752 . . . . 0.0 111.025 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.12 15.97 9.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 110.168 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' THR . 83.9 m -115.38 -171.39 1.95 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.145 -0.972 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.3 m -114.9 -178.59 3.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.055 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.583 ' HG3' ' HB1' ' A' ' 3' ' ' ALA . 1.8 mt-10 -61.31 -50.21 73.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.615 -0.678 . . . . 0.0 110.056 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mp -54.62 -24.27 20.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.354 -0.841 . . . . 0.0 110.209 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 78.4 p -131.92 88.02 42.9 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.89 8.2 4.18 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -125.86 145.41 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.02 -1.05 . . . . 0.0 110.767 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -123.96 96.38 4.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -126.0 147.18 49.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.685 -0.635 . . . . 0.0 109.946 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mtm-85 60.16 33.26 21.12 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.654 -0.654 . . . . 0.0 109.757 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.8 29.53 70.52 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -142.92 167.56 21.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.589 -0.948 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -108.68 138.68 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.494 -0.754 . . . . 0.0 110.24 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.752 ' O ' HG12 ' A' ' 23' ' ' VAL . 26.1 m -150.75 -173.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -86.16 122.63 30.43 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.222 0.534 . . . . 0.0 109.67 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -61.9 -30.63 71.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.707 -0.621 . . . . 0.0 109.631 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.88 74.42 0.44 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.96 54.25 2.41 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.579 2.853 . . . . 0.0 110.549 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.37 50.57 0.11 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.1 tp -163.44 81.84 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.499 -1.001 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 t -133.01 -64.92 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.62 -0.675 . . . . 0.0 109.463 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.98 143.79 8.43 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.78 54.41 0.13 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tp -82.15 -26.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.556 -0.967 . . . . 0.0 109.7 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -98.28 -179.46 4.37 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.65 -0.656 . . . . 0.0 109.561 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.95 -60.25 2.08 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' HD13 ' A' ' 44' ' ' ILE . . . 106.58 94.2 2.35 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 43' ' ' GLY . 43.6 mm -129.13 -56.14 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.652 -0.911 . . . . 0.0 109.518 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 44' ' ' ILE . 5.2 mp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.47 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.94 76.61 8.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.566 -0.708 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -123.84 55.06 1.28 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.153 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -177.41 96.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.28 -36.18 83.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.693 -0.629 . . . . 0.0 109.496 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -139.12 -78.17 0.34 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.708 -0.62 . . . . 0.0 109.725 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.56 27.74 46.17 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.28 10.98 22.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -1.047 . . . . 0.0 110.287 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.4 -3.38 73.26 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 121.187 -0.946 . . . . 0.0 111.093 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -124.53 136.34 53.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.268 . . . . 0.0 109.472 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.3 p -150.76 168.14 25.31 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.657 0.742 . . . . 0.0 110.783 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.3 m -112.5 -10.95 13.68 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -163.63 175.15 10.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.41 -37.06 84.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 109.82 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -68.31 -11.06 58.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.444 -0.785 . . . . 0.0 110.981 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 16.76 8.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 21' ' ' THR . 88.7 m -116.27 -172.19 2.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.025 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.9 m -114.75 -178.08 3.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.52 -0.738 . . . . 0.0 109.746 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 2.7 tm-20 -62.47 -47.67 82.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.06 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.24 -23.32 35.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.326 -0.859 . . . . 0.0 110.151 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 77.5 p -132.13 87.33 44.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.45 5.86 4.84 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.854 2.369 . . . . 0.0 112.279 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -125.9 146.61 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.036 -1.04 . . . . 0.0 110.857 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.6 t -124.61 94.78 4.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -127.12 150.8 49.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.718 -0.614 . . . . 0.0 109.823 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.99 31.1 20.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.71 -0.619 . . . . 0.0 109.679 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 30.1 74.39 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -146.06 169.98 17.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.949 . . . . 0.0 109.558 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.96 139.34 43.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.462 -0.774 . . . . 0.0 110.396 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.714 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.7 m -150.75 -171.95 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.19 120.36 25.71 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.329 0.585 . . . . 0.0 109.738 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.9 p -59.69 -28.16 67.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.642 -0.661 . . . . 0.0 109.84 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.97 -177.69 19.33 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -86.43 141.14 6.63 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 123.452 2.768 . . . . 0.0 110.565 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.92 -61.28 0.04 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.1 mp -75.92 172.49 12.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.628 -0.925 . . . . 0.0 109.317 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.0 t 66.88 -71.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.673 -0.642 . . . . 0.0 109.983 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.12 179.81 16.12 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.24 147.16 17.26 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.9 tp -66.82 -24.99 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.964 . . . . 0.0 109.85 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.7 mt -104.46 163.03 12.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.515 -0.741 . . . . 0.0 109.524 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.54 75.24 0.16 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.13 112.79 0.27 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.4 mt -99.07 82.25 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.95 . . . . 0.0 109.359 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.466 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -154.52 98.55 2.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.518 -0.739 . . . . 0.0 109.35 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -105.14 36.4 2.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.489 -0.757 . . . . 0.0 109.543 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.9 t -177.42 95.5 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 mt -77.57 -26.92 51.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.699 -0.626 . . . . 0.0 109.793 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -122.43 -81.29 0.64 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.466 -0.771 . . . . 0.0 110.031 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.06 28.74 44.17 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -110.85 10.97 22.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -1.026 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.94 8.28 60.84 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.19 -0.944 . . . . 0.0 110.931 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -129.31 135.2 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.129 -1.218 . . . . 0.0 108.941 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.72 165.41 33.55 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.821 0.82 . . . . 0.0 111.138 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -105.59 -28.62 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -145.04 -176.7 5.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -68.27 -36.29 79.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.385 -0.822 . . . . 0.0 109.868 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -68.1 -10.31 52.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.351 -0.843 . . . . 0.0 110.956 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.55 15.69 8.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.272 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 21' ' ' THR . 87.5 m -114.25 -171.21 1.87 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.27 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.8 m -114.38 -179.23 3.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.494 -0.754 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.699 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 4.9 tp10 -61.7 -49.94 74.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.618 -0.676 . . . . 0.0 110.121 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -54.64 -23.89 19.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.33 -0.856 . . . . 0.0 110.129 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 71.0 p -132.88 89.43 34.62 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.3 Cg_endo -82.56 9.69 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.818 2.345 . . . . 0.0 111.609 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.4 p -126.16 145.12 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.7 t -122.68 98.16 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' A' ' 23' ' ' VAL . 18.4 mtmt -126.51 145.81 50.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.708 -0.62 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.72 35.14 22.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.634 -0.666 . . . . 0.0 109.931 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.42 65.95 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 m -141.68 167.88 21.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.456 -1.026 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.6 m -109.57 141.11 42.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.805 . . . . 0.0 110.18 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 23' ' ' VAL . 25.8 m -150.23 177.25 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 38.7 t -93.36 108.02 19.75 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.234 0.54 . . . . 0.0 109.91 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.9 -72.42 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.677 -0.64 . . . . 0.0 109.314 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.4 86.72 0.04 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.86 38.52 0.38 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.672 2.914 . . . . 0.0 110.904 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.33 94.66 0.01 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 37' ' ' VAL . 3.1 tt -173.39 127.97 0.43 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.545 -0.974 . . . . 0.0 109.53 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.503 ' O ' HD23 ' A' ' 36' ' ' LEU . 22.3 m -108.46 -173.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.618 -0.677 . . . . 0.0 109.476 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.06 171.52 52.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.08 167.07 25.28 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 tt -106.58 -21.7 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.502 -0.999 . . . . 0.0 109.959 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.75 120.64 18.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.62 87.45 0.79 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.06 -134.99 1.76 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 pt -74.33 169.24 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.49 -1.006 . . . . 0.0 109.511 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt -88.69 96.83 10.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.547 -0.721 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.43 55.54 1.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.356 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.5 t -177.75 97.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.9 mt -70.04 -33.23 71.7 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -146.24 -76.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.664 -0.648 . . . . 0.0 109.75 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 30.47 30.63 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.2 13.14 15.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.967 . . . . 0.0 110.302 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.44 -2.47 77.56 Favored Glycine 0 N--CA 1.489 2.175 0 O-C-N 121.234 -0.916 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 4.3 ptp180 -126.28 138.08 53.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.993 -1.298 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.85 168.11 25.45 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.73 0.776 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -107.35 -28.24 9.99 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.3 p -146.89 -179.37 6.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.26 -37.25 86.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.0 109.996 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -68.09 -9.9 49.8 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.494 -0.754 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.17 14.86 9.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' THR . 84.3 m -114.73 -170.41 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.053 -1.029 . . . . 0.0 110.093 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -115.94 -176.71 3.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.504 -0.748 . . . . 0.0 110.077 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.75 -49.81 74.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.1 -23.59 21.51 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.357 -0.839 . . . . 0.0 110.153 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 63.6 p -134.31 89.48 27.56 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 41.5 Cg_endo -83.21 8.7 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.758 2.305 . . . . 0.0 111.456 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 30' ' ' VAL . 11.9 p -125.02 145.17 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.0 110.466 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -125.83 98.9 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -126.91 145.83 50.53 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.897 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 60.09 33.88 21.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.678 . . . . 0.0 109.808 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.98 28.98 69.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -140.51 165.61 26.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -1.016 . . . . 0.0 109.5 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.77 142.45 42.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 23' ' ' VAL . 23.5 m -150.39 172.44 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.436 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 37.4 t -95.2 110.34 22.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.173 0.511 . . . . 0.0 109.723 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.619 ' HB3' HG11 ' A' ' 23' ' ' VAL . 38.3 p -118.8 -54.31 2.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.694 -0.629 . . . . 0.0 109.555 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.96 -80.74 0.28 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.74 -165.32 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.444 2.763 . . . . 0.0 110.372 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.62 79.85 0.32 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 36' ' ' LEU . 6.7 tt -148.76 86.99 1.53 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.568 -0.96 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 38' ' ' GLY . 3.3 t -113.78 166.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.571 -0.705 . . . . 0.0 109.154 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 37' ' ' VAL . . . 85.76 85.14 1.03 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.87 163.65 13.8 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 40' ' ' ILE . 47.9 mt -109.33 49.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.548 -0.972 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.6 mt -95.39 165.73 12.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.474 -0.766 . . . . 0.0 109.441 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.7 45.6 0.02 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 175.58 -117.86 0.63 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.9 pt -62.7 148.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.579 -0.954 . . . . 0.0 109.527 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.468 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.986 0.422 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.92 27.69 49.08 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.85 8.76 33.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.475 -1.015 . . . . 0.0 110.404 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.14 -5.66 70.86 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.109 -0.995 . . . . 0.0 111.068 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -125.2 140.39 52.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.134 -1.215 . . . . 0.0 109.423 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.27 165.18 33.77 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.77 0.795 . . . . 0.0 110.862 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.44 -26.48 11.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 p -147.32 -177.97 5.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.0 -36.51 82.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.441 -0.787 . . . . 0.0 109.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -68.41 -10.22 53.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.429 -0.794 . . . . 0.0 110.913 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -89.05 14.54 10.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 21' ' ' THR . 99.2 m -115.68 -170.85 1.86 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 m -115.92 -176.51 2.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -49.19 77.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.532 -0.73 . . . . 0.0 110.133 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 20' ' ' LEU . 2.6 tt -55.15 -23.85 23.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.435 -0.791 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 75.9 p -132.7 86.97 42.68 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.74 6.75 4.67 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.934 2.423 . . . . 0.0 112.068 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -126.12 147.83 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.057 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.4 t -123.94 97.35 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' HG11 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.39 144.0 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.643 -0.661 . . . . 0.0 110.003 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 59.69 35.85 22.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.652 . . . . 0.0 110.025 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.4 28.21 64.38 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -140.35 166.25 25.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.977 . . . . 0.0 109.27 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.3 m -108.19 138.78 43.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.0 m . . . . . 0 N--CA 1.484 1.273 0 O-C-N 121.506 -0.746 . . . . 0.0 109.055 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.4 34.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.44 11.77 20.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.427 -1.043 . . . . 0.0 110.293 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.74 -4.78 72.65 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -125.43 136.87 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.57 1.185 . . . . 0.0 109.213 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.2 p -150.72 170.67 18.66 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.73 0.776 . . . . 0.0 110.84 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -117.09 -6.25 11.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.3 p -166.68 173.08 9.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.89 -37.97 86.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 109.974 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -68.4 -10.67 56.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.424 -0.798 . . . . 0.0 110.975 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.61 15.13 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.276 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 21' ' ' THR . 96.8 m -117.42 -170.9 1.94 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.091 -1.006 . . . . 0.0 109.93 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.3 m -115.74 -177.27 3.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.25 -49.1 78.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 mt -54.85 -25.31 27.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.118 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 65.5 p -131.74 86.74 47.6 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.46 6.16 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.915 2.41 . . . . 0.0 112.089 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -125.78 145.98 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.03 -1.044 . . . . 0.0 110.803 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -127.05 148.41 50.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.726 -0.609 . . . . 0.0 109.985 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 59.59 33.02 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.706 -0.621 . . . . 0.0 109.934 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.87 72.37 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -144.59 168.21 20.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.595 -0.944 . . . . 0.0 109.462 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.7 m -108.71 139.3 43.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 110.15 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.3 m . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 120.951 0.405 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.93 48.17 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -94.16 8.95 39.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.556 -0.967 . . . . 0.0 110.456 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -5.29 70.37 Favored Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.236 -0.915 . . . . 0.0 111.155 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -124.76 137.64 54.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.093 -1.24 . . . . 0.0 109.339 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 p -150.85 173.83 13.79 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.8 0.809 . . . . 0.0 110.751 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -124.11 4.26 8.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 p -175.44 170.19 3.04 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.04 -38.76 89.92 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.0 109.837 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -68.52 -10.77 57.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.772 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.79 15.38 9.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.131 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 21' ' ' THR . 93.8 m -117.58 -171.09 1.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.147 -0.971 . . . . 0.0 109.897 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -115.26 -175.98 2.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.475 -0.765 . . . . 0.0 109.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -46.09 89.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 20' ' ' LEU . 3.4 tt -56.72 -23.5 42.78 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.447 -0.783 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 57.1 p -133.8 87.51 35.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.74 5.04 5.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.4 p -126.13 146.37 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.051 -1.03 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.3 t -124.59 97.34 5.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -126.62 146.67 50.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.621 -0.674 . . . . 0.0 109.855 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 60.17 33.7 21.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.615 -0.678 . . . . 0.0 109.85 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.62 29.09 68.92 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -142.39 166.76 23.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 109.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.81 140.03 42.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.45 -0.781 . . . . 0.0 110.138 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.4 m . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.73 30.0 27.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.98 12.4 17.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.566 -0.961 . . . . 0.0 110.283 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.12 -2.43 75.92 Favored Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.159 -0.963 . . . . 0.0 111.025 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -125.95 137.98 53.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.134 -1.215 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -150.44 166.32 30.47 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.725 0.774 . . . . 0.0 110.792 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -26.37 11.27 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -148.24 -179.47 6.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.1 -37.76 88.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 mtt-85 -67.86 -10.16 50.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.513 -0.742 . . . . 0.0 111.16 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.02 14.73 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.429 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -115.35 -172.28 2.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.085 -1.009 . . . . 0.0 109.974 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -113.99 -175.52 2.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -0.773 . . . . 0.0 109.721 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -63.31 -46.1 88.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.941 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.1 mp -56.93 -23.32 44.38 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.447 -0.783 . . . . 0.0 110.114 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 45.4 p -132.74 86.87 42.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -77.58 5.15 5.4 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.879 2.386 . . . . 0.0 112.265 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.7 p -127.06 146.68 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.97 -1.081 . . . . 0.0 110.941 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.23 96.38 5.02 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -124.83 145.13 49.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.748 -0.595 . . . . 0.0 109.95 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 60.01 34.52 21.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.621 -0.674 . . . . 0.0 109.839 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.03 29.0 67.17 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -141.83 167.27 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.585 -0.95 . . . . 0.0 109.337 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.8 m -108.79 138.06 45.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.373 -0.829 . . . . 0.0 110.265 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.712 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.4 m . . . . . 0 N--CA 1.485 1.286 0 O-C-N 121.657 -0.652 . . . . 0.0 109.274 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 120.86 0.362 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.92 28.53 37.54 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -96.91 7.32 46.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -1.016 . . . . 0.0 110.524 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.96 -4.36 70.98 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 121.181 -0.949 . . . . 0.0 111.134 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -125.21 139.13 54.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.091 -1.241 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 p -150.44 166.08 31.22 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.687 0.756 . . . . 0.0 110.954 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.2 m -106.81 -26.44 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.2 p -148.16 -178.57 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.02 -36.69 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.409 -0.807 . . . . 0.0 109.901 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -10.58 54.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.464 -0.772 . . . . 0.0 111.016 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.86 15.55 9.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 21' ' ' THR . 88.8 m -115.5 -170.54 1.79 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.926 . . . . 0.0 109.981 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -116.38 -177.18 3.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.974 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -61.5 -49.61 76.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.58 -0.7 . . . . 0.0 110.241 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 tp -55.21 -23.56 22.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 81.7 p -132.82 88.27 38.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.0 108.955 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -80.12 7.62 4.57 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.82 2.347 . . . . 0.0 111.921 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -125.51 146.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.048 -1.032 . . . . 0.0 110.695 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.99 97.61 5.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -125.71 144.25 50.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.695 -0.628 . . . . 0.0 110.02 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 59.89 36.06 21.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.649 -0.657 . . . . 0.0 109.939 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.42 64.13 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -140.33 165.9 26.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.565 -0.962 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -109.04 139.1 44.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.424 -0.798 . . . . 0.0 110.24 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 23' ' ' VAL . 24.6 m . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.16 10.59 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.85 16.08 13.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.532 -0.981 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.95 8.43 61.16 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.012 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -129.55 134.77 47.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.173 -1.192 . . . . 0.0 109.058 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.67 166.92 28.9 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.902 0.858 . . . . 0.0 111.18 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 m -106.78 -28.71 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -145.42 -177.37 5.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.25 -37.55 83.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.311 -0.868 . . . . 0.0 110.011 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.46 -10.37 50.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.39 -0.819 . . . . 0.0 111.052 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.74 15.1 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 0.0 110.321 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' THR . 90.6 m -114.74 -171.31 1.91 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.088 -1.008 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.01 -179.26 3.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 110.046 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.28 -50.53 72.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.176 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -54.56 -23.99 19.07 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.353 -0.842 . . . . 0.0 110.219 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 70.2 p -132.42 89.08 37.51 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.92 10.33 3.69 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.875 2.383 . . . . 0.0 111.648 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.4 p -126.18 145.29 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.742 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.8 t -122.89 96.94 5.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -125.81 145.98 49.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.736 -0.602 . . . . 0.0 110.001 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 59.33 34.94 23.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.75 -0.594 . . . . 0.0 109.872 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.33 27.67 65.87 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 m -140.84 168.78 18.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.477 -1.014 . . . . 0.0 109.425 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.55 140.18 43.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 23' ' ' VAL . 30.6 m . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.53 31.69 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -90.4 12.58 18.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.974 . . . . 0.0 110.214 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 -3.87 76.29 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.15 -0.969 . . . . 0.0 110.988 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.258 . . . . 0.0 109.405 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.43 166.26 30.65 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.813 0.816 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -106.63 -28.21 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -145.75 -177.4 5.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.79 -36.52 80.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.394 -0.816 . . . . 0.0 109.848 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttt85 -67.85 -10.47 53.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.17 14.51 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.452 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 21' ' ' THR . 75.1 m -116.49 -169.77 1.69 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -117.52 -177.57 3.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.458 -0.776 . . . . 0.0 110.352 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.17 -52.3 65.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.631 . . . . 0.0 110.227 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -52.9 -25.52 12.0 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.35 -0.844 . . . . 0.0 110.14 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 62.2 p -132.77 87.74 40.01 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.93 8.91 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.793 2.329 . . . . 0.0 111.675 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.5 p -125.66 145.0 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.2 t -122.99 96.52 5.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -125.29 146.51 49.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.609 -0.682 . . . . 0.0 109.919 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 59.9 33.64 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.601 -0.687 . . . . 0.0 109.878 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.28 29.31 71.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -143.16 168.03 20.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 0.0 109.352 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.1 m -109.61 141.45 42.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.74 ' O ' HG12 ' A' ' 23' ' ' VAL . 26.3 m . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 120.967 0.413 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.68 29.01 49.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.02 9.86 35.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.522 -0.987 . . . . 0.0 110.409 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.56 72.6 Favored Glycine 0 N--CA 1.49 2.271 0 O-C-N 121.121 -0.987 . . . . 0.0 111.084 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -125.1 137.04 54.19 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.648 1.224 . . . . 0.0 109.276 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.52 165.9 31.84 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.814 0.816 . . . . 0.0 110.987 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 p -106.13 -26.95 11.38 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.56 -177.7 5.92 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.75 -35.76 80.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.431 -0.793 . . . . 0.0 109.874 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -67.95 -10.83 56.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.496 -0.753 . . . . 0.0 110.939 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.41 16.44 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 0.0 110.096 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' THR . 94.5 m -116.92 -170.98 1.94 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.1 m -116.89 -178.79 3.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.333 -0.854 . . . . 0.0 110.058 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -61.13 -50.74 71.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.579 -0.7 . . . . 0.0 110.143 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 tp -53.45 -24.94 14.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.33 -0.856 . . . . 0.0 110.128 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 60.9 p -132.67 88.88 37.08 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -82.66 8.77 4.37 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.803 2.336 . . . . 0.0 111.533 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.3 p -125.64 144.14 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.109 -0.995 . . . . 0.0 110.448 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.01 96.64 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -129.06 150.93 50.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.739 -0.601 . . . . 0.0 109.63 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 60.56 30.91 20.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.737 -0.602 . . . . 0.0 109.647 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.03 28.27 70.19 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -144.7 170.49 16.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.972 . . . . 0.0 109.484 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.6 m -109.62 141.88 41.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 110.239 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 23' ' ' VAL . 28.2 m . . . . . 0 C--N 1.308 -1.216 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.53 28.31 33.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.8 14.05 24.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.982 . . . . 0.0 110.18 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.89 9.54 59.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -129.28 133.01 47.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.233 -1.157 . . . . 0.0 108.898 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.9 p -150.91 166.88 29.25 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -106.53 -28.23 10.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -146.53 -177.79 5.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.45 -35.55 79.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -67.97 -10.83 56.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.19 16.66 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.206 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' THR . 91.0 m -115.62 -171.45 1.97 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 110.304 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.8 m -113.12 177.82 4.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 109.956 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.12 -47.71 83.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.67 . . . . 0.0 109.811 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.41 -25.8 38.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 64.8 p -131.26 88.91 43.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.44 9.93 3.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.881 2.387 . . . . 0.0 111.946 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.1 p -125.6 144.41 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.067 -1.021 . . . . 0.0 110.735 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -122.76 95.81 4.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -127.34 149.98 49.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 0.0 109.759 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 59.87 32.21 21.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.721 -0.612 . . . . 0.0 109.626 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.27 28.11 68.7 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m -143.53 170.45 15.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -1.001 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.9 m -109.57 140.61 43.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.417 -0.802 . . . . 0.0 110.268 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.751 ' O ' HG12 ' A' ' 23' ' ' VAL . 24.6 m . . . . . 0 C--N 1.308 -1.2 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 120.92 0.391 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.71 27.6 50.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.14 8.26 42.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -1.03 . . . . 0.0 110.443 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.46 -8.87 66.45 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.187 -0.946 . . . . 0.0 111.084 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 33.5 ptt180 -123.48 138.96 54.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -1.179 . . . . 0.0 109.37 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 12.1 p -150.07 166.66 29.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.678 0.751 . . . . 0.0 110.768 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 p -107.72 -24.87 11.54 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 p -149.96 -179.75 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.38 -35.65 81.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -68.37 -10.85 57.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.413 -0.804 . . . . 0.0 110.883 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.7 OUTLIER -90.37 15.9 9.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.152 -0.967 . . . . 0.0 110.137 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' THR . 87.8 m -116.26 -170.86 1.89 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -118.21 -176.72 3.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 109.829 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.38 -48.03 81.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.608 -0.683 . . . . 0.0 109.991 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.19 -23.9 24.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.468 -0.77 . . . . 0.0 110.104 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 77.7 p -133.56 87.93 35.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.13 5.98 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.912 2.408 . . . . 0.0 112.093 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 30' ' ' VAL . 11.2 p -125.91 146.13 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.011 -1.056 . . . . 0.0 110.831 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.6 t -124.13 96.14 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 150.26 50.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.678 -0.639 . . . . 0.0 109.802 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.29 31.62 20.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.556 -0.715 . . . . 0.0 109.72 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.33 71.51 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 3.1 m -144.71 169.28 18.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.975 . . . . 0.0 109.509 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.4 m -108.82 139.12 44.08 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.8 m . . . . . 0 N--CA 1.483 1.206 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 34.75 20.84 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -95.23 21.89 7.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.492 -1.005 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.59 7.13 64.1 Favored Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.382 -0.824 . . . . 0.0 111.305 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -129.8 133.67 47.11 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 118.734 1.267 . . . . 0.0 109.339 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.28 167.73 26.94 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.728 0.775 . . . . 0.0 110.987 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.1 p -106.27 -29.55 9.73 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 p -145.6 -177.4 5.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.91 -37.66 84.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 109.983 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -68.02 -9.68 47.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.415 -0.803 . . . . 0.0 111.133 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 13.91 10.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.118 -0.989 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' THR . 80.4 m -114.6 -171.16 1.88 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 110.065 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.1 m -112.82 179.93 3.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.745 . . . . 0.0 109.932 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.04 -47.0 88.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.627 -0.671 . . . . 0.0 109.921 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.93 -27.96 54.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 67.1 p -128.99 87.17 55.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -80.91 7.8 4.69 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.92 2.413 . . . . 0.0 111.909 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.0 p -125.3 143.41 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.061 -1.025 . . . . 0.0 110.684 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -121.97 95.77 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -121.3 143.47 49.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 110.111 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 59.16 35.35 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.802 -0.561 . . . . 0.0 109.992 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.85 29.89 71.56 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -141.64 166.4 24.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.605 -0.938 . . . . 0.0 109.295 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.54 140.23 43.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.405 -0.81 . . . . 0.0 110.446 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 23' ' ' VAL . 22.4 m . . . . . 0 C--N 1.309 -1.155 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.88 28.88 24.88 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -91.23 11.66 22.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.607 -0.937 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.58 1.35 70.9 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.092 -1.005 . . . . 0.0 111.027 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -126.29 136.71 53.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.17 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 13.2 p -150.57 166.28 30.74 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.607 0.717 . . . . 0.0 110.797 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -107.25 -24.7 11.8 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p -150.04 178.79 8.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -63.36 -37.52 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -67.97 -10.47 53.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.477 -0.764 . . . . 0.0 111.099 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 4.7 m-20 -90.35 15.8 9.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 21' ' ' THR . 94.5 m -114.28 -172.98 2.2 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.4 m -114.02 -175.81 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.46 -45.32 87.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.801 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.063 HD12 HG23 ' A' ' 21' ' ' THR . 1.3 pp -58.01 -20.84 41.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.254 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 1.063 HG23 HD12 ' A' ' 20' ' ' LEU . 22.7 p -133.74 88.28 33.67 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.77 4.93 5.23 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.95 2.433 . . . . 0.0 112.397 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.5 p -128.21 147.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.975 -1.078 . . . . 0.0 110.961 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -123.6 97.42 5.38 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -127.74 147.11 50.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.708 -0.62 . . . . 0.0 109.997 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 59.99 33.97 21.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.64 -0.662 . . . . 0.0 109.901 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.29 29.34 68.62 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -143.45 167.96 20.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.595 -0.944 . . . . 0.0 109.343 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.7 m -108.9 138.13 45.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.8 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 23' ' ' VAL . 18.3 m . . . . . 0 N--CA 1.486 1.363 0 O-C-N 121.594 -0.691 . . . . 0.0 109.262 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.74 28.94 33.59 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -90.26 11.81 20.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.53 -0.983 . . . . 0.0 110.274 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.88 73.52 Favored Glycine 0 N--CA 1.49 2.293 0 O-C-N 121.217 -0.927 . . . . 0.0 111.162 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -126.26 136.84 53.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.059 -1.26 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 9.3 p -150.54 166.06 31.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.726 0.774 . . . . 0.0 110.9 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.1 m -106.19 -26.93 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -148.11 -178.94 6.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.7 -36.52 83.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 109.893 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -67.95 -10.56 54.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.983 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.3 m-20 -89.79 15.69 9.32 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 110.282 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' THR . 90.0 m -115.46 -171.34 1.94 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.089 -1.007 . . . . 0.0 110.015 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.8 m -115.57 -178.62 3.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.54 -0.725 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.41 -49.58 76.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.665 -0.647 . . . . 0.0 110.168 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.72 -24.31 21.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.351 -0.843 . . . . 0.0 110.09 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 75.9 p -132.06 87.29 44.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.2 7.51 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.864 2.376 . . . . 0.0 112.123 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -126.02 145.17 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.046 . . . . 0.0 110.892 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.95 95.63 4.69 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 148.78 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.756 -0.59 . . . . 0.0 109.793 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 59.45 33.04 22.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.816 -0.552 . . . . 0.0 109.808 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.92 28.9 69.35 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -143.49 169.29 17.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.507 -0.996 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.1 m -109.13 139.05 44.54 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.3 m . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.002 0.429 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.1 27.78 55.26 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.4 7.65 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.431 -1.041 . . . . 0.0 110.392 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.52 -2.7 71.26 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.177 -0.952 . . . . 0.0 111.207 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.969 -1.312 . . . . 0.0 109.474 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 7.6 p -150.17 166.5 29.64 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.74 0.781 . . . . 0.0 111.092 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.99 -28.11 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -145.66 -177.96 5.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.25 -36.71 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -67.86 -10.47 53.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.98 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 3.8 m-20 -88.4 14.78 8.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.362 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' THR . 96.6 m -115.62 -169.91 1.68 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 110.207 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 m -114.24 179.48 3.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -51.69 68.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.655 -0.653 . . . . 0.0 109.952 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.09 -25.59 13.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.392 -0.817 . . . . 0.0 109.997 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 65.9 p -132.24 87.9 41.86 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -83.12 11.22 3.34 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.819 2.346 . . . . 0.0 111.702 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.3 p -125.74 145.47 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.618 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -123.22 97.57 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.24 145.41 50.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.67 . . . . 0.0 109.944 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.12 34.9 21.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.647 -0.658 . . . . 0.0 109.827 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.79 27.94 64.97 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -140.68 167.7 21.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -1.02 . . . . 0.0 109.374 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.28 140.38 43.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.754 ' O ' HG12 ' A' ' 23' ' ' VAL . 29.4 m . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.029 0.442 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.86 28.03 67.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.92 7.3 38.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.478 -1.013 . . . . 0.0 110.383 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.27 -17.22 54.96 Favored Glycine 0 N--CA 1.488 2.127 0 O-C-N 121.217 -0.927 . . . . 0.0 111.105 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 147.17 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.92 173.24 14.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 0.0 110.596 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -123.83 6.16 8.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.2 p -177.63 169.73 2.08 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.28 -39.12 91.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.367 -0.833 . . . . 0.0 109.809 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -68.88 -10.5 57.38 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.76 15.13 10.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' THR . 89.4 m -116.01 -171.06 1.91 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.088 -1.008 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.6 m -114.03 -177.87 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.446 -0.784 . . . . 0.0 109.749 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.29 -48.05 81.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.64 -0.663 . . . . 0.0 110.018 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -23.6 27.28 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.387 -0.821 . . . . 0.0 110.065 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 74.4 p -132.93 87.7 39.43 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.15 6.15 4.89 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.772 2.314 . . . . 0.0 112.198 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -126.11 146.86 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.997 -1.064 . . . . 0.0 110.852 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -124.94 98.04 5.52 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -130.76 148.07 52.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.672 -0.643 . . . . 0.0 109.796 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 59.86 33.97 21.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.71 -0.619 . . . . 0.0 109.791 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.68 25.88 61.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 m -142.06 156.79 45.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.463 -1.022 . . . . 0.0 109.385 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -98.47 140.51 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.526 -0.733 . . . . 0.0 110.052 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 23' ' ' VAL . 21.3 m . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.039 0.447 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.6 29.96 54.16 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' CB ' ' NH1' ' A' ' 10' ' ' ARG . 7.7 m120 -89.88 11.38 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.992 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -7.79 72.39 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.187 -0.946 . . . . 0.0 111.07 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -125.59 140.8 52.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.061 -1.258 . . . . 0.0 109.689 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -150.35 167.9 25.67 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.625 0.726 . . . . 0.0 110.81 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 t -107.45 -28.04 10.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.9 p -146.52 179.11 7.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -64.04 -38.48 91.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 109.938 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -67.81 -9.78 47.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.159 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.75 13.75 9.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.084 -1.01 . . . . 0.0 110.455 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 21' ' ' THR . 78.2 m -114.42 -168.92 1.44 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.043 -1.036 . . . . 0.0 109.928 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 m -116.67 -176.55 2.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.373 -0.829 . . . . 0.0 110.195 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.41 -51.75 68.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.656 -0.653 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.93 -24.51 16.59 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.292 -0.88 . . . . 0.0 110.11 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 72.1 p -133.91 88.9 31.04 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.31 9.76 3.96 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.77 2.313 . . . . 0.0 111.531 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.7 p -126.34 146.08 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.98 96.97 5.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 142.22 50.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.676 -0.64 . . . . 0.0 110.091 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 59.55 36.8 22.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.696 -0.627 . . . . 0.0 110.003 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.52 28.93 65.73 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -140.12 165.58 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.634 -0.921 . . . . 0.0 109.265 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -108.6 139.91 42.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.467 -0.77 . . . . 0.0 110.216 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 23' ' ' VAL . 27.5 m . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.92 0.391 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.2 28.81 55.31 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -89.79 9.44 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.491 -1.005 . . . . 0.0 110.37 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.99 -6.6 70.17 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 121.213 -0.93 . . . . 0.0 111.276 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -124.62 139.6 53.71 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 118.694 1.247 . . . . 0.0 109.784 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 p -150.51 166.24 30.81 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.722 0.773 . . . . 0.0 110.604 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.1 m -106.3 -26.47 11.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.9 -178.65 6.48 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.88 -36.43 83.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.473 -0.767 . . . . 0.0 109.937 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.99 -10.6 54.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.497 -0.752 . . . . 0.0 111.025 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.12 15.97 9.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 110.168 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' THR . 83.9 m -115.38 -171.39 1.95 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.145 -0.972 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.3 m -114.9 -178.59 3.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.055 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.31 -50.21 73.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.615 -0.678 . . . . 0.0 110.056 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mp -54.62 -24.27 20.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.354 -0.841 . . . . 0.0 110.209 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 78.4 p -131.92 88.02 42.9 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.89 8.2 4.18 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -125.86 145.41 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.02 -1.05 . . . . 0.0 110.767 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -123.96 96.38 4.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -126.0 147.18 49.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.685 -0.635 . . . . 0.0 109.946 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mtm-85 60.16 33.26 21.12 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.654 -0.654 . . . . 0.0 109.757 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.8 29.53 70.52 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -142.92 167.56 21.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.589 -0.948 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -108.68 138.68 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.494 -0.754 . . . . 0.0 110.24 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.752 ' O ' HG12 ' A' ' 23' ' ' VAL . 26.1 m . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.56 27.74 46.17 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -90.28 10.98 22.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -1.047 . . . . 0.0 110.287 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.4 -3.38 73.26 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 121.187 -0.946 . . . . 0.0 111.093 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -124.53 136.34 53.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.268 . . . . 0.0 109.472 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.3 p -150.76 168.14 25.31 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.657 0.742 . . . . 0.0 110.783 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.3 m -112.5 -10.95 13.68 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -163.63 175.15 10.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.41 -37.06 84.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 109.82 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -68.31 -11.06 58.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.444 -0.785 . . . . 0.0 110.981 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 16.76 8.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 21' ' ' THR . 88.7 m -116.27 -172.19 2.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.025 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.9 m -114.75 -178.08 3.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.52 -0.738 . . . . 0.0 109.746 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.47 -47.67 82.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.06 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.24 -23.32 35.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.326 -0.859 . . . . 0.0 110.151 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 77.5 p -132.13 87.33 44.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.45 5.86 4.84 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.854 2.369 . . . . 0.0 112.279 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -125.9 146.61 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.036 -1.04 . . . . 0.0 110.857 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.6 t -124.61 94.78 4.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -127.12 150.8 49.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.718 -0.614 . . . . 0.0 109.823 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.99 31.1 20.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.71 -0.619 . . . . 0.0 109.679 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 30.1 74.39 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -146.06 169.98 17.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.949 . . . . 0.0 109.558 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.96 139.34 43.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.462 -0.774 . . . . 0.0 110.396 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.714 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.7 m . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.913 0.387 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.06 28.74 44.17 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -110.85 10.97 22.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -1.026 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.94 8.28 60.84 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.19 -0.944 . . . . 0.0 110.931 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -129.31 135.2 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.129 -1.218 . . . . 0.0 108.941 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.72 165.41 33.55 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.821 0.82 . . . . 0.0 111.138 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -105.59 -28.62 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -145.04 -176.7 5.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -68.27 -36.29 79.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.385 -0.822 . . . . 0.0 109.868 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -68.1 -10.31 52.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.351 -0.843 . . . . 0.0 110.956 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.55 15.69 8.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.272 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 21' ' ' THR . 87.5 m -114.25 -171.21 1.87 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.27 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.8 m -114.38 -179.23 3.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.494 -0.754 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.7 -49.94 74.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.618 -0.676 . . . . 0.0 110.121 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -54.64 -23.89 19.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.33 -0.856 . . . . 0.0 110.129 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 71.0 p -132.88 89.43 34.62 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.56 9.69 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.818 2.345 . . . . 0.0 111.609 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.4 p -126.16 145.12 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.7 t -122.68 98.16 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' A' ' 23' ' ' VAL . 18.4 mtmt -126.51 145.81 50.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.708 -0.62 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.72 35.14 22.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.634 -0.666 . . . . 0.0 109.931 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.42 65.95 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 m -141.68 167.88 21.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.456 -1.026 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.6 m -109.57 141.11 42.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.805 . . . . 0.0 110.18 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 23' ' ' VAL . 25.8 m . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 30.47 30.63 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.2 13.14 15.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.967 . . . . 0.0 110.302 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.44 -2.47 77.56 Favored Glycine 0 N--CA 1.489 2.175 0 O-C-N 121.234 -0.916 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 4.3 ptp180 -126.28 138.08 53.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.993 -1.298 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.85 168.11 25.45 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.73 0.776 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -107.35 -28.24 9.99 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.3 p -146.89 -179.37 6.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.26 -37.25 86.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.0 109.996 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -68.09 -9.9 49.8 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.494 -0.754 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.17 14.86 9.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' THR . 84.3 m -114.73 -170.41 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.053 -1.029 . . . . 0.0 110.093 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -115.94 -176.71 3.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.504 -0.748 . . . . 0.0 110.077 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.75 -49.81 74.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.1 -23.59 21.51 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.357 -0.839 . . . . 0.0 110.153 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 63.6 p -134.31 89.48 27.56 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.21 8.7 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.758 2.305 . . . . 0.0 111.456 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 30' ' ' VAL . 11.9 p -125.02 145.17 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.0 110.466 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -125.83 98.9 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -126.91 145.83 50.53 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.897 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 60.09 33.88 21.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.678 . . . . 0.0 109.808 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.98 28.98 69.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -140.51 165.61 26.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -1.016 . . . . 0.0 109.5 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.77 142.45 42.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 23' ' ' VAL . 23.5 m . . . . . 0 C--N 1.308 -1.219 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 2' ' ' LEU . 5.2 tt -157.91 87.7 0.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.672 -0.642 . . . . 0.0 109.527 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -148.95 56.99 1.02 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.635 -0.666 . . . . 0.0 109.288 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.9 t -177.32 96.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.87 -29.9 62.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.741 -0.6 . . . . 0.0 109.661 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -137.98 -78.91 0.37 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.58 -0.7 . . . . 0.0 110.04 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.92 27.69 49.08 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.85 8.76 33.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.475 -1.015 . . . . 0.0 110.404 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.14 -5.66 70.86 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.109 -0.995 . . . . 0.0 111.068 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -125.2 140.39 52.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.134 -1.215 . . . . 0.0 109.423 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.27 165.18 33.77 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.77 0.795 . . . . 0.0 110.862 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.44 -26.48 11.43 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 p -147.32 -177.97 5.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.0 -36.51 82.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.441 -0.787 . . . . 0.0 109.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -68.41 -10.22 53.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.429 -0.794 . . . . 0.0 110.913 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -89.05 14.54 10.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 110.282 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 21' ' ' THR . 99.2 m -115.68 -170.85 1.86 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 m -115.92 -176.51 2.95 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.47 -0.769 . . . . 0.0 109.761 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.565 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 2.8 tt0 -61.49 -49.19 77.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.532 -0.73 . . . . 0.0 110.133 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 20' ' ' LEU . 2.6 tt -55.15 -23.85 23.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.435 -0.791 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 75.9 p -132.7 86.97 42.68 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.74 6.75 4.67 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.934 2.423 . . . . 0.0 112.068 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -126.12 147.83 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.01 -1.057 . . . . 0.0 110.821 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.4 t -123.94 97.35 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' HG11 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.39 144.0 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.643 -0.661 . . . . 0.0 110.003 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 59.69 35.85 22.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.656 -0.652 . . . . 0.0 110.025 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.4 28.21 64.38 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -140.35 166.25 25.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.54 -0.977 . . . . 0.0 109.27 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.3 m -108.19 138.78 43.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.168 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.0 m -150.7 -172.61 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 O-C-N 121.506 -0.746 . . . . 0.0 109.055 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.3 p -83.77 120.4 25.98 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.286 0.565 . . . . 0.0 109.769 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 95.9 p -60.6 -57.6 12.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.716 -0.615 . . . . 0.0 109.75 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.62 -150.25 39.59 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.0 179.91 3.52 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.416 2.744 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.27 -94.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 36' ' ' LEU . 9.1 tp -139.3 158.89 43.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.548 -0.972 . . . . 0.0 109.447 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.8 m -63.0 173.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.514 -0.741 . . . . 0.0 109.499 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.6 -77.17 0.64 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.78 133.47 6.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.408 ' HB ' HD12 ' A' ' 41' ' ' LEU . 47.2 mt -74.71 -24.87 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.513 -0.993 . . . . 0.0 109.964 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 40' ' ' ILE . 5.1 mp -119.19 97.09 5.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.565 -0.71 . . . . 0.0 109.456 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.06 105.82 0.18 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.64 29.96 10.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mt -130.98 144.07 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.6 -0.941 . . . . 0.0 109.503 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.71 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mt -131.37 -170.72 2.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . . . -170.31 83.48 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.612 -0.68 . . . . 0.0 109.518 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.2 t -177.17 96.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 15' ' ' ARG . 45.7 mt -73.45 -30.86 63.46 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -145.65 -78.6 0.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.709 -0.619 . . . . 0.0 109.756 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.4 34.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.44 11.77 20.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.427 -1.043 . . . . 0.0 110.293 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.74 -4.78 72.65 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -125.43 136.87 53.85 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.57 1.185 . . . . 0.0 109.213 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.2 p -150.72 170.67 18.66 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.73 0.776 . . . . 0.0 110.84 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -117.09 -6.25 11.38 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.3 p -166.68 173.08 9.97 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.89 -37.97 86.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 109.974 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.562 ' O ' HD12 ' A' ' 5' ' ' LEU . 12.3 ttt180 -68.4 -10.67 56.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.424 -0.798 . . . . 0.0 110.975 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.61 15.13 10.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.276 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 21' ' ' THR . 96.8 m -117.42 -170.9 1.94 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.091 -1.006 . . . . 0.0 109.93 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 47.3 m -115.74 -177.27 3.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 3' ' ' ALA . 1.3 tt0 -61.25 -49.1 78.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 109.976 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 mt -54.85 -25.31 27.8 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 110.118 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 65.5 p -131.74 86.74 47.6 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.46 6.16 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.915 2.41 . . . . 0.0 112.089 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -125.78 145.98 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.03 -1.044 . . . . 0.0 110.803 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -124.11 96.42 4.92 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -127.05 148.41 50.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.726 -0.609 . . . . 0.0 109.985 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 59.59 33.02 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.706 -0.621 . . . . 0.0 109.934 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.87 72.37 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -144.59 168.21 20.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.595 -0.944 . . . . 0.0 109.462 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 77.7 m -108.71 139.3 43.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.483 -0.761 . . . . 0.0 110.15 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.3 m -150.63 -173.82 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 p -83.62 121.61 27.48 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.294 0.569 . . . . 0.0 109.829 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.6 p -59.64 -29.21 67.87 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.719 -0.613 . . . . 0.0 109.722 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.5 80.16 0.74 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.76 50.54 2.28 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.412 2.742 . . . . 0.0 110.425 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.74 -32.45 2.53 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.0 137.11 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.585 -0.95 . . . . 0.0 109.26 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -103.07 -174.01 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.611 -0.681 . . . . 0.0 109.552 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.04 -71.54 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.82 -106.85 1.0 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 40' ' ' ILE . 4.6 mp -116.59 53.51 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.65 -0.912 . . . . 0.0 109.4 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.9 mt -63.1 159.3 17.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.42 -0.8 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.21 59.18 0.28 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.34 -119.58 0.9 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.76 160.49 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.627 -0.925 . . . . 0.0 109.309 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.695 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 tp -153.71 108.68 3.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.518 -0.739 . . . . 0.0 109.456 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.38 44.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.675 -0.64 . . . . 0.0 109.286 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.1 t -177.44 96.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.53 -33.96 76.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.805 -0.559 . . . . 0.0 109.593 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -136.75 -79.86 0.39 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.63 -0.669 . . . . 0.0 110.01 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.93 48.17 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -94.16 8.95 39.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.556 -0.967 . . . . 0.0 110.456 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.73 -5.29 70.37 Favored Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.236 -0.915 . . . . 0.0 111.155 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -124.76 137.64 54.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.093 -1.24 . . . . 0.0 109.339 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 p -150.85 173.83 13.79 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.8 0.809 . . . . 0.0 110.751 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -124.11 4.26 8.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 p -175.44 170.19 3.04 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.04 -38.76 89.92 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.392 -0.817 . . . . 0.0 109.837 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -68.52 -10.77 57.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.464 -0.772 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.79 15.38 9.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.131 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 21' ' ' THR . 93.8 m -117.58 -171.09 1.98 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.147 -0.971 . . . . 0.0 109.897 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -115.26 -175.98 2.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.475 -0.765 . . . . 0.0 109.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -46.09 89.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.576 -0.703 . . . . 0.0 109.889 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 20' ' ' LEU . 3.4 tt -56.72 -23.5 42.78 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.447 -0.783 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 57.1 p -133.8 87.51 35.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.74 5.04 5.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.87 2.38 . . . . 0.0 112.145 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.4 p -126.13 146.37 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.051 -1.03 . . . . 0.0 110.764 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.3 t -124.59 97.34 5.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -126.62 146.67 50.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.621 -0.674 . . . . 0.0 109.855 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 60.17 33.7 21.1 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.615 -0.678 . . . . 0.0 109.85 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.62 29.09 68.92 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -142.39 166.76 23.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.98 . . . . 0.0 109.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.81 140.03 42.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.45 -0.781 . . . . 0.0 110.138 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.4 m -150.59 -174.21 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 m -83.25 118.49 23.67 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.276 0.56 . . . . 0.0 110.007 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.8 p -63.16 -49.66 73.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.724 -0.61 . . . . 0.0 109.384 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.16 151.18 5.93 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.87 78.3 2.72 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 123.251 2.634 . . . . 0.0 110.44 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.29 106.9 3.0 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 mt -84.96 107.6 17.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.649 -0.913 . . . . 0.0 109.557 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.8 t -97.98 -38.83 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.588 -0.695 . . . . 0.0 109.459 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.49 -85.68 1.53 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.46 -172.18 39.11 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 40' ' ' ILE . 40.3 mm -100.46 34.81 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.564 -0.962 . . . . 0.0 109.328 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.4 mt -113.02 85.09 2.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.13 -102.02 0.21 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.37 29.62 44.13 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 45' ' ' LEU . 11.4 mt 60.61 162.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.582 -0.951 . . . . 0.0 109.529 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' N ' HG22 ' A' ' 44' ' ' ILE . 6.1 mp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.508 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.428 ' N ' HD23 ' A' ' 2' ' ' LEU . 0.6 OUTLIER -137.82 37.92 2.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.603 -0.686 . . . . 0.0 109.432 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -100.93 40.27 1.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.564 -0.71 . . . . 0.0 109.42 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.7 t -177.61 97.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.7 mt -73.87 -30.96 62.92 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -145.45 -77.72 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.666 -0.646 . . . . 0.0 109.744 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.73 30.0 27.82 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.98 12.4 17.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.566 -0.961 . . . . 0.0 110.283 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.12 -2.43 75.92 Favored Glycine 0 N--CA 1.489 2.205 0 O-C-N 121.159 -0.963 . . . . 0.0 111.025 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -125.95 137.98 53.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.134 -1.215 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -150.44 166.32 30.47 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.725 0.774 . . . . 0.0 110.792 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -26.37 11.27 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -148.24 -179.47 6.96 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.1 -37.76 88.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.418 -0.801 . . . . 0.0 109.912 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 mtt-85 -67.86 -10.16 50.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.513 -0.742 . . . . 0.0 111.16 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.02 14.73 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 110.429 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -115.35 -172.28 2.11 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.085 -1.009 . . . . 0.0 109.974 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -113.99 -175.52 2.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -0.773 . . . . 0.0 109.721 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 15.8 tt0 -63.31 -46.1 88.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.523 -0.735 . . . . 0.0 109.941 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.1 mp -56.93 -23.32 44.38 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.447 -0.783 . . . . 0.0 110.114 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 45.4 p -132.74 86.87 42.79 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -77.58 5.15 5.4 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.879 2.386 . . . . 0.0 112.265 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.7 p -127.06 146.68 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.97 -1.081 . . . . 0.0 110.941 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.23 96.38 5.02 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -124.83 145.13 49.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.748 -0.595 . . . . 0.0 109.95 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 60.01 34.52 21.45 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.621 -0.674 . . . . 0.0 109.839 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.03 29.0 67.17 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -141.83 167.27 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.585 -0.95 . . . . 0.0 109.337 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.8 m -108.79 138.06 45.73 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.373 -0.829 . . . . 0.0 110.265 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.712 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.4 m -150.82 -173.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.657 -0.652 . . . . 0.0 109.274 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -80.67 116.11 20.51 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.324 0.583 . . . . 0.0 109.88 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 p -57.1 -30.31 64.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.671 -0.643 . . . . 0.0 110.101 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.95 -68.08 0.02 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -86.09 101.95 0.65 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.42 2.747 . . . . 0.0 110.486 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -129.24 -47.3 0.16 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tp 58.37 61.01 2.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.487 -1.008 . . . . 0.0 109.763 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 m -110.76 -173.68 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.503 -0.748 . . . . 0.0 109.507 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.88 133.7 23.0 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -108.77 -134.55 7.18 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 40' ' ' ILE . 39.8 mm -119.78 33.05 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.997 . . . . 0.0 109.521 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 33.9 mt -111.12 131.38 55.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.58 -0.7 . . . . 0.0 109.461 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.83 -108.07 0.01 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.3 106.19 0.23 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.7 mm -108.89 -30.71 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.613 -0.933 . . . . 0.0 109.41 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.453 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -132.07 88.94 2.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.554 -0.716 . . . . 0.0 109.471 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.775 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -127.27 47.81 2.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.619 -0.675 . . . . 0.0 109.337 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 51.0 t -177.12 96.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.6 mt -71.31 -31.11 67.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.686 -0.634 . . . . 0.0 109.741 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -133.74 -80.68 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.594 -0.691 . . . . 0.0 110.088 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.92 28.53 37.54 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -96.91 7.32 46.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -1.016 . . . . 0.0 110.524 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.96 -4.36 70.98 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 121.181 -0.949 . . . . 0.0 111.134 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -125.21 139.13 54.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.091 -1.241 . . . . 0.0 109.418 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 p -150.44 166.08 31.22 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.687 0.756 . . . . 0.0 110.954 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.2 m -106.81 -26.44 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.2 p -148.16 -178.57 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.02 -36.69 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.409 -0.807 . . . . 0.0 109.901 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -10.58 54.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.464 -0.772 . . . . 0.0 111.016 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.86 15.55 9.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 21' ' ' THR . 88.8 m -115.5 -170.54 1.79 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.219 -0.926 . . . . 0.0 109.981 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.7 m -116.38 -177.18 3.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.974 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.775 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 4.2 tt0 -61.5 -49.61 76.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.58 -0.7 . . . . 0.0 110.241 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 tp -55.21 -23.56 22.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.343 -0.848 . . . . 0.0 110.303 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 81.7 p -132.82 88.27 38.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.474 -0.766 . . . . 0.0 108.955 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -80.12 7.62 4.57 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.82 2.347 . . . . 0.0 111.921 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -125.51 146.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.048 -1.032 . . . . 0.0 110.695 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.99 97.61 5.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -125.71 144.25 50.7 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.695 -0.628 . . . . 0.0 110.02 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 59.89 36.06 21.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.649 -0.657 . . . . 0.0 109.939 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.18 28.42 64.13 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -140.33 165.9 26.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.565 -0.962 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -109.04 139.1 44.37 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.424 -0.798 . . . . 0.0 110.24 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 23' ' ' VAL . 24.6 m -150.72 -174.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -86.32 120.26 27.47 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.338 0.59 . . . . 0.0 109.738 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.2 p -60.47 -44.73 95.59 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.633 -0.667 . . . . 0.0 109.632 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.29 173.45 1.76 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.6 -166.2 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.473 2.782 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -108.11 58.87 0.39 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tt -120.11 84.73 2.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.553 -0.969 . . . . 0.0 109.443 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.29 -65.93 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.0 109.366 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.35 85.46 0.78 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.73 -29.43 6.95 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.8 mt -126.03 81.33 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.572 -0.958 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -92.89 143.49 26.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.712 -0.618 . . . . 0.0 109.528 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.85 -80.09 0.33 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.11 97.62 0.19 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt 59.53 76.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.564 -0.962 . . . . 0.0 109.696 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.716 -179.897 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 tp -102.17 97.29 7.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.595 -0.691 . . . . 0.0 109.497 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.818 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -162.18 44.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.624 -0.672 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.8 t -177.56 96.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.0 mt -64.59 -36.69 85.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.719 -0.613 . . . . 0.0 109.368 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -141.92 -76.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.492 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.16 10.59 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.85 16.08 13.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.532 -0.981 . . . . 0.0 110.149 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.95 8.43 61.16 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.012 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -129.55 134.77 47.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.173 -1.192 . . . . 0.0 109.058 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.67 166.92 28.9 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.902 0.858 . . . . 0.0 111.18 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 m -106.78 -28.71 9.98 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -145.42 -177.37 5.53 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.25 -37.55 83.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.311 -0.868 . . . . 0.0 110.011 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.46 -10.37 50.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.39 -0.819 . . . . 0.0 111.052 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.74 15.1 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 0.0 110.321 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' THR . 90.6 m -114.74 -171.31 1.91 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.088 -1.008 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.2 m -113.01 -179.26 3.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 110.046 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.818 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -61.28 -50.53 72.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.176 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -54.56 -23.99 19.07 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.353 -0.842 . . . . 0.0 110.219 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 70.2 p -132.42 89.08 37.51 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.2 Cg_endo -82.92 10.33 3.69 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.875 2.383 . . . . 0.0 111.648 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.4 p -126.18 145.29 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.085 -1.009 . . . . 0.0 110.742 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.8 t -122.89 96.94 5.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -125.81 145.98 49.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.736 -0.602 . . . . 0.0 110.001 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 59.33 34.94 23.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.75 -0.594 . . . . 0.0 109.872 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.33 27.67 65.87 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 m -140.84 168.78 18.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.477 -1.014 . . . . 0.0 109.425 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.55 140.18 43.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.487 -0.758 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 23' ' ' VAL . 30.6 m -150.32 178.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 33.5 t -93.96 109.73 21.44 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.169 0.509 . . . . 0.0 109.829 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -59.38 3.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.703 -0.623 . . . . 0.0 109.487 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.35 70.4 1.14 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -86.05 79.49 1.98 Allowed 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 123.457 2.771 . . . . 0.0 110.364 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.61 84.34 1.53 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.57 29.04 7.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.56 -0.965 . . . . 0.0 109.635 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.95 178.64 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.626 -0.671 . . . . 0.0 109.5 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.75 126.94 2.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 172.33 -155.94 24.38 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 40' ' ' ILE . 56.9 mt -113.12 40.57 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.57 -0.959 . . . . 0.0 109.361 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.663 HD13 HD11 ' A' ' 44' ' ' ILE . 42.0 mt -95.61 167.98 10.96 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.525 -0.734 . . . . 0.0 109.49 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.51 -34.33 2.29 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.03 121.3 0.74 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.663 HD11 HD13 ' A' ' 41' ' ' LEU . 41.0 mm -101.62 93.38 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.648 -0.913 . . . . 0.0 109.467 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 26.7 tp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 2' ' ' LEU . 0.3 OUTLIER -107.17 76.22 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.532 -0.73 . . . . 0.0 109.295 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -158.01 34.38 0.25 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.463 -0.773 . . . . 0.0 109.626 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.1 t -177.5 97.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 15' ' ' ARG . 26.6 mt -76.01 -30.28 58.44 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -147.93 -76.85 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.65 -0.656 . . . . 0.0 109.679 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 30.53 31.69 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -90.4 12.58 18.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.974 . . . . 0.0 110.214 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.55 -3.87 76.29 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.15 -0.969 . . . . 0.0 110.988 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.061 -1.258 . . . . 0.0 109.405 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 p -150.43 166.26 30.65 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.813 0.816 . . . . 0.0 110.989 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -106.63 -28.21 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -145.75 -177.4 5.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.79 -36.52 80.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.394 -0.816 . . . . 0.0 109.848 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.643 ' O ' HD12 ' A' ' 5' ' ' LEU . 32.8 ttt85 -67.85 -10.47 53.31 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.47 -0.769 . . . . 0.0 110.975 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.17 14.51 9.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.123 -0.986 . . . . 0.0 110.452 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 21' ' ' THR . 75.1 m -116.49 -169.77 1.69 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.129 -0.982 . . . . 0.0 110.006 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -117.52 -177.57 3.27 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.458 -0.776 . . . . 0.0 110.352 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.623 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 5.8 tt0 -60.17 -52.3 65.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.631 . . . . 0.0 110.227 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mt -52.9 -25.52 12.0 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.35 -0.844 . . . . 0.0 110.14 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 62.2 p -132.77 87.74 40.01 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.0 Cg_endo -82.93 8.91 4.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.793 2.329 . . . . 0.0 111.675 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.5 p -125.66 145.0 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.489 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.2 t -122.99 96.52 5.05 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -125.29 146.51 49.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.609 -0.682 . . . . 0.0 109.919 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 mtm-85 59.9 33.64 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.601 -0.687 . . . . 0.0 109.878 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.28 29.31 71.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -143.16 168.03 20.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 0.0 109.352 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.1 m -109.61 141.45 42.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.74 ' O ' HG12 ' A' ' 23' ' ' VAL . 26.3 m -150.3 176.24 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 12.2 p -92.8 108.95 20.38 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.244 0.545 . . . . 0.0 109.815 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -75.21 -50.18 17.02 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.502 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.91 -68.57 0.25 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.655 ' HG2' HG11 ' A' ' 37' ' ' VAL . 43.3 Cg_endo -86.86 -165.02 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.465 2.776 . . . . 0.0 110.33 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.75 -44.63 0.1 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -94.53 71.27 3.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.53 -0.982 . . . . 0.0 109.702 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.655 HG11 ' HG2' ' A' ' 34' ' ' PRO . 15.8 m -128.45 160.29 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.534 -0.728 . . . . 0.0 109.416 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.23 87.82 0.04 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.8 173.64 37.33 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 40' ' ' ILE . 57.6 mt -99.0 51.22 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.586 -0.949 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -101.22 178.26 4.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.492 -0.755 . . . . 0.0 109.494 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.69 59.5 4.57 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -157.14 108.57 0.37 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.5 mt -120.57 -41.53 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.472 -1.016 . . . . 0.0 109.439 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.482 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 1' ' ' LEU . 4.2 mp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.15 114.48 21.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.632 -0.667 . . . . 0.0 109.64 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -132.93 60.7 1.7 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.602 -0.686 . . . . 0.0 109.339 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 45.4 t -177.47 97.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.3 mt -73.86 -30.34 62.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.717 -0.615 . . . . 0.0 109.662 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -135.52 -79.71 0.43 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.612 -0.68 . . . . 0.0 109.951 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.68 29.01 49.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -94.02 9.86 35.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.522 -0.987 . . . . 0.0 110.409 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.64 -2.56 72.6 Favored Glycine 0 N--CA 1.49 2.271 0 O-C-N 121.121 -0.987 . . . . 0.0 111.084 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -125.1 137.04 54.19 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.648 1.224 . . . . 0.0 109.276 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.4 p -150.52 165.9 31.84 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.814 0.816 . . . . 0.0 110.987 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 p -106.13 -26.95 11.38 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.56 -177.7 5.92 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.75 -35.76 80.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.431 -0.793 . . . . 0.0 109.874 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -67.95 -10.83 56.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.496 -0.753 . . . . 0.0 110.939 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.41 16.44 8.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.105 -0.997 . . . . 0.0 110.096 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' THR . 94.5 m -116.92 -170.98 1.94 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 0.0 110.179 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.1 m -116.89 -178.79 3.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.333 -0.854 . . . . 0.0 110.058 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 20.9 tp10 -61.13 -50.74 71.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.579 -0.7 . . . . 0.0 110.143 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.5 tp -53.45 -24.94 14.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.33 -0.856 . . . . 0.0 110.128 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 60.9 p -132.67 88.88 37.08 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 40.8 Cg_endo -82.66 8.77 4.37 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.803 2.336 . . . . 0.0 111.533 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.3 p -125.64 144.14 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.109 -0.995 . . . . 0.0 110.448 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.01 96.64 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -129.06 150.93 50.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.739 -0.601 . . . . 0.0 109.63 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 60.56 30.91 20.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.737 -0.602 . . . . 0.0 109.647 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.03 28.27 70.19 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -144.7 170.49 16.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.547 -0.972 . . . . 0.0 109.484 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 71.6 m -109.62 141.88 41.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 110.239 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 23' ' ' VAL . 28.2 m -150.31 176.66 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 11.1 m -92.52 105.74 17.85 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.105 0.478 . . . . 0.0 109.859 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.24 157.75 0.14 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.01 49.12 1.91 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 123.497 2.798 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.25 51.78 6.57 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.25 158.33 20.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.578 -0.954 . . . . 0.0 109.557 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 38' ' ' GLY . 3.6 t -123.35 166.78 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 37' ' ' VAL . . . 145.46 -38.07 1.25 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.99 130.83 10.37 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 40' ' ' ILE . 62.4 mt -90.27 52.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.616 -0.932 . . . . 0.0 109.474 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.0 mt -85.25 110.11 18.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.508 -0.745 . . . . 0.0 109.464 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.2 118.66 0.63 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.45 -127.81 1.31 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -111.28 137.7 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.549 -0.971 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.436 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 2' ' ' LEU . 10.2 mt -124.9 107.22 10.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.621 -0.675 . . . . 0.0 109.458 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -168.97 40.27 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.672 -0.643 . . . . 0.0 109.312 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.5 t -177.47 97.24 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 mt -69.44 -33.27 72.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.692 -0.63 . . . . 0.0 109.544 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -133.24 -79.09 0.48 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.651 -0.656 . . . . 0.0 109.741 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.53 28.31 33.12 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -95.8 14.05 24.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.53 -0.982 . . . . 0.0 110.18 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.89 9.54 59.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -129.28 133.01 47.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.233 -1.157 . . . . 0.0 108.898 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.9 p -150.91 166.88 29.25 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -106.53 -28.23 10.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.7 p -146.53 -177.79 5.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -67.45 -35.55 79.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.319 -0.863 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -67.97 -10.83 56.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.455 -0.778 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.19 16.66 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.206 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' THR . 91.0 m -115.62 -171.45 1.97 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 0.0 110.304 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.8 m -113.12 177.82 4.5 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.473 -0.767 . . . . 0.0 109.956 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.598 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 5.6 tt0 -62.12 -47.71 83.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.628 -0.67 . . . . 0.0 109.811 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.41 -25.8 38.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 64.8 p -131.26 88.91 43.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.3 Cg_endo -81.44 9.93 3.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.881 2.387 . . . . 0.0 111.946 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.1 p -125.6 144.41 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.067 -1.021 . . . . 0.0 110.735 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -122.76 95.81 4.77 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -127.34 149.98 49.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.662 -0.649 . . . . 0.0 109.759 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 59.87 32.21 21.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.721 -0.612 . . . . 0.0 109.626 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.27 28.11 68.7 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m -143.53 170.45 15.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.498 -1.001 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.9 m -109.57 140.61 43.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.417 -0.802 . . . . 0.0 110.268 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.751 ' O ' HG12 ' A' ' 23' ' ' VAL . 24.6 m -150.44 178.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 1.5 m -91.13 126.57 36.25 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.317 0.58 . . . . 0.0 109.606 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.8 p -61.02 -52.77 63.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.699 -0.626 . . . . 0.0 109.579 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.1 -76.59 0.22 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.65 66.04 5.65 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.43 2.754 . . . . 0.0 110.614 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -107.51 -33.68 3.06 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.94 140.88 49.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.922 . . . . 0.0 109.169 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.2 m -63.66 -174.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.56 -0.712 . . . . 0.0 109.419 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 169.35 134.6 1.76 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.79 -126.14 4.94 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 40' ' ' ILE . 55.7 mt -94.0 45.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.557 -0.967 . . . . 0.0 109.471 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.9 mt -105.46 36.02 2.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 109.53 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.12 -76.37 0.67 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.65 116.52 3.7 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 44' ' ' ILE . 6.7 tt -88.55 56.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.52 -0.988 . . . . 0.0 109.177 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.52 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mt -145.11 132.86 21.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.622 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -104.18 46.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.648 -0.658 . . . . 0.0 109.227 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -176.84 96.23 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 15' ' ' ARG . 40.4 mt -75.94 -28.49 57.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.745 -0.597 . . . . 0.0 109.728 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -138.81 -79.54 0.33 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.542 -0.724 . . . . 0.0 109.969 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.71 27.6 50.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -94.14 8.26 42.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -1.03 . . . . 0.0 110.443 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.46 -8.87 66.45 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.187 -0.946 . . . . 0.0 111.084 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 33.5 ptt180 -123.48 138.96 54.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -1.179 . . . . 0.0 109.37 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 12.1 p -150.07 166.66 29.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.678 0.751 . . . . 0.0 110.768 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 p -107.72 -24.87 11.54 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.4 p -149.96 -179.75 7.4 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.38 -35.65 81.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.542 ' O ' HD12 ' A' ' 5' ' ' LEU . 41.1 mtt180 -68.37 -10.85 57.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.413 -0.804 . . . . 0.0 110.883 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.7 OUTLIER -90.37 15.9 9.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.152 -0.967 . . . . 0.0 110.137 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' THR . 87.8 m -116.26 -170.86 1.89 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 109.932 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -118.21 -176.72 3.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 109.829 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 4.4 tm-20 -62.38 -48.03 81.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.608 -0.683 . . . . 0.0 109.991 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.19 -23.9 24.26 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.468 -0.77 . . . . 0.0 110.104 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 77.7 p -133.56 87.93 35.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.13 5.98 5.0 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.912 2.408 . . . . 0.0 112.093 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 30' ' ' VAL . 11.2 p -125.91 146.13 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.011 -1.056 . . . . 0.0 110.831 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.6 t -124.13 96.14 4.82 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 150.26 50.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.678 -0.639 . . . . 0.0 109.802 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.29 31.62 20.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.556 -0.715 . . . . 0.0 109.72 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.33 71.51 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 3.1 m -144.71 169.28 18.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.543 -0.975 . . . . 0.0 109.509 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 80.4 m -108.82 139.12 44.08 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.447 -0.783 . . . . 0.0 110.091 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.8 m -150.57 -172.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 O-C-N 121.554 -0.716 . . . . 0.0 109.101 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.5 m -83.09 124.63 30.64 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.0 p -52.87 -49.76 65.18 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.753 -0.592 . . . . 0.0 110.331 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.54 -145.78 49.73 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -83.58 -165.29 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 123.205 2.603 . . . . 0.0 110.487 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.96 -110.13 2.7 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -85.27 157.31 20.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.615 -0.933 . . . . 0.0 109.559 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 t 67.67 -70.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.698 -0.626 . . . . 0.0 109.857 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.64 -147.73 47.27 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.49 154.06 6.62 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.84 -23.69 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.541 -0.976 . . . . 0.0 109.981 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 41' ' ' LEU . 15.5 mt -140.24 164.49 29.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.62 -0.675 . . . . 0.0 109.49 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.25 -83.92 1.1 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.48 -125.84 0.84 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -130.44 108.8 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.643 -0.916 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.511 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -84.0 99.59 10.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.489 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.96 37.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.666 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.8 t -177.82 97.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -66.85 -35.52 80.22 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -149.04 -75.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.807 -0.558 . . . . 0.0 109.573 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.88 34.75 20.84 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -95.23 21.89 7.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.492 -1.005 . . . . 0.0 109.966 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.59 7.13 64.1 Favored Glycine 0 N--CA 1.491 2.323 0 O-C-N 121.382 -0.824 . . . . 0.0 111.305 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -129.8 133.67 47.11 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 118.734 1.267 . . . . 0.0 109.339 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.28 167.73 26.94 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.728 0.775 . . . . 0.0 110.987 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.1 p -106.27 -29.55 9.73 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.9 p -145.6 -177.4 5.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -66.91 -37.66 84.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.28 -0.887 . . . . 0.0 109.983 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -68.02 -9.68 47.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.415 -0.803 . . . . 0.0 111.133 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 13.91 10.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.118 -0.989 . . . . 0.0 110.392 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' THR . 80.4 m -114.6 -171.16 1.88 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 110.065 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.1 m -112.82 179.93 3.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.745 . . . . 0.0 109.932 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.04 -47.0 88.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.627 -0.671 . . . . 0.0 109.921 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.93 -27.96 54.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 67.1 p -128.99 87.17 55.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.3 Cg_endo -80.91 7.8 4.69 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.92 2.413 . . . . 0.0 111.909 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.0 p -125.3 143.41 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.061 -1.025 . . . . 0.0 110.684 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -121.97 95.77 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -121.3 143.47 49.16 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 110.111 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.2 mtt180 59.16 35.35 23.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.802 -0.561 . . . . 0.0 109.992 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.85 29.89 71.56 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -141.64 166.4 24.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.605 -0.938 . . . . 0.0 109.295 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.54 140.23 43.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.405 -0.81 . . . . 0.0 110.446 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.748 ' O ' HG12 ' A' ' 23' ' ' VAL . 22.4 m -150.37 179.55 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.413 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 9.0 t -90.16 116.53 28.23 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.273 0.558 . . . . 0.0 109.79 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 p -61.08 -31.86 71.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.76 -0.588 . . . . 0.0 109.524 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.17 164.78 16.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.24 166.64 9.42 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.439 2.759 . . . . 0.0 110.55 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.46 -68.76 0.03 OUTLIER Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.17 82.1 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.54 -0.977 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.62 -174.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.555 -0.716 . . . . 0.0 109.599 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.94 66.31 3.74 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.63 117.94 4.52 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.606 HD12 ' H ' ' A' ' 40' ' ' ILE . 4.5 mp -86.85 -24.16 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.577 -0.955 . . . . 0.0 109.954 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -141.88 147.03 36.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.522 -0.736 . . . . 0.0 109.529 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.08 83.48 0.13 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.26 -131.35 6.47 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mt -88.08 154.24 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.641 -0.917 . . . . 0.0 109.259 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.436 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 1' ' ' LEU . 2.9 mm? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 tp -164.99 86.26 0.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.626 -0.671 . . . . 0.0 109.489 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -171.84 39.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.536 -0.727 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.0 t -177.67 97.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.92 -33.73 74.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.644 -0.66 . . . . 0.0 109.49 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -138.63 -79.3 0.34 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.68 -0.638 . . . . 0.0 109.755 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.88 28.88 24.88 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -91.23 11.66 22.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.607 -0.937 . . . . 0.0 110.257 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.58 1.35 70.9 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.092 -1.005 . . . . 0.0 111.027 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -126.29 136.71 53.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.17 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 13.2 p -150.57 166.28 30.74 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.607 0.717 . . . . 0.0 110.797 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -107.25 -24.7 11.8 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p -150.04 178.79 8.61 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -63.36 -37.52 87.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.07 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -67.97 -10.47 53.72 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.477 -0.764 . . . . 0.0 111.099 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 4.7 m-20 -90.35 15.8 9.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.234 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 21' ' ' THR . 94.5 m -114.28 -172.98 2.2 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.4 m -114.02 -175.81 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.693 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 1.8 tt0 -64.46 -45.32 87.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.55 -0.719 . . . . 0.0 109.801 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.063 HD12 HG23 ' A' ' 21' ' ' THR . 1.3 pp -58.01 -20.84 41.64 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.254 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 1.063 HG23 HD12 ' A' ' 20' ' ' LEU . 22.7 p -133.74 88.28 33.67 Favored Pre-proline 0 N--CA 1.492 1.673 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.77 4.93 5.23 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.95 2.433 . . . . 0.0 112.397 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.5 p -128.21 147.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.975 -1.078 . . . . 0.0 110.961 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -123.6 97.42 5.38 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -127.74 147.11 50.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.708 -0.62 . . . . 0.0 109.997 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 59.99 33.97 21.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.64 -0.662 . . . . 0.0 109.901 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.29 29.34 68.62 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -143.45 167.96 20.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.595 -0.944 . . . . 0.0 109.343 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.7 m -108.9 138.13 45.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.8 . . . . 0.0 110.055 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 23' ' ' VAL . 18.3 m -150.48 -173.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.594 -0.691 . . . . 0.0 109.262 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -79.72 115.53 19.38 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.378 0.609 . . . . 0.0 109.752 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.4 p -55.12 -28.05 49.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.633 -0.667 . . . . 0.0 110.159 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.1 145.03 17.16 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.2 172.66 8.32 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 123.22 2.613 . . . . 0.0 110.457 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -104.95 31.53 8.48 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 36' ' ' LEU . 8.0 tp -141.6 157.52 44.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.613 -0.933 . . . . 0.0 109.411 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 t -84.61 -64.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.494 -0.754 . . . . 0.0 109.491 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.15 -145.5 5.79 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.16 -57.47 0.07 OUTLIER Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 40' ' ' ILE . 4.8 mp -129.1 46.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.571 -0.958 . . . . 0.0 109.479 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.63 128.01 33.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.463 -0.773 . . . . 0.0 109.51 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.31 55.74 0.03 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.06 -119.85 0.56 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.1 mm -67.1 -52.65 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.564 -0.962 . . . . 0.0 109.475 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.435 HD23 ' O ' ' A' ' 45' ' ' LEU . 1.4 tt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 1' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 2' ' ' LEU . 1.1 pp -155.87 119.72 4.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.597 -0.689 . . . . 0.0 109.386 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.13 41.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.445 -0.785 . . . . 0.0 109.427 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.0 t -177.7 97.02 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 65.1 mt -62.89 -37.63 87.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.752 -0.592 . . . . 0.0 109.504 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -140.33 -77.91 0.31 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.727 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.74 28.94 33.59 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -90.26 11.81 20.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.53 -0.983 . . . . 0.0 110.274 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.4 -0.88 73.52 Favored Glycine 0 N--CA 1.49 2.293 0 O-C-N 121.217 -0.927 . . . . 0.0 111.162 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -126.26 136.84 53.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.059 -1.26 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 9.3 p -150.54 166.06 31.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.726 0.774 . . . . 0.0 110.9 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.1 m -106.19 -26.93 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -148.11 -178.94 6.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.7 -36.52 83.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 109.893 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -67.95 -10.56 54.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.489 -0.757 . . . . 0.0 110.983 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.3 m-20 -89.79 15.69 9.32 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.981 . . . . 0.0 110.282 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' THR . 90.0 m -115.46 -171.34 1.94 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.089 -1.007 . . . . 0.0 110.015 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.8 m -115.57 -178.62 3.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.54 -0.725 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.41 -49.58 76.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.665 -0.647 . . . . 0.0 110.168 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.72 -24.31 21.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.351 -0.843 . . . . 0.0 110.09 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 75.9 p -132.06 87.29 44.54 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -79.2 7.51 4.36 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.864 2.376 . . . . 0.0 112.123 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -126.02 145.17 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.026 -1.046 . . . . 0.0 110.892 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.95 95.63 4.69 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 148.78 49.54 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.756 -0.59 . . . . 0.0 109.793 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 59.45 33.04 22.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.816 -0.552 . . . . 0.0 109.808 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.92 28.9 69.35 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -143.49 169.29 17.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.507 -0.996 . . . . 0.0 109.448 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.1 m -109.13 139.05 44.54 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.744 ' O ' HG12 ' A' ' 23' ' ' VAL . 20.3 m -150.59 -174.11 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -85.3 120.24 26.57 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.294 0.569 . . . . 0.0 109.787 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -62.28 -32.46 73.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.721 -0.612 . . . . 0.0 109.598 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.26 171.24 16.66 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.06 165.7 9.87 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 123.448 2.766 . . . . 0.0 110.51 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.4 -68.71 0.04 OUTLIER Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tp -141.46 114.68 8.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.657 -0.908 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.04 175.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.716 . . . . 0.0 109.618 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.9 -100.52 0.94 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.83 147.64 13.31 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 tt -99.81 -21.87 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.655 -0.909 . . . . 0.0 109.989 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.4 mt -84.55 154.38 22.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 109.654 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.73 -106.71 2.56 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.435 ' H ' HD12 ' A' ' 44' ' ' ILE . . . -155.54 27.21 0.6 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.435 HD12 ' H ' ' A' ' 43' ' ' GLY . 4.6 mp -140.61 137.69 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.425 -1.044 . . . . 0.0 109.405 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.426 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -88.56 99.92 12.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.658 -0.651 . . . . 0.0 109.446 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -101.13 46.42 0.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.596 -0.69 . . . . 0.0 109.348 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.407 ' H ' HD23 ' A' ' 2' ' ' LEU . 52.7 t -177.71 97.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.3 mt -71.56 -31.67 67.25 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.797 -0.564 . . . . 0.0 109.635 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -132.53 -79.68 0.5 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.015 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.1 27.78 55.26 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -93.4 7.65 43.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.431 -1.041 . . . . 0.0 110.392 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.52 -2.7 71.26 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 121.177 -0.952 . . . . 0.0 111.207 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.969 -1.312 . . . . 0.0 109.474 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 16' ' ' ASP . 7.6 p -150.17 166.5 29.64 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.74 0.781 . . . . 0.0 111.092 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.99 -28.11 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 p -145.66 -177.96 5.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.25 -36.71 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.788 . . . . 0.0 109.84 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -67.86 -10.47 53.29 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.98 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 3.8 m-20 -88.4 14.78 8.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 110.362 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' THR . 96.6 m -115.62 -169.91 1.68 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.062 -1.024 . . . . 0.0 110.207 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 m -114.24 179.48 3.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.586 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 0.9 OUTLIER -60.68 -51.69 68.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.655 -0.653 . . . . 0.0 109.952 -179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.09 -25.59 13.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.392 -0.817 . . . . 0.0 109.997 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 65.9 p -132.24 87.9 41.86 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 41.8 Cg_endo -83.12 11.22 3.34 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.819 2.346 . . . . 0.0 111.702 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.3 p -125.74 145.47 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.618 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.3 t -123.22 97.57 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.24 145.41 50.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.67 . . . . 0.0 109.944 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.12 34.9 21.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.647 -0.658 . . . . 0.0 109.827 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.79 27.94 64.97 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -140.68 167.7 21.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -1.02 . . . . 0.0 109.374 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -109.28 140.38 43.01 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.754 ' O ' HG12 ' A' ' 23' ' ' VAL . 29.4 m -150.41 178.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -94.82 120.55 35.23 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.232 0.539 . . . . 0.0 109.945 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.6 p -72.75 -46.43 53.49 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.63 -162.4 11.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -86.39 156.67 9.42 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.425 2.75 . . . . 0.0 110.51 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.11 -54.8 0.06 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.26 154.47 40.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.558 -0.966 . . . . 0.0 109.491 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.84 -173.39 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.603 -0.685 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.52 49.26 2.39 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.62 -179.58 21.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 40' ' ' ILE . 63.0 mt -132.97 42.45 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.591 -0.947 . . . . 0.0 109.454 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.16 39.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.531 -0.731 . . . . 0.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.06 -61.88 4.62 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.1 109.37 0.23 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 tt -63.55 157.92 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.613 -0.934 . . . . 0.0 109.345 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.68 -179.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.52 -161.0 0.76 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -131.28 32.36 4.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.505 -0.747 . . . . 0.0 109.513 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -177.93 97.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.7 mt -76.64 -28.77 56.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.725 -0.61 . . . . 0.0 109.906 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.56 -73.99 0.39 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.526 -0.734 . . . . 0.0 110.252 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.86 28.03 67.74 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.92 7.3 38.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.478 -1.013 . . . . 0.0 110.383 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.27 -17.22 54.96 Favored Glycine 0 N--CA 1.488 2.127 0 O-C-N 121.217 -0.927 . . . . 0.0 111.105 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 147.17 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.3 p -150.92 173.24 14.51 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 0.0 110.596 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -123.83 6.16 8.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.2 p -177.63 169.73 2.08 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.28 -39.12 91.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.367 -0.833 . . . . 0.0 109.809 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -68.88 -10.5 57.38 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.455 -0.778 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.76 15.13 10.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' THR . 89.4 m -116.01 -171.06 1.91 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.088 -1.008 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.6 m -114.03 -177.87 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.446 -0.784 . . . . 0.0 109.749 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 4.5 tt0 -62.29 -48.05 81.58 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.64 -0.663 . . . . 0.0 110.018 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -23.6 27.28 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.387 -0.821 . . . . 0.0 110.065 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 74.4 p -132.93 87.7 39.43 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.15 6.15 4.89 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.772 2.314 . . . . 0.0 112.198 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -126.11 146.86 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.997 -1.064 . . . . 0.0 110.852 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.5 t -124.94 98.04 5.52 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -130.76 148.07 52.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.672 -0.643 . . . . 0.0 109.796 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 59.86 33.97 21.68 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.71 -0.619 . . . . 0.0 109.791 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.68 25.88 61.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.6 m -142.06 156.79 45.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.463 -1.022 . . . . 0.0 109.385 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.2 m -98.47 140.51 32.6 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.526 -0.733 . . . . 0.0 110.052 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.738 ' O ' HG12 ' A' ' 23' ' ' VAL . 21.3 m -150.57 -172.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 p -83.71 119.77 25.19 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.247 0.546 . . . . 0.0 109.993 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 p -63.27 -39.73 95.41 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.22 67.55 1.88 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.97 100.09 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.51 2.807 . . . . 0.0 110.45 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.36 86.13 0.08 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 tp -65.5 94.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.617 -0.931 . . . . 0.0 109.583 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 m -110.53 -174.04 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.532 -0.73 . . . . 0.0 109.465 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.04 179.92 6.57 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.04 -137.4 2.25 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.8 mt -87.21 -23.87 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.547 -0.972 . . . . 0.0 109.962 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.52 83.84 2.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.471 -0.768 . . . . 0.0 109.555 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.05 -45.81 7.39 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.82 103.43 1.37 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.6 mt -135.11 102.58 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.922 . . . . 0.0 109.467 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 45' ' ' LEU . 4.5 mp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.523 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 1' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.4 tp -84.8 88.52 7.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.622 -0.674 . . . . 0.0 109.515 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.31 42.72 1.08 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 109.359 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.7 t -177.53 96.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.6 mt -72.11 -31.31 65.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.68 -0.637 . . . . 0.0 109.645 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -144.89 -76.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.581 -0.699 . . . . 0.0 110.032 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.6 29.96 54.16 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' CB ' ' NH1' ' A' ' 10' ' ' ARG . 7.7 m120 -89.88 11.38 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.514 -0.992 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.78 -7.79 72.39 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 121.187 -0.946 . . . . 0.0 111.07 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -125.59 140.8 52.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.061 -1.258 . . . . 0.0 109.689 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.2 p -150.35 167.9 25.67 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.625 0.726 . . . . 0.0 110.81 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 t -107.45 -28.04 10.06 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.9 p -146.52 179.11 7.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -64.04 -38.48 91.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.438 -0.789 . . . . 0.0 109.938 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -67.81 -9.78 47.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.159 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.75 13.75 9.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.084 -1.01 . . . . 0.0 110.455 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 21' ' ' THR . 78.2 m -114.42 -168.92 1.44 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.043 -1.036 . . . . 0.0 109.928 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.3 m -116.67 -176.55 2.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.373 -0.829 . . . . 0.0 110.195 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.41 -51.75 68.17 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.656 -0.653 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.93 -24.51 16.59 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.292 -0.88 . . . . 0.0 110.11 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 72.1 p -133.91 88.9 31.04 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 41.6 Cg_endo -83.31 9.76 3.96 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.77 2.313 . . . . 0.0 111.531 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.7 p -126.34 146.08 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.719 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.98 96.97 5.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 142.22 50.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.676 -0.64 . . . . 0.0 110.091 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 59.55 36.8 22.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.696 -0.627 . . . . 0.0 110.003 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.52 28.93 65.73 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 m -140.12 165.58 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.634 -0.921 . . . . 0.0 109.265 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 96.9 m -108.6 139.91 42.72 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.467 -0.77 . . . . 0.0 110.216 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 23' ' ' VAL . 27.5 m -150.44 177.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 15.7 t -93.41 108.59 20.24 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.194 0.521 . . . . 0.0 109.759 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.97 -43.6 74.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.744 -0.598 . . . . 0.0 109.627 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 169.75 91.6 0.08 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.14 85.16 1.27 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.379 2.719 . . . . 0.0 110.465 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.64 -33.78 0.22 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.36 76.44 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.594 -0.945 . . . . 0.0 109.382 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 m -114.8 175.99 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.547 -0.72 . . . . 0.0 109.451 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.61 -100.51 2.16 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.62 -173.75 3.6 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.8 tt -93.97 -18.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.616 -0.932 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.79 118.3 6.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.422 -0.799 . . . . 0.0 109.627 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.48 46.79 0.26 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.684 ' C ' HD12 ' A' ' 44' ' ' ILE . . . -168.1 122.5 1.03 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.684 HD12 ' C ' ' A' ' 43' ' ' GLY . 4.6 mp 59.47 98.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.963 . . . . 0.0 109.646 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.462 -179.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 19.7 tp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.51 98.34 8.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.731 . . . . 0.0 109.488 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.583 ' HB1' ' HG3' ' A' ' 19' ' ' GLU . . . -96.64 50.73 1.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.667 -0.645 . . . . 0.0 109.307 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.9 t -177.91 97.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.2 mt -65.56 -36.13 82.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.743 -0.598 . . . . 0.0 109.625 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -138.63 -76.24 0.37 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.701 -0.624 . . . . 0.0 110.05 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.2 28.81 55.31 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -89.79 9.44 27.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.491 -1.005 . . . . 0.0 110.37 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.99 -6.6 70.17 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 121.213 -0.93 . . . . 0.0 111.276 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -124.62 139.6 53.71 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 118.694 1.247 . . . . 0.0 109.784 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 p -150.51 166.24 30.81 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.722 0.773 . . . . 0.0 110.604 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.1 m -106.3 -26.47 11.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 81.6 p -148.9 -178.65 6.48 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -65.88 -36.43 83.4 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.473 -0.767 . . . . 0.0 109.937 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.99 -10.6 54.88 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.497 -0.752 . . . . 0.0 111.025 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.12 15.97 9.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 110.168 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' THR . 83.9 m -115.38 -171.39 1.95 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.145 -0.972 . . . . 0.0 110.079 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.3 m -114.9 -178.59 3.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.055 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.583 ' HG3' ' HB1' ' A' ' 3' ' ' ALA . 1.8 mt-10 -61.31 -50.21 73.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.615 -0.678 . . . . 0.0 110.056 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mp -54.62 -24.27 20.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.354 -0.841 . . . . 0.0 110.209 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 78.4 p -131.92 88.02 42.9 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -79.89 8.2 4.18 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.9 p -125.86 145.41 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.02 -1.05 . . . . 0.0 110.767 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -123.96 96.38 4.92 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -126.0 147.18 49.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.685 -0.635 . . . . 0.0 109.946 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mtm-85 60.16 33.26 21.12 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.654 -0.654 . . . . 0.0 109.757 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.8 29.53 70.52 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 m -142.92 167.56 21.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.589 -0.948 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 90.5 m -108.68 138.68 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.494 -0.754 . . . . 0.0 110.24 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.752 ' O ' HG12 ' A' ' 23' ' ' VAL . 26.1 m -150.75 -173.51 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -86.16 122.63 30.43 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.222 0.534 . . . . 0.0 109.67 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -61.9 -30.63 71.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.707 -0.621 . . . . 0.0 109.631 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.88 74.42 0.44 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.96 54.25 2.41 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.579 2.853 . . . . 0.0 110.549 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.37 50.57 0.11 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.1 tp -163.44 81.84 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.499 -1.001 . . . . 0.0 109.476 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 t -133.01 -64.92 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.62 -0.675 . . . . 0.0 109.463 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.98 143.79 8.43 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.78 54.41 0.13 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tp -82.15 -26.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.556 -0.967 . . . . 0.0 109.7 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -98.28 -179.46 4.37 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.65 -0.656 . . . . 0.0 109.561 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.95 -60.25 2.08 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' HD13 ' A' ' 44' ' ' ILE . . . 106.58 94.2 2.35 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 43' ' ' GLY . 43.6 mm -129.13 -56.14 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.652 -0.911 . . . . 0.0 109.518 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 44' ' ' ILE . 5.2 mp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.47 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 tt -81.94 76.61 8.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.566 -0.708 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -123.84 55.06 1.28 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.153 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -177.41 96.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.28 -36.18 83.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.693 -0.629 . . . . 0.0 109.496 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -139.12 -78.17 0.34 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.708 -0.62 . . . . 0.0 109.725 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.56 27.74 46.17 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -90.28 10.98 22.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.42 -1.047 . . . . 0.0 110.287 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.4 -3.38 73.26 Favored Glycine 0 N--CA 1.49 2.284 0 O-C-N 121.187 -0.946 . . . . 0.0 111.093 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -124.53 136.34 53.91 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.268 . . . . 0.0 109.472 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.3 p -150.76 168.14 25.31 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.657 0.742 . . . . 0.0 110.783 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.3 m -112.5 -10.95 13.68 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -163.63 175.15 10.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.41 -37.06 84.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 109.82 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -68.31 -11.06 58.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.444 -0.785 . . . . 0.0 110.981 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 16.76 8.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 21' ' ' THR . 88.7 m -116.27 -172.19 2.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.025 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 50.9 m -114.75 -178.08 3.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.52 -0.738 . . . . 0.0 109.746 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 2.7 tm-20 -62.47 -47.67 82.98 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.06 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.24 -23.32 35.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.326 -0.859 . . . . 0.0 110.151 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 77.5 p -132.13 87.33 44.11 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.45 5.86 4.84 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.854 2.369 . . . . 0.0 112.279 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 30' ' ' VAL . 14.8 p -125.9 146.61 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.036 -1.04 . . . . 0.0 110.857 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.6 t -124.61 94.78 4.29 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -127.12 150.8 49.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.718 -0.614 . . . . 0.0 109.823 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.99 31.1 20.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.71 -0.619 . . . . 0.0 109.679 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 30.1 74.39 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -146.06 169.98 17.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.949 . . . . 0.0 109.558 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.9 m -108.96 139.34 43.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.462 -0.774 . . . . 0.0 110.396 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.714 ' O ' HG12 ' A' ' 23' ' ' VAL . 19.7 m -150.75 -171.95 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.19 120.36 25.71 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.329 0.585 . . . . 0.0 109.738 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.9 p -59.69 -28.16 67.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.642 -0.661 . . . . 0.0 109.84 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.97 -177.69 19.33 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -86.43 141.14 6.63 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 123.452 2.768 . . . . 0.0 110.565 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.92 -61.28 0.04 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.1 mp -75.92 172.49 12.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.628 -0.925 . . . . 0.0 109.317 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.0 t 66.88 -71.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.673 -0.642 . . . . 0.0 109.983 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.12 179.81 16.12 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.24 147.16 17.26 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.9 tp -66.82 -24.99 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.964 . . . . 0.0 109.85 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.7 mt -104.46 163.03 12.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.515 -0.741 . . . . 0.0 109.524 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.54 75.24 0.16 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.13 112.79 0.27 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.4 mt -99.07 82.25 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.585 -0.95 . . . . 0.0 109.359 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.466 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -154.52 98.55 2.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.518 -0.739 . . . . 0.0 109.35 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . -105.14 36.4 2.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.489 -0.757 . . . . 0.0 109.543 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.9 t -177.42 95.5 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 mt -77.57 -26.92 51.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.699 -0.626 . . . . 0.0 109.793 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -122.43 -81.29 0.64 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.466 -0.771 . . . . 0.0 110.031 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.06 28.74 44.17 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -110.85 10.97 22.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.455 -1.026 . . . . 0.0 110.47 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.94 8.28 60.84 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.19 -0.944 . . . . 0.0 110.931 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -129.31 135.2 48.45 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.129 -1.218 . . . . 0.0 108.941 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.72 165.41 33.55 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.821 0.82 . . . . 0.0 111.138 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -105.59 -28.62 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -145.04 -176.7 5.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -68.27 -36.29 79.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.385 -0.822 . . . . 0.0 109.868 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -68.1 -10.31 52.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.351 -0.843 . . . . 0.0 110.956 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.55 15.69 8.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.272 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 21' ' ' THR . 87.5 m -114.25 -171.21 1.87 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.122 -0.986 . . . . 0.0 110.27 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 54.8 m -114.38 -179.23 3.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.494 -0.754 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.699 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . 4.9 tp10 -61.7 -49.94 74.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.618 -0.676 . . . . 0.0 110.121 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -54.64 -23.89 19.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.33 -0.856 . . . . 0.0 110.129 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 71.0 p -132.88 89.43 34.62 Favored Pre-proline 0 N--CA 1.487 1.388 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 42.3 Cg_endo -82.56 9.69 3.92 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.818 2.345 . . . . 0.0 111.609 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 30' ' ' VAL . 13.4 p -126.16 145.12 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.733 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.7 t -122.68 98.16 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' A' ' 23' ' ' VAL . 18.4 mtmt -126.51 145.81 50.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.708 -0.62 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.72 35.14 22.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.634 -0.666 . . . . 0.0 109.931 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.42 65.95 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 m -141.68 167.88 21.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.456 -1.026 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 93.6 m -109.57 141.11 42.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.805 . . . . 0.0 110.18 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 23' ' ' VAL . 25.8 m -150.23 177.25 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 38.7 t -93.36 108.02 19.75 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.234 0.54 . . . . 0.0 109.91 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.9 -72.42 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.677 -0.64 . . . . 0.0 109.314 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.4 86.72 0.04 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.86 38.52 0.38 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.672 2.914 . . . . 0.0 110.904 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.33 94.66 0.01 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 37' ' ' VAL . 3.1 tt -173.39 127.97 0.43 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.545 -0.974 . . . . 0.0 109.53 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.503 ' O ' HD23 ' A' ' 36' ' ' LEU . 22.3 m -108.46 -173.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.618 -0.677 . . . . 0.0 109.476 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.06 171.52 52.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.08 167.07 25.28 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.6 tt -106.58 -21.7 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.502 -0.999 . . . . 0.0 109.959 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.75 120.64 18.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.62 87.45 0.79 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.06 -134.99 1.76 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 pt -74.33 169.24 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.49 -1.006 . . . . 0.0 109.511 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mt -88.69 96.83 10.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.547 -0.721 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.43 55.54 1.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.586 -0.696 . . . . 0.0 109.356 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.5 t -177.75 97.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.9 mt -70.04 -33.23 71.7 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -146.24 -76.78 0.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.664 -0.648 . . . . 0.0 109.75 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.3 30.47 30.63 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.2 13.14 15.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.967 . . . . 0.0 110.302 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.44 -2.47 77.56 Favored Glycine 0 N--CA 1.489 2.175 0 O-C-N 121.234 -0.916 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 4.3 ptp180 -126.28 138.08 53.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.993 -1.298 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 p -150.85 168.11 25.45 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.73 0.776 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -107.35 -28.24 9.99 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.3 p -146.89 -179.37 6.75 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.26 -37.25 86.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.0 109.996 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -68.09 -9.9 49.8 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.494 -0.754 . . . . 0.0 111.032 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.17 14.86 9.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 110.337 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' THR . 84.3 m -114.73 -170.41 1.73 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.053 -1.029 . . . . 0.0 110.093 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.7 m -115.94 -176.71 3.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.504 -0.748 . . . . 0.0 110.077 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.75 -49.81 74.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 110.112 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.1 -23.59 21.51 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.357 -0.839 . . . . 0.0 110.153 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 63.6 p -134.31 89.48 27.56 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 31' ' ' SER . 41.5 Cg_endo -83.21 8.7 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.758 2.305 . . . . 0.0 111.456 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 30' ' ' VAL . 11.9 p -125.02 145.17 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.0 110.466 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -125.83 98.9 5.72 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -126.91 145.83 50.53 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.897 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 60.09 33.88 21.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.678 . . . . 0.0 109.808 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.98 28.98 69.62 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -140.51 165.61 26.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.472 -1.016 . . . . 0.0 109.5 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.77 142.45 42.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -0.812 . . . . 0.0 110.471 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 23' ' ' VAL . 23.5 m -150.39 172.44 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.436 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 37.4 t -95.2 110.34 22.32 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.173 0.511 . . . . 0.0 109.723 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.619 ' HB3' HG11 ' A' ' 23' ' ' VAL . 38.3 p -118.8 -54.31 2.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.694 -0.629 . . . . 0.0 109.555 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.96 -80.74 0.28 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.74 -165.32 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.444 2.763 . . . . 0.0 110.372 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.62 79.85 0.32 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.439 ' O ' HD23 ' A' ' 36' ' ' LEU . 6.7 tt -148.76 86.99 1.53 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.568 -0.96 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 38' ' ' GLY . 3.3 t -113.78 166.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.571 -0.705 . . . . 0.0 109.154 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 37' ' ' VAL . . . 85.76 85.14 1.03 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.87 163.65 13.8 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 40' ' ' ILE . 47.9 mt -109.33 49.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.548 -0.972 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.6 mt -95.39 165.73 12.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.474 -0.766 . . . . 0.0 109.441 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.7 45.6 0.02 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 175.58 -117.86 0.63 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.9 pt -62.7 148.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.579 -0.954 . . . . 0.0 109.527 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.468 179.994 . . . . . . . . 0 0 . 1 stop_ save_